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Keratinocytes are the first target of infection for lymphogranuloma venereum (LGV) 
Chlamydia trachomatis, yet they have been omitted from pathogenesis studies.  We infect 
keratinocytes and cervical cells with C. trachomatis and hypothesize different growth and 
cytotoxicity profiles among the strains.  
Methods 
HaCaT human keratinocytes and ME-180 cervical cells were infected with C. trachomatis 
(multiplicity of infection (MOI) 0.025) serovars L1, L2, L3, 3 LGV clinical isolates or 
serovar E and incubated at 37 or 33°C for 5 days.  Cytotoxicity was quantified daily using 
the CytoTox96® Non-Radioactive Cytotoxicity Assay, cells stained with the MicroTrak C. 
trachomatis Culture Confirmation kit and growth quantified by area of 100X photographs 
covered by Chlamydia.  HaCaT and ME-180 cervical cells were infected with 
C. trachomatis (MOI 0.25) serovar L2 or E, incubated at 37 or 33°C for 48 hours and 
viewed with a transmission electron microscope (TEM).  Mitochondrial activity was 
quantified using the MTT assay.  The DeadEnd
TM
 Colorimetric TUNEL System with C. 
trachomatis Culture Confirmation kit as a counter-stain was used to assess cell death in 
infected versus uninfected cells.  The BioVision
TM
 CaspGLOW Fluorescein Caspase 
Staining Kit and Transwell
®
 Permeable Supports was used to differentiate between 
apoptosis mediated by cell-to-cell contact or a secreted molecule. 
Results 
Growth in ME-180 versus HaCaT cells at 37°C was similar, but slower at 33 versus 37°C 
in HaCaT cells (p < 0.05).  By day 5 L2 had grown faster than other strains in HaCaT cells 
at 37°C (p < 0.05), faster than clinical isolates in ME180 cells (p < 0.01), and faster than 
 xxi
serovar E, and 2 clinical isolates at 33°C (p < 0.01).  After 5 days L2 induced cytotoxicty 
was 11% in ME180 cells, which was higher than the clinical isolates (p < 0.01).  In HaCaT 
cells at 33°C L2 EB were identified in a non-membrane state in the cytoplasm but not in 
the inclusion at 48 hours post infection. Serovar E but not L2 caused mitochondrial 
swelling at 1 h post infection in HaCaT cells at 37°C.  This corresponded with a 16% 
reduction in mitochondrial activity (p < 0.001).   TUNEL assay analyses demonstrated 
numerous dead cells adjacent to chlamydial inclusions for strains L2 and L3 but not L1 and 
E.  An elevated number of caspase positive cells was detected in uninfected cell 
monolayers exposed to both L2 and E at 37°C but not 33°C. 
 
Conclusions 
1. C. trachomatis infects human keratinocytes in vitro. 
2. Fresh clinical isolates behaved differently to the L2 reference strain.  This demonstrates 
the need for fresh clinical isolates in pathogenesis studies of LGV. 
3. In HaCaT cells at 33°C serovar L2 EB leave the intact inclusion and migrate through 
the cytoplasm in a non-membrane bound state 
4. C. trachomatis induces apoptosis in uninfected cells exposed to infected cells via a 











CHAPTER 1 – INTRODUCTION 
 
Chlamydia trachomatis is a sexually transmitted obligate intracellular human pathogen 
with several different disease manifestations depending on the site of infection and biovar 
of the microbe present (Ward 2002).  
 
Based on their differences in disease presentation and in vitro cell growth characteristics, 
the species, C. trachomatis, has been divided into two biovars: the oculogenital (OG) 
biovar and the lymphogranuloma venereum (LGV) biovar (Ward 2002).  Due to 
differences in immunological cross-reactivity with the major outer membrane protein 
(MOMP) these biovars are further subdivided into different serovars which reflect 
differences in tissue tropism (Ward 2002).  Within the trachoma biovar, serovars A to C 
cause ocular trachoma, while serovars D to K cause genital tract infections and 
conjunctivitis (Ward 2002).  The LGV biovar, which includes serovars L1 to L3, causes 
LGV, a more invasive genital tract infection (Ward 2002). 
 
C. trachomatis replicates using a biphasic growth cycle comprising two alternating life 
forms: the extracellular, metabolically inactive, infective form called the elementary body 
(EB), and the intracellular, metabolically active, non-infective form called the reticulate 
body (RB).  Infection is initiated by attachment and entry of the EB into the host cell where 
it remains enclosed in a vesicle called an inclusion.  The EB develops into a RB and 
multiplies within the inclusion before condensing to form an EB which is released from the 
host cell by exocytosis. 
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Over the years efforts have been made to determine the exact mode of attachment and 
entry of C. trachomatis EB into their target host cells, however, despite the fact that LGV 
begins as a genital ulcer on the skin, no previous research has been published on the 
interaction of C. trachomatis with keratinocytes.  Since the mode of C. trachomatis entry 
into host cells depends on each host cell type concerned and the biovar investigated, 
(Bavoil et al 2000) it is of paramount importance that chlamydial pathogenesis studies be 
carried out on the host cell type affected in vivo.  For the LGV organism keratinocytes are 
the primary target of infection, while the cervical cells are one of the primary targets of 
infection for the urogenital OG serovars. 
 
In this study the HaCaT cell line was be utilized since it is a well characterized 
immortalized human keratinocyte cell line which has retained a similar differentiation 
pattern to that of normal keratinocytes (Boukamp et al 1988).  The ME-180 cell line, was 
used since it is a spontaneously immortalized human cervical carcinoma cell line which 
has retained the characteristic of its wild type counterparts (Sykes et al 1970). 
 
Past research has also been carried out primarily on characterized reference strains whose 
behaviour may have been altered by many years of in vitro propagation in culture systems 
and cell lines which are not the natural host.  To investigate this possibility, fresh LGV 
clinical isolates were used in addition to the LGV reference strains since the LGV 
organisms were the focus of these investigations.  One serovar E OG clinical isolate was 
used for comparison purposes. 
 
This work is of relevance in South Africa since LGV is the second most common cause of 
genital ulcers in our setting (Moodley et al, 2003) and is found in 13.6% of men (O’Farrell 
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et al 2008), and 15.4% of women (Moodley et al 2003) with ulcers.  Male chlamydial 
urethritis is also common and is detected in 16% of urethritis patients (Sturm et al 2004). 
 
The development of a more appropriate in vitro model on which to study the interaction of 
this microbe with its host cell may lead to a better understanding of C. trachomatis 
attachment and entry, which could ultimately enable the development of new and better 
methods of patient treatment. 
 
In this study we demonstrate for the first time the ability of C. trachomatis to enter and 
replicate within keratinocytes.  This was achieved in the absence of cycloheximide and at 
both 37 and 33°C.  37°C is core body temperature, while 33°C is the temperature of human 
skin.  C. trachomatis was also grown in cervical cells at 37°C.  These models of infection 
were used for the experiments. 
 
Chlamydial growth curves were set up to investigate the rate of replication of several 
chlamydial strains under conditions described above.  The lactate dehydrogenase (LDH) 
assay was used to quantify chlamydia-induced cell lysis under these same conditions.  
 
Transmission electron microscopy (TEM) was used to monitor the ultrastructural effect of 
the serovar L2 reference strain and one OG clinical isolate on their host cells. 
 
Because the results of the LDH assay and TEM analyses indicated cytotoxicity and 




The TUNEL assay, with counter staining for C. trachomatis was used to investigate the 
spatial relationship between dying and infected cells.  The MTT assay was used to quantify 
the mitochondrial degradation observed on TEM analysis.  The caspase assay coupled with 
Transwell® Permeable Supports was used to investigate whether the cytotoxic effects were 
apoptotic or not, and to determine if this occurred by cell-to-cell contact or via a secreted 
molecule. 
 
Methods which quantify apoptosis and necrosis using flow cytometry were not used 
because unlike other cell lines which are traditionally used for chlamydial studies, HaCaT 
keratinocytes are difficult to trypsinize.  This also leads to the formation of cell clumps 
which may clog the flow cytometer.  The comparatively harsh trypsinization procedure 
compared to other cell lines would increase the opportunity for the more fragile cells at the 
late stages of infection to rupture and be omitted from the analyses causing bias.   
 
Furthermore, propidium iodide staining was not used because chlamydial infection 
produces a rapid transient translocation of phosphatidylserine (Goth and Stephens 2001) 
which would lead to the detection of false positives.  Although this phenomenon is 
transient, the duration of the chlamydial replication cycle is not exact and new chlamydial 
inclusions may already begin to develop before 36 hours post infection. 
 
The aims of this study were as follows: 
• To investigate whether C. trachomatis does infect HaCaT keratinocytes  
• To establish differences in infectivity and growth rate at 37 and 33°C 
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• To investigate differences in growth between the LGV and OG strains with a focus on 
the LGV strains, and to investigate differences between the LGV reference strains and 
LGV clinical isolates over 5 days using growth curve analyses 
• To investigate the cytotoxic effect of C. trachomatis on HaCaT and ME-180 cell 
monolayers using the lactate dehydrogenase assay 
• To investigate the ultrastructural effect that C. trachomatis has on HaCaT and ME-180 
host cells 
• To quantify C. trachomatis-induced mitochondrial damage on HaCaT and ME-180 
cells using the MTT assay 
• To investigate the spatial relationship between dying cells and infected cells using the 
TUNEL assay with a counter stain for C. trachomatis 
• To determine whether caspase-mediated cell death (apoptosis) takes place, and if so, 
whether this occurs via cell-to-cell contact or a secreted molecule 
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CHAPTER 2 – LITERATURE REVIEW 
 
2.1 Historical aspects and classification of Chlamydia trachomatis 
 
Chlamydia trachomatis is a highly specialised, obligate intracellular Gram negative 
eubacterium (Weisburg et al 1986) which has left a trail of taxonomic confusion due to its 
unique characteristics.  In 1907 Halberstaedter and von Prowazek first reported inclusions 
of the trachoma agent in infected ocular material, but mistaking these organisms for 
protozoans, conferred the name Chlamydozoaceae to what they saw as “mantled animals” 
(Ward 1983, Gilbert 1996).  Hence the term Chlamydia (a cloak) is actually a misnomer, 
but has precedence in the international rules for bacterial nomenclature (Ward 1983). 
 
Although Durand, Nicolas and Favre recognised LGV as a separate venereal disease in 
1913, it was only in 1930 that the causative agent was transmitted to animals by 
Hellerström and Wassén, and in 1933 Findlay isolated the organism in mice.  Findlay also 
recognised the similarities in the growth cycle of the LGV organism with that of the 
psittacosis agent which had already been described (Ward 1983). 
 
Chlamydia was later classified, along with other filterable agents that grow in living cells, 
as viruses (Ward 1983).  They were further grouped according to their host and tissue 
tropisms and referred to as Bedsoniae and trachoma inclusion conjunctivitis (TRIC) agents, 
however this method of classification was unsatisfactory since a laboratory isolate could 
only be classified if the clinical source of the isolate was known (Ward 1983). 
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Later, once Stanier and Lwoff formulated the concepts describing the basic differences 
between viruses and bacteria, it became accepted that Chlamydiae are bacteria, not viruses, 
since they posses both DNA and RNA, and multiply by binary fission rather than self-
assembly (Moulder 1966).  These organisms are distinguished from the rickettsiae, another 
group of intracellular bacteria, by their developmental cycle, and their requirement for high 
energy compounds from their host (Weiss and Wilson 1969, Hatch 1975), as well as their 
lack of cytochromes and other components of the respiratory electron chain (Ward 1983).  
 
Although the family Chlamydiaceae was previously thought to contain a single genus, 
Chlamydia, which comprised four species: C. trachomatis, C. pneumonia, C. psittaci and 
C. pecorum; ribosomal sequence data has incited revision of this classification such that 
the family Chlamydiaceae comprises two geni: Chlamydia and Chlamydophila.  The genus 
Chlamydia comprises a two species; C. trachomatis and C. muridarum, while the genus 
Chlamydophila includes all the other Chlamydiaceae species (Ward 2002). 
 
The species C. trachomatis, however, is further subdivided into two biovars based on 
fundamental differences in their involvement in human disease, and invasiveness for cell 
culture (Ward 2002).  The oculogenital (OG) biovar includes those organisms which cause 
trachoma, inclusion conjunctivitis (TRIC agents) and genital discharge disease, while the 
lymphogranuloma venereum (LGV) biovar includes those organisms which cause the more 
invasive disease, LGV (Ward 2002, Gilbert 1996).  Each biovar is further subdivided into 
several serovars or serotypes, based on differences in the epitopes carried on the major 
outer membrane protein (MOMP) (Ward 2002).  Serovars A, B, Ba and C of the OG 
biovar cause trachoma; serovars D, Da, E, F, G, H, I, J and K of the same biovar cause 
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genital tract infection or conjunctivitis; and the LGV biovar, which comprises serovars L1, 
L2, L2a and L3, causes LGV (Ward 2002, Gilbert 1996, Wang and Grayston 1991).  
 
2.2 Clinical manifestations and epidemiology 
 
Despite enormous similarity in the genomic makeup of C. trachomatis serovars (Carlson et 
al 2004), these organisms are responsible for a wide range of disease presentations (Ward 
2002). 
 
Within the OG biovar strains A-C cause ocular trachoma.  Within the same biovar serovars 
D-K cause discharge diseases (urethritis or cervicitis) which may progress to epididymitis 
and possibly to prostatitis or pelvic inflammatory disease in males and females 
respectively. These serovars also cause inclusion conjunctivitis in neonates (Ward 2002).  
 
Serovars L1-L3 within the LGV biovar cause LGV.  This more invasive genital tract 
infection begins as a painless genital ulcer or papule in the skin in the primary stage, and 
then progresses to the secondary stage which is usually characterised by inguinal 
lymphadenopathy (Schachter and Osoba 1983).  A tertiary stage or genito-anorectal 
syndrome may follow.  This is usually associated with hypertropic and necrotic lymphnode 
packages, occasionally resulting in elephantiasis.  Although patients classically present in 
the secondary stage (Schachter et al 1969), in our setting they usually present in the 
primary stage with chancroid-like lesions that are usually painful rather than painless 
(Sturm et al 2005).  Several cases of proctitis caused by the LGV biovar have recently 
been reported from developed countries, particularly amongst men who have sex with men 
(Nieuwenhuis et al 2004).  This disease is characterised by rectal ulceration with a purulent 
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anal discharge and fever, lower abdominal pain and tenesmus (Workowski and Berman 
2007). 
 
C. trachomatis infection is a world-wide problem.  In the USA, about 3 million cases 
(serovars D-K) occur annually (Workowski and Berman 2007) and the prevalence varies in 
different parts of the world (Johnson et al, 2005, Behets et al, 1999). 
 
LGV is of particular interest in South Africa since it is the second most common cause of 
genital ulcers (Moodley et al 2003) and the occurance has increased over the past few 
years. LGV is found 13.6% of men (O’Farrell et al 2008) and 15.4% of women (Moodley 
et al 2003) with genital ulcers.  Chlamydia is detected in 16% of male patients with 
urethritis (Sturm et al 2004). 
 
The Centers for Disease Control and Prevention (CDC) treatment guidelines for 2007 
indicate azithromycin or doxycycline for the treatment of C. trachomatis infection 
(Workowski and Berman 2007).  In South Africa LGV is treated according to local 
syndromic management guidelines for genital ulcer disease (Moodley et al 2003).  These 
guidelines advise the use of erythromycin and benzathine penicillin for the treatment of 
genital ulcer disease. The spectrum of erythromycin includes LGV. 
 
2.3 Laboratory diagnosis 
 
2.3.1 Specimen collection and transport 
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Due to the fastidious nature of the organism, proper specimen collection and transport is 
vital.  The collected specimen must contain epithelial cells which harbour the organism, 
and a cold chain of transport must be maintained to preserve viability of the organism for 
culture (reviewed in Black 1997).  
 
2.3.2 Cultural methods 
 
Culture has a specificity of almost 100%, and until recently was considered the “gold 
standard” for the detection of C. trachomatis in urogenital specimens (reviewed in Black 
1997).  Due to its relatively low sensitivity (70 – 85%) compared with DNA amplification 
tests, stringent requirement of refrigerated specimen transport as well as the fact that it is 
expensive, requires a high level of technical expertise and takes 3 to 7 days before results 
are available, culture has largely been replaced by nucleic acid amplification techniques 
(reviewed in Black 1997). 
 
Before modern day tissue culture technology LGV C. trachomatis was cultured in the 
brains of mice, then later in the yolk sac of hens’ eggs (Shaffer et al 1944). 
 
Nowadays, C. trachomatis is cultured in cell culture monolayers, usually McCoy or HeLa 
229 cells.  To allow the chlamydia to successfully compete with the host cell’s metabolism, 
the monolayers are pretreated with cycloheximide, DEAE-dextran or irradiation and the 
inoculum centrifuged onto the monolayer. Both these steps enhance the rate of detection 
(reviewed in Black 1997).  Cultures are incubated for 48 to 72 hours, and inclusions 
visualized by staining with fluorescently labelled antibodies directed against the 
chlamydial lipopolysaccharide (LPS) for identification of all chlamydial species, or the 
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major outer membrane protein (MOMP) for C. trachomatis-species identification.  It is the 
distinctive morphology of the inclusions with this fluorescent stain that accounts for the 
near 100% specificity. This identification test does not differentiate between the serovars 
(Black 1997). 
 
Although the OG strains target the cervical, urethral and conjunctival epithelium, while the 
LGV strains target keratinocytes and lymphocytes, infection in in vitro cell culture does 
not always reflect these tissue tropisms.  Although the growth rate in in vitro cell culture 
systems does reflect the tissue tropisms of each pathotype i.e. LGV strains replicate more 
rapidly, followed by OG strains isolated from the genitalia and lastly the trachoma causing-
OG strains (Miyairi et al 2006). 
 
2.3.3 Non-cultural Methods 
 
In the 1980’s antigen and nucleic acid detection technologies were developed and found 
widespread applications in diagnosis due to the reduced requirements in cost, expertise, 
preservation of infectivity during transport, and the time required to obtain results (Black 
1997).  Due to the technical difficulties of culture techniques, many papers report that these 
tests are more sensitive than culture, revealing that the prevalence of C. trachomatis in 
most populations is higher than was previously believed (Black 1997). 
 
There are numerous non-culture diagnostic tests available based on a wide variety of 
technologies: nucleic acid amplification, direct visualisation of the organism by staining 
with fluorescein-labelled specific antibodies, immunohistochemical detection of the 
antigens and detection of hybridization to a DNA probe (Black 1997). 
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Chlamydia trachomatis is a small Gram negative bacterium suited to its intracellular 
lifestyle with a biphasic developmental cycle comprising two ultrastructurally and 
metabolically distinct forms, the elementary body (EB) and the reticulate body (RB). 
 
2.4.1.1 Elementary Body 
 
The EB is responsible for the infectious stage of the developmental cycle and is more 
compact and osmotically stable than the RB to withstand environmental stress during 
passage from one host cell to another (Ward 1983, Ward 2002).  It is spherical with a 
diameter of 300-350nm (Ward 2002).  Since this developmental form is metabolically and 
transcriptionally inert, it has a compact DNA core tightly bound to three different DNA 
binding proteins (Wagar and Stephens 1988).  Of these, the Hc1 protein is homologous to 
eukaryotic histone H1 protein (Hackstadt et al 1991, Tao et al 1991).  This condensed 
DNA core occupies most of the cell and there is little cytoplasm. 
 
2.4.1.2 Reticulate body 
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The RB, which is the osmotically fragile, metabolically active intracellular replicating 
form of C. trachomatis is larger than the EB, pleomorphic in shape, and has a diameter of 
about 1µm (Ward 2002, Ward 1983).  Since chlamydial organisms in this stage are 
metabolically active, the nucleoid is diffuse and does not contain the chlamydial histone 
analogue found in the EB (Hackstadt et al 1991).  The diffuse nucleiod allows for 
transcription and the cytoplasm is rich in ribosomes which synthesise protein (Ward 2002).  
While replicating, RB are located on the periphery of the inclusion in close association 
with the inclusion membrane (Peterson and de la Maza, 1988).  During this time the region 
of the RB in contact with the inclusion membrane exhibits an apparently rigid structure 
(Peterson and de la Maza, 1988).  The double trilaminar membrane is well-defined and 
appears to be septated by electron dense structures which connect the two membranes 
(Peterson and de la Maza, 1988).  Wyrick (2000) suggested that these electron-dense 
structures connecting the two membranes may be a type III secretion system. 
 
2.4.1.3 Architecture of the cell envelope 
 
Like typical Gram-negative bacteria, chlamydial EB and RB are enclosed in an inner 
cytoplasmic membrane and an external cell wall covered with projections and rosettes on 
the external surface (Ward 1983).  In addition, the EB cell envelope comprises an 
additional layer not detected in RB, termed the periplasmic or P layer which is composed 
of regularly arranged hexagonal subunits located on the internal surface of the cell wall 
(Matsumoto and Manire 1970).   
 
The chlamydial cell wall is comprised of chlamydial lipopolysaccharide (LPS) which 
shares 2 of the 3 antigenic domains with typical bacterial LPS (Weisburg et al 1986). 
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Since the primary purpose of the cell wall is to protect the EB while outside the host cell, it 
is a highly specialised structure which unlike other Gram negative eubacteria, contains 
almost no detectable muramic acid (Ghuysen and Goffin 1999, Barbour et al 1982).  
Instead, the EB outer envelope is thought to derive its rigidity and resistance to osmotic 
pressure from sulphur bridges between the cysteine-rich proteins present in the outer 
envelope (Bavoil et al 1984, Newhall and Jones 1983). 
 
The major outer membrane protein (MOMP) is a ~40 kDa protein present on the outer 
envelope of both EB and RB (Hatch et al, 1984).  MOMP has heterogeneity in four 
hypervariable segments which confer different antigenic properties to C. trachomatis 
strains and allow classification of these strains into different serovars (Stothard et al 1998). 
Serovars can be identified by means of the micro-immunofluorescence test (Wang et al 
1973) or by sequencing of the hypervariable regions in the genome (Stephens et al 1988, 
Sturm-Ramirez et al 2000).  
 
Chlamydia also produce a genus specific lipopolysaccharide (LPS) on their outer 
membrane (Brade et al 1985) composed of a linear trisaccharide of 3-deoxy-D-manno-
octulosonic acid (KDO) linked to a lipid A moiety (Brade et al 1987, Rund et al 1999, 
Nurminen et al  1985).  Chlamydial LPS differs from that of typical Gram negative LPS in 
that the chlamydial lipid A moiety has five not six fatty acyl groups, its fatty acyl groups 
are longer, and it contains normal fatty acids instead of hydroxyl fatty acids which are 
directly linked to the carbohydrate region via an ester linkage (Qureshi et al 1997).  These 
differences between typical LPS and chlamydial LPS may be responsible for the reduced 
level of endotoxic activity which chlamydial LPS produces compared to typical bacterial 
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LPS (Heine et al 2003).  This reduced proinflammatroy response due to an altered LPS 
structure allows chlamydia to establish asympotomatic cervicitis and subsequently ascend 
up the genital tract to previously sterile sites (Ingalls et al 1995) and cause infertility either 
due to scarring of the fallopian tubes (Ingalls et al 1995) or by inducing apoptosis of sperm 
cells (Eley et al 2005).  
 
2.4.2 Developmental cycle 
 
Chlamydial infection is initiated by the attachment of an EB to a host cell, usually at the 
base of the microvilli (Ward 2002).  With the OG biovar entry is facilitated by 
microfilaments, while entry of the LGV organisms is thought to be independent of the 
cytoskeleton (Schramm and Wyrick 1995).  The organism becomes incorporated into a 
vacuole termed an inclusion.  It escapes the endocytic pathway to the exocytic pathway 
and the inclusion is translocated to the perinuclear region (Wyrick 2000).  This 
parasitophorous vacuole does not fuse with the hosts lysosomes (Friis 1972, Scidmore et 
al. 1996).  At 6 to 9 hours after entry the EB expands, the DNA in the dense core unravels 
and becomes diffuse, ribosomes are synthesised and a RB is formed (Ward 1983).  RB 
replicate by binary fission with a doubling time of about 2.4 hours (Miyairi et al 2006).  
During this time the chlamydial inclusion intercepts sphingomyelin and cholesterol from 
the host’s exocytic pathway (Hackstadt et al 1995).  After 24 to 40 hours some RB begin to 
reorganise and form intermediate bodies that develop into EB.  During this time the DNA 
is recondensed to form a tight core (Ward 1983).  EB are then released from infected host 
cells by exocytosis in the case of the OG strains, or cell lysis in the case of the LGV strains 
(Todd and Caldwell 1985). 
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In the presence of nutrient deficiency, and certain antimicrobial agents and immunological 
factors, the replication cycle may be paused in vitro until favourable conditions return.  
This condition, known as persistence, is characterised by organisms in a non-infectious but 
viable state.  During this time RB display an altered morphology.  They may be swollen or 




The chlamydial genome is relatively small.  In the case of C. trachomatis, the genome 
comprises a 1042519 base pair chromosome (59% A + T) and 7493 base pair plasmid 
(Stephens et al 1998).  Analysis of the sequenced genome identified 894 likely protein 
coding genes.  The functions of 604 putative proteins could be inferred, 35 were similar to 
hypothetical proteins of other bacteria and 255 were not similar to any sequences deposited 
in GenBank (Stephens et al 1998).   
 
Key genetic features of the C. trachomatis genome (Stephens et al 1998) are listed in table 
1. 
 
Table 1. Key genetic features of the C. trachomatis genome 
Gene function Status within the genome 
DNA replication, repair, transcription and translation, as 
well as helicases 
Genes present 
Glycolytic pathway Genes present except one 
Hexose monophosphate shunt Genes present 
Tricarboxylic acid (TCA) cycle Many genes are missing 
Aerobic respiration Genes present 
ADP/ATP translocases Two genes present 
Amino acid biosynthesis Few genes present 
ABC transporters for amino acids and oligopeptides with 
Na+ and H+ amino acid symporters 
Thirteen genes present 
Permeases for magnesium, phosphate, nitrate and sulphate Genes present 
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Fatty acid and phospholipids synthesis Numerous genes present 
Complete peptidoglycan synthesis, membrane assembly 
and recycling 
Genes present 
Disulphide bond isomerases Five genes present 
Polymorphic outer membrane proteins Nine genes present 
Complete type III secretion system Genes present 
Complete synthesis of purine and pyrimidine nucleotides Genes absent except for 
cytosine triphosphate 
Interconversion of deoxyribonucleotides Genes present except for 
thymidylate synthase 
Transformation and acquisition of exogenous DNA or 




Phylogenetic analyses of the C. trachomatis genome indicates that Chlamydia represent a 
distinct bacterial lineage (Stephens et al 1998).  Several features of the genome suggest 
horizontal gene transfer from both bacterial ancestors and eukaryotic hosts.  There are 35 
protein coding sequences, mainly house keeping genes, which are phylogenetically 
grouped with eukaryotic homologues.  This is a higher frequency than detected in the 
sequenced genomes of other bacterial pathogens (Stephens et al 1998). 
 
Genetic variability amongst chlamydial genomes occurs predominantly in a region about 
50 kb in length, dubbed the “plasticity zone” (PZ) (Read et al, 2000).  This region houses 
the genes for a toxin similar to clostridial toxin B.  C. trachomatis (mouse pneumonitis 
(MoPn) strain) encodes the full gene, serovar D possesses a deletion but the region 
encoding the enzymatic active site remains; while most of this gene is absent in serovar L2 
(Belland et al, 2001).  Both C. trachomatis serovar D and MoPn encode genes for 
phospholipase D-endonuclease in this region (Read et al, 2000).  Genes encoding purine 
interconversion are present in the MoPn strain but absent in serovar D (Read et al, 2000). 
Genes encoding tryptophan biosynthesis are present in serovar D but absent in the MoPn 
strain (Read et al, 2000).  Clinical isolates obtained from the genitalia have been  shown to 
encode a gene for the production functional tryptophan synthase, while this gene in ocular 
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isolates has an insertion which results in a frame shift and encodes nonfunctional 
tryptophan synthase (Caldwell et al, 2003). 
 
2.4.4 Gene expression 
 
A study by Shaw et al (2000) has indicated the presence of three temporal classes of 
C. trachomatis gene expression.  The authors selected 70 genes identified from the 
published sequence for the serovar D genome (Stephens et al 1998), but used serovar L2 
for their analyses. 
 
Three temporal classes of gene expression were described (Shaw et al 2000).  Early genes 
were transcribed by 2 hours after infection, mid-cycle gene products were not present at 2 
or 6 hours post infection, but were present at 12 hours, and late gene expression included 
those gene products first detected at 20 hours post infection. 
 
Genes involved in DNA replication, transcription, translation and protein modification are 
transcribed early in the developmental cycle.  Many confirmed or putative inclusion 
membrane proteins (Inc) are expressed by 2 hours post infection.  These include IncB to 
IncG as well as the putative inclusion membrane proteins with their characteristic 
hydrophobic transmembrane domains.  Genes encoding macromolecular synthesis, 
subunits of RNA and DNA polymerase, 16S ribosomal RNA, recA and the chlamydial heat 
shock protein (HSP) 60 homologue are transcribed early.  These findings are consistent 
with the reported early transcription of ribosomal subunits by Gerard et al 1997.  The 
ATP/ADP translocase and ribonucleosidetriphosphate/H+ symporter was also expressed 
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early (Shaw et al 2000), as was gigG, a gene encoding an enzyme necessary for glycogen 
synthesis, and yjjK, which encodes an ABC transporter homologue (Shaw et al 2000). 
 
Genes encoding intermediate metabolism, such as pyk, eno and sdhA of the glycolytic 
pathway and pentose phosphate shunt are not expressed until mid-cycle.  This is confirmed 
by the study of Iliffe-Lee and McClarty (1999) which reported delayed expression of the 
glycolytic pathway and pentose phosphate shunt enzymes encoded by gap, zwf and pgk, 
which coincided with pyk expression.  At mid-cycle genes encoding structural proteins 
such as MOMP, outer membrane protein 2, peptidoglycan and LPS are expressed, as well 
as the type III secretion system genes, yscJ and yscN.  IncA is also transcribed and thought 
to mediate homotypic fusion of chlamydial inclusions (Hackstadt et al 1999).  Nine other 
predicted inclusion membrane proteins are also expressed (Shaw et al 2000). 
 
Finally, at 20 h post infection genes involved in the switch of RB back to EB are 
expressed.  These include Hc1, the chlamydial histone H1 analogue, and the cysteine rich 




C. trachomatis exerts a pathogenic effect firstly, by creating an intracellular niche to hide 
from the immune system while within the host cell (Giles and Wyrick 2008).  The 
organism is pathogenic in its interaction with its host cell, during release from the host cell, 
and by affecting neighbouring uninfected cells. 
 
2.5.1 Creation of an intracellular niche 
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EB uptake is initiated when an EB binds to the tips of microvilli on susceptible cells, and 
becomes internalized via coated pits at the base of the microvilli (Hodinka et al 1988, 
Hodinka and Wyrick 1986, Wyrick et al 1989).  Serovar E may require host cell 
microfilaments to internalise clathrin-coated pits on the apicial membrane for endocytosis 
(Schramm and Wyrick 1995).  Since L2 can enter cells without an intact cytoskeleton, 
these organisms may also enter via a receptor which does not require the cytoskeleton for 
uptake (Schramm and Wyrick 1995).  Molecules which enter without clathrin-coated pits 
have been shown to enter the same endocytic vesicles as molecules which enter via 
clathrin-coated pits (Hansen et al 1993).  The LGV organisms may thus utilize more than 
one mechanism of entry on apical and basolateral surfaces (Schramm and Wyrick 1995).  
However, after uptake, the L2 organisms appear to require an intact cytoskeleton for fusion 
of inclusions in cells where multiple EB have entered, but serovar E does not (Schramm 
and Wyrick 1995).  Several studies have tried to to elucidate the mechanism of attachment 
of the organism to its host cell.  A number of proposed antigens have been described, but 
their role in chlamydial entry into the cell is not confirmed. 
 
Chlamydia are unique compared to other intracellular bacteria in that its entry into 
epithelial host cells appears to be silent; proinflammatory cytokines are not secreted on 
entry but only from 8 hours and continue through the developmental cycle (Rasmussen et 
al 1997).  This phenomenon may be due to the small size (350 nm) compared to other 
bacteria (Rasmussen et al 1997). 
 
Once the organism has entered it prevents lysosomal fusion and escapes the endocytic 
pathway.  This is a chlamydia-mediated event which requires chlamydia protein synthesis 
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(Scidmore et al. 1996).  Even opsonised C. trachomatis EB which enter HeLa 229 cells by 
Fc-mediated endocytosis have been shown to escape lysosomal death and undergo a 
normal replication cycle (Scidmore et al. 1996).  Evasion of the endocytic pathway is 
likely to occur in two stages: via an intrinsic property of EB, followed by chlamydial 
protein synthesis (reviewed in Fields et al 2002).  In a reverse transcriptase PCR based 
study, 29 of the 39 putative inclusion membrane proteins were already expressed just 2 
hours post-infection (Shaw et al 2000).  This indicates that chlamydia significantly modify 
their inclusions upon entry to ensure a suitable niche prior to replication (Fields et al 
2002).  
 
2.5.2 Interaction with host cell processes 
 
A microarray study by Xia et al (2003) revealed that C. trachomatis serovar L2 infection 
of HeLa 229 cells alters the expression of 13 host cell genes by 2 h post infection, and 130 
genes at 16 h post infection.  These genes encode cytoskeletal components, metabolic 
enzymes, factors which regulate cell differentiation, transcription factors and inhibition of 
apoptosis factor, as well as proinflammatory cytokines.  This clearly indicates that despite 
being sequestered within a membrane-bound inclusion, C. trachomatis is able to modulate 
numerous host cell processes. 
 
2.5.2.1 Inclusion membrane 
 
The inclusion membrane is important in the pathogenesis of C. trachomatis infection since 
it serves as the interface between the organism and its host cell.  Since C. trachomatis 
prevents fusion with host lysosomes, the chlamydial inclusion is non-lysosomal (Friis 
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1972).  Instead it interacts with the exocytic pathway.  Sphingomyelin is transported from 
the trans-Golgi to the chlamydial inclusion where it becomes incorporated at the inner face 
of the inclusion membrane and ultimately becomes part of the chlamydial cell walls 
(Hackstadt et al 1995).  Cholesterol (Carabeo et al 2003) and phospholipids (Wylie et al 
1997) are also acquired by the organism.   
 
The C. trachomatis inclusion membrane is modified by numerous inclusion membrane 
proteins termed Incs (Scidmore-Carlson et al. 1999).  The common feature amongst Inc 
proteins is a predicted hydrophobic domain comprising about 40 amino acids (Scidmore-
Carlson et al. 1999), but there is little or no sequence homology even within the 
hydrophobic domain (Bannantine et al 2000).  Studies have shown the presence of 5 Inc 
proteins located on the cytoplasmic face of C. trachomatis inclusions (Hackstadt et al. 
1999, Field and Hackstadt 2002).  This allows interaction with host cell proteins such as 
14-3-3β, a eukaryotic protein which is part of a highly conserved family of dimeric 
phosphoserine-binding proteins responsible for signal transduction (Scidmore and 
Hackstadt 2001).  14-3-3β binds IncG in the C. trachomatis inclusion, but neither 
C. psittaci nor C. pneumoniae express IncG, and 14-3-3β does not bind to their inclusion 
membrane (Scidmore and Hackstadt 2001). 
 
Other inclusion membrane proteins without the hydrophobic domain which characterizes 
Inc proteins have also been associated with the chlamydial inclusion.  These include CopN 
which is part of the chlamydial type III secretion system (Fields and Hackstadt 2000) and 
Cap1 (Fling et al. 2001). 
 
2.5.2.2 Type III secretion system 
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Like many other pathogenic gram-negative bacteria, C. trachomatis encodes (Stephens et 
al. 1998) and expresses (Fields and Hackstadt 2000) genes for a type III or contact-
dependent secretion system (TTSS). 
 
Although the exact role of the TTSS in chlamydia has not been demonstrated, such a 
structure is crucial in the translocation of chlamydial enzymes to the host cytoplasm 
enabling it to modify host cell processes.  Chlamydial antigens including MOMP, LPS and 
IncA have been detected in the endoplasmic reticulum of the host (Giles and Wyrick 
2008). 
 
Although genes encoding a TTSS are only expressed at mid-cycle, the surface projections 
present on EB and RB may correspond to a TTSS.  Purification of projections from EB 
produced structures similar to the purified parts of a Salmonella typhimurium TTSS 
(Kubori et al. 1998).  This TTSS may be involved in attachment and entry into susceptible 
hosts possibly by injecting substances through the host cell to mobilize the cytoskeleton 
and facilitate uptake of the organism (Wyrick 2000).  Wyrick (2000) also suggested that 
the region of the well defined double trilaminar membrane may represent the TTSS.  
 
2.5.2.3 Acquisition of energy and nutrients 
 
Historically Chlamydiae were classified as energy parasites, but more recent data has 
indicated that chlamydiae can synthesise ATP (see Read et al. 2000, Stephens et al. 1998, 
Iliffe-Lee & McClarty 1999).   However, many intermediate metabolic genes are only 
expressed at mid-cycle (Iliffe-Lee & McClarty 1999, Shaw et al. 2000); while the ATP-
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ADP exchange mechanism described by Hatch et al (1982) is expressed early in the 
developmental cycle (Shaw et al. 2000) and mitochondrial activity has been shown to 
increase in C. trachomatis infected HeLa cells (Hatch & McClarty 1998). 
 
Chlamydia acquire precursors such as nucleotides and amino acids (Hatch et al 1982, 
Hatch 1975), but the method of uptake is not clear.  Grieshaber et al (2002) demonstrated 
the possibility that the inclusion membrane may be permeable to cytoplasmic ions, but 
Heinzen and Hackstadt (1997) report that this membrane is impermeable to molecules 
ranging from 520 D to 500 kD.  Genes encoding peptide transporters are present, but their 
occurrence on the inclusion membrane has not been confirmed (Stephens et al. 1998). 
 
Like other pathogenic bacteria, iron is essential for chlamydial growth (Freidank et al 
2001, Al-Younes et al 2001). Endosomes with transferrin-transferrin receptor complexes 
have been identified in close association with the chlamydial inclusion (van Ooij et al 
1997), but since these endosomes do not appear to fuse with the inclusion, the mechanism 
of iron acquisition by chlamydia is uncertain (Raulston 1997).  Endosomes with 
transferrin-transferrin receptor complexes have been shown to release Fe2+ into the 
cytoplasm upon acidification of the vesicle and reduction (Núnez et al 1990).  Since these 
endosomes containing transferrin and its receptor have been identified in close proximity 
to the chlamydial inclusion (van Ooij et al 1997, Al-Younes et al 2001) and since the 
inclusion membrane has been shown to be permeable by ions (Grieshaber et al, 2002), Fe2+ 
may be transported to the inclusion membrane by endosomes.  Fe2+ may then be released 




As the number of organisms within the inclusion increases, chlamydia compete with their 
host cells for nutrients.  When many organisms are present host cell replication may be 
halted (Horoschak and Moulder 1978).  Replication is slowed down or unaffected by low 
numbers of organisms and either one or both daughter cells may house a chlamydial 
inclusion after mitosis (Horoschak and Moulder 1978, Bose and Liebhaber 1979). 
 
2.5.2.4 Reorganisation of the host cytoskeleton and organelles 
 
The developing chlamydial inclusion affects the ultrastructural organization of its host.  As 
the inclusion of replicating bacteria grows, it pushes the nucleus aside.  Mitochondria and 
endoplasmic reticulum are located in close proximity to the inclusion, to meet the needs of 
the replicating bacteria (Peterson and de la Maza 1988). 
 
A chlamydia-induced effect on the cytoskeleton occurs before the EB has even been 
internalized.  Attachment of EB to microvilli initiates the phosphorylation of proteins 
(Birkelund et al. 1994) and mobilisation of actin (Fawaz et al. 1997), resulting in the 
internalisation of the organism (OG biovar) (Schramm and Wyrick 1995).  Microfilaments, 
microtubules, and motor protein dynein then mobilise the inclusion to the perinuclear 
region (Schramm and Wyrick 1995).  Annexins located in the peri-inclusion region may 
facilitate movement or interactions with the inclusion (Majeed et al. 1994). 
 
2.5.2.5 Chlamydial toxin 
 
Immediate toxicity of cell culture monolayers infected at a high MOI has been reported 
(Kuo CC 1978, Moulder et al 1976) as well as rapid death of mice infected with a high 
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inoculum of chlamydia (Rake and Jones, 1944), but until relatively recently a chlamydial 
toxin was not described. 
 
In 2001 Belland et al reported the presence of a preformed cytotoxin located within the EB 
of C. trachomatis serovar D but not L2.  This cytotoxin shares significant homology with 
the large cytotoxins (LCT) A and B produced by Clostridium difficile (Busch et al, 2000) 
which disrupts the actin cytoskeleton and intracellular trafficking (von Eichel-Streiber et al 
1996).  While the mouse strain encoded the full-length clostridial toxin B, serovar D 
encoded a shorter protein which only showed homology to the toxin active site. Serovar L2 
exhibited a larger deletion rendering the transcript non-functional. 
 
Cells infected with serovar D EB at high MOI showed cell rounding and actin 
depolymerization compared to serovar L2 infected cells which retained their shape and 
cytoskeletal arrangement.  This effect occurred independently of EB viability and protein 
sysnthesis, indicating that the toxin was transcribed prior to infection of the new host cell. 
 
The abridged gene is present in serovars D-K of OG biovar, while a functional gene is 
absent in serovars L1-L3 of the LGV biovar (Carlson et al, 2004). 
 
2.5.3 Release from the host cell 
 
 
Given that strains from the LGV biovar cause ulcers, the mechanism of release from the 
host cell can be a pathogenic factor. 
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C. trachomatis release from host cells occurs via 2 distinct pathways with different 
outcomes.  Host cell lysis causes death of the host cell while extrusion does not (Hybiske 
and Stephens 2007).  Both processes have been investigated by Hybiske and Stephens 
(2007). 
 
Cell lysis is a relatively rapid process (about 20 min) involving an ordered set of protease 
dependent events (Hybiske and Stephens 2007).  First the inclusion membrane ruptures, 
followed by permeablisation of cellular organelles and finally the cell membrane.  This 
final step is Ca2+ dependent. 
 
Extrusion involves the packaged release of organisms leaving the host cell intact.  Three 
signature events have been described.  First, a portion of the membrane bound inclusion 
projects out of the cell; the inclusion is pinched off into separate compartments; and this 
pinched off, protruded inclusion is then attached to the cell periphery.  This process is 
dependent on actin polymerisation, the actin nucleation factor Neuronal Wiskott-Aldrich 
Syndrome Protein (N-WASP), Myosin II and Rho GTPase.  After 2-3 hours membrane 
bound chlamydial particles are released.  Extrusion may be beneficial to the organism in 
that chlamydial particles are shielded from the dangers of the extracellular environment 
allowing a longer period before invading a new susceptible host. 
 
Prior to the study by Hybiske and Stephens (2007), Todd and Caldwell (1985) described 
cell lysis and exocytosis as the mechanisms of C. trachomatis release from their host cells.  
Exocytosis may present a third mechanism by which chlamydia are released from their 
host cells.  The large cavern-like crypts observed on the surface of cells infected with an 
OG isolate late in the developmental (Todd and Caldwell 1985) are unlikely to be 
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synonymous with the protrusions described by Hybiske and Stevens (2007).  It is possible 
that different methods of release occur in vitro depending on the cell type, strain and 
culture conditions.  Hybiske and Stephens (2007) report the occurrence of extrusion and 
lysis in cell monolayers infected with an OG strain and an LGV strain, while Todd and 
Caldwell (1985) report lysis as the only method of EB release with the LGV biovar. 
 
These two biovars also show differences in pathogenicity in terms of the surface from 
which they are released.  While the OG strains are released from the apical surface of their 
host cell, LGV strains may also be released from the basolateral surface of polarised cells 
(Wyrick et al 1989).  This would enable the LGV strains to penetrate the epithelium to 
infect the underlying tissue and ultimately migrate to the lymph nodes. 
 
2.5.4 Effect on neighbouring uninfected cells 
 
The effect of C. trachomatis infection on neighbouring uninfected cells has not been 
widely investigated, however the organism does, either directly or indirectly, result in a 
pathogenic effect on uninfected neighbouring cells.  Schöier et al (2001) and Greene et al 
(2004) demonstrated the presence of apoptotic uninfected cells in monolayers infected with 
C. trachomatis.  This effect may be mediated indirectly since infected epithelial cells have 
been shown to secrete proinflammatory cytokines (Rasmussen et al 1997).  The fact that 
extra-inclusion vesicles have been detected in the cytoplasm of infected cells (Giles et al 
2006) indicates the possibility that chlamydia may affect neighbouring uninfected cells via 
a chlamydial molecule which is secreted by the host cell. 
 
2.6 Interaction with the immune system 
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Chlamydia attempt to hide from the immune system, but both innate and adaptive immune 
responses are mounted.  While the immune system identifies and eliminates pathogens, in 
the case of C. trachomatis the immune response contributes to tissue pathology and 
severity of disease (Roan and Starnbach 2008). 
 
2.6.1 Innate immunity 
 
Although they are not professional antigen presenting cells, epithelial cells of the genital 
tract possess features of innate immunity (Quale 2002).  These cells can recognise antigens 
via the presence of MHC class I and II, mediate bacterial and viral killing, and respond to 
and secrete chemokines to recruit leukocytes (Quale 2002). 
 
Chlamydia infection can induce the production of a range of proinflammatory cytokines, 
including interleukin-6 (IL-6), IL-8 and granulocyte-macrophage colony-stimulating factor 
(GM-CSF) (Rasmussen et al 1997), as well as IL-1 and tumour necrosis factor-α (TNF-α) 
(Dessus-Babus et al 2002).  IL-8 recruits neutrophils to the site of infection (Taub et al, 
1996) and these recruited cells secrete more cytokines such as TNF-α (Dessus-Babus et al 
2002).  Although TNF-α can restrict the growth of C. trachomatis, elevated levels of TNF-
α and IL-6 may cause increased pathology (Darville et al 2003).  NK cells migrate to the 
site of infection quickly where they lyse infected cells and produce interferon-γ (INF-γ) 
(Tseng and Rank 1998). 
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INF-γ has been shown to inhibit replication of all C. trachomatis serovars in vitro, but 
some serovars are more susceptible to INF-γ-induced effects than others (Morrison 2000).  
INF-γ restricts chlamydial growth in the following ways: 
• Up regulation of the IFN-γ-inducible nitric oxide (NO) synthase pathway (Igietseme et 
al 1997).  NO has been shown to inhibit the intraepithelial replication of C. trachomatis 
serovars E, H and L2 (Igietseme et al 1997). 
• Induction of indoleamine 2,3-dioxygenase (IDO) which catabolises tryptophan (Taylor 
and Feng 1991).  A reduction in the intracellular tryptophan pools restricts chlamydia 
replication (Byrne et al 1986) and may induce a state of persistent infection (Beatty et 
al 1994a).  Genital isolates of C. trachomatis are resistant to this method of INF-γ 
restriction due to functional tryptophan synthase enabling these strains to synthesise 
tryptophan from indole unlike the ocular trachoma strains (Caldwell et al 2003). 
• Inhibition of sphingomyelin acquisition (serovar L2) (Nelson et al, 2005) 
• Down regulation of intracellular ferritin, the protein responsible for iron storage by 
cells (Byrd and Horwitz, 1993).  This may restrict the growth of C. trachomatis due to 
iron starvation (Freidank et al, 2001) 
• Increase the phagocytic activity of macrophages by up regulation of MHC class II 
expression (Zhong and de la Maza, 1988) 
 
The link between the innate and adaptive immune response are dendritic cells (DC) which 
process and present chlamydial antigens to T cells (Steele et al 2004). 
 
2.6.2 Adaptive Immunity 
 
A B cell response is mounted against chlamydia. Although it doesn’t prevent subsequent 
infection, B cell deficient mice are slightly more susceptible to subsequent infection than 
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wild type mice (Su et al 1997, Williams et al 1997).  Although antibodies can neutralize 
extracellular organisms, both CD4+ and CD8+ T cells are required for eliminating 
intracellular chlamydia (Starnbach et al 1994, Su and Caldwell 1995, Roan and Starnbach 
2006).  The CD4+ T cells recognize chlamydial antigen bound to MHC class II on the 
surface of antigen presenting cells (Roan and Starnbach 2006), while the CD8+ T cells 
recognise chlamydial antigen bound to MHC class I molecules presented on the surface of 
the infected cells (Cresswell et al 2005). 
 
C. trachomatis has been shown to interfere with antigen presentation.  Serovar L2 was 
shown to down regulate INF-γ-inducible MHC class II by degrading upstream stimulatory 
factor (USF)-1 (Zhong et al 1999).  This in turn prevents the induction of class II 
transactivator (CIITA) which is required for expression of INF-γ-induced MHC class II 
molecules (Zhong et al 1999).  The same strain of C. trachomatis LGV biovar has been 
shown to suppress both the constitutive and INF-γ-induced expression of MHC class I 
molecules on infected cells (Zhong et al 2000).  This is mediated by the degradation of 
RFX5 by chlamydial proteasome-like activity in the host cell cytoplasm (Zhong et al 
2001).  Decreased levels of antigen presentation of MHC class I and II molecules would 
limit the ability of CD8+ and CD4+ T cells to recognise infected cells and professional 
antigen presenting cells respectively (Roan and Starnbach 2008).  This may also increase 
the likelihood of NK cell mediated lysis which has been shown in vitro (Hook et al, 2004).  
It is possible the MHC class I molecule down regulation may also be mediated by 
deubiquitinases (DUB) encoded by the C. trachomatis genome (Misaghi et al. 2006).  If 
transcribed these proteins could target host cell ubiquitin thereby interfering with antigen 
presentation (Roan and Starnbach 2008). 
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CD4+ T cells exist as two clones, T helper type (Th) 1 and Th2.  The Th1 cells produce 
INF-γ which assists in the clearance of chlamydia (Perry et al 1997).  Th2 cells enhance 
antibody production but do not aid clearance of the organism (Perry et al 1997, Hawkins et 
al 2002).  When the Th1 response is insufficient and the organism is not cleared, sustained 
high levels of inflammatory cytokines can cause tissue damage (Perfettini et al, 2003a).  




Like CD4+ T cells, CD8+ T cells can produce INF-γ to mediate intra-cellular kill of the 
organism.  It is only these chlamydia-specific CD8+ T cells capable of producing INF-γ 
which have this effect (Roan et al., 2006).  CD8+ T cells also recognize chlamydia-infected 
cells via presentation of chlamydial antigens on MHC class I molecules and kill these cells 
(Starnbach et al., 1994).  Theoretically this should aid in removal of the organism, but this 
has not been shown in vivo (Roan and Starnbach 2008).  This may be due to the presence 
of small numbers infectious EB relatively early in infection.  Lysis of the host cell would 
enable EBs to enter a new host and continue its replication cycle.  Phagocytosis of EB by 
antigen presenting cells does not guarantee death of the organism.  Opsonised 
C. trachomatis EB which enter host cells by Fc-mediated endocytosis have been shown to 
escape lysosomal death and undergo a normal replication cycle (Scidmore et al. 1996). 
 
Activation and proliferation of CD4+ and CD8+ T cells occurs in the nearby lymph nodes 
which drain antigen from the genital mucosa.  These cells develop their INF-γ producing 
capacity prior to migration to the site of infection where they aid in chlamydial clearance 
(Roan and Starnbach 2006; Roan et al., 2006). 
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The persistent dormant form of the organism may contribute to disease.  Reversible 
persistence can be induced by INF-γ (Beatty et al, 1993).  The organism remains dormant 
until this cytokine is removed, then reactivates and stimulates inflammation and immune 
cells.  Alternating cycles of the persistent dormant form followed by an inflammatory 
immune response may result in chronic chlamydia-induced disease and tissue damage 
(Roan and Starnbach 2008). 
 
2.7 Cell death 
 
Cell death is an important part of cellular turnover and plays a role in homeostasis of 
multicellular eukaryotes (Miyairi and Byrne, 2006), as well as in the elimination of 
invading organisms (Fink and Cookson 2005).  Cell death is generally divided into 2 
categories, apoptosis and necrosis, but several other categories of cell death have been 




Apoptosis is defined as “caspase-mediated cell death with associated apoptotic 
morphology” (Samali et al 1999).  It is a regulated process for the removal of unwanted 
cells without causing damage to neighbouring cells and has distinct morphological 
characteristics (Boatright and Salvesen 2003). 
 
The caspase family of enzymes, which orchestrate apoptosis, is a group of peptidases with 
a cysteine residue at the catalytic site (Boatright and Salvesen 2003).  These enzymes 
cleave target proteins at a site adjacent to aspartic acid residues (Boatright and Salvesen 
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2003).  Some members of the caspase family are involved in implementing the apoptotic 
pathway, while others are responsible for the activation of inflammatory cytokine 
precursors (Los et al, 1999).  The group of caspases involved in apoptosis is further 
classified as initiator and effector caspases to reflect their role in the caspase cascade as 
well as the structural differences between the two groups (Fink and Cookson 2005).  
 
 
Apoptosis is a complex biochemical process which can be initiated by numerous stimuli to 
effect caspase-mediate cell death via a number of pathways. 
 
2.7.1.1 Initiation of apoptosis 
 
Apoptosis may be initiated by a number of stimuli including cellular and DNA damage, 
withdrawal of growth factors or hormones, receptor-ligand interactions and cytotoxic T 
cells (Cotran et al, 1999).  The biochemistry of effector caspase activation varies 
depending on the type of apoptotic stimulus. 
 
Cellular damage may induce apoptosis via the p53 or the Bcl (B cell leukaemia) -2 family 
of proteins.  In the case of DNA damage p53 arrests the cell cycle to DNA repair 
(Velculescu and El-Deiry 1996), and if this fails the effector caspases are activated (Cotran 
et al, 1999).  In the presence of other types of cell damage, the Bcl-2 family of proteins 
present in the mitochondrial outer membrane allow the release of cytochrome c (Green and 
Reed, 1998) which recruits and activates the intrinsic pathway of caspase activation 
(Boatright and Salvesen 2003).  Procaspase-9 becomes activated by the apoptosome 
complex (Zou et al 1999) and activates effector caspases (Boatright and Salvesen 2003).  
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Apoptosis may also occur via receptor-ligand interaction to mediate the removal of 
unwanted cells which have been tagged, either by the immune system or other processes 
(Boatright and Salvesen 2003). 
 
Upon attachment of a death ligand, death receptors, such as Fas, at the cell surface trigger 
the apoptosis cascade (Ashkenazi and Dixit, 1998).  Fas-associated protein with death 
domain (FADD) associates with the cytoplasmic death domains of the Fas receptor 
(Ashkenazi and Dixit, 1998).  The death-effector domain of FADD catalyses the activation 
of caspase-8 (Ashkenazi and Dixit, 1998).  Caspase-8 in turn activates the effector 
caspases (Boatright and Salvesen 2003). 
 
Caspase-8 may also be activated by other death ligands which bind to other death 
receptors, but Fas-mediated activation of caspase-8 is the pathway used to kill infected 
cells by NK cells or cytotoxic T lymphocytes (Ashkenazi and Dixit, 1998). 
 
Cytotoxic T lymphocytes may also mediate apoptosis by another mechanism which 
bypasses initiator caspase activation (Cotran et al 1999).  The transmembrane pore forming 
molecule, perforin, punctures through the membrane and secretes Granzyme B molecules 
into the cytoplasm which activate effector caspases (Cotran et al 1999). 
 
2.7.1.3 Execution of apoptosis 
 
The activated initiator caspases from the intrinsic and extrinsic pathways, caspase-9 and -8 
respectively, activate the effector caspases (Boatright and Salvesen 2003).  It is caspase-3, 
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-6 and -7 which disassemble the cell and mediate the morphological changes which 
characterise apoptosis (Boatright and Salvesen 2003, Fink and Cookson 2005). 
 
Cleavage of structural proteins cause nuclear shrinkage and fragmentation, loss of overall 
structure of the cell, membrane blebbing, and detachment from the basement membrane 
and surrounding cells (Fink and Cookson 2005).  The genome is dismantled by a caspase 
activated DNAase (CAD) (Enari et al, 1998) which cleaves genomic DNA within the 
internucleosomal linker regions to produce stepwise DNA fragments of 185 bp in length 
and multiples thereof (Arends et al, 1990).  Apoptotic bodies are formed, which in the in 
vivo situation would be phagocytosed by surrounding cells (Fink and Cookson, 2005).   
The cell membrane of affected cells display phosphatidylserine (PS) on the outer leaflet of 
their lipid bilayer (Martin et al, 1995).  This is normally restricted to the inner leaflet in 




In the cell death literature, necrosis is the term used to describe non-apoptotic or accidental 
cell death.  This process is characterised by cell and organelle swelling.  Ultimately the cell 
bursts and releases inflammatory contents (Fink and Cookson, 2005).  Necrosis thus leads 
to an inflammatory response and tissue damage (Miyairi and Byrne, 2006) 
 
In the situation where apoptotic bodies are not phagocytosed, they may lose their 
membrane integrity and lyse (Fink and Cookson, 2005).  This would result in an 
inflammatory response, despite death via the apoptotic pathway (Majno and Joris, 1995).  
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The term apoptotic necrosis is used to denote apoptotic cellular material which reaches this 
point via apoptotic pathways (Majno and Joris, 1995). 
 
2.7.3 Chlamydia and cell death 
 
Chlamydia have a complicated interaction with their host cells.  In the early and mid stages 
of their life cycle anti-apoptotic mechanisms predominate, while in the later stages of their 
developmental cycle these organisms may induce cell death (Miyairi and Byrne 2006). 
 
2.7.3.1 Inhibition of apoptosis 
 
The anti-apoptotic effect of chlamydia is largely shown by its ability to inhibit chemically 
and spontaneously induced apoptosis (Miyairi and Byrne 2006), and microarray analysis 
has indicated the up regulation of anti-apoptotic genes such as inhibitor of apoptosis (IAP) 
homolog B (Xia et al, 2003).  Although some variability in the levels of anti-apoptotic 
activity amongst the serovars has been reported (Greene et al, 2004), all strains tested 
demonstrated anti-apoptotic activity in infected cells. 
 
Chlamydia may mediate an anti-apoptotic effect via the Bcl family of proteins (Green and 
Reed 1998), which consists of three groups of proteins responsible for regulating 
cytochrome c release from mitochondria, Bax, Bcl-2 and BH3 (Miyairi and Byrne 2006).  
The Bax subfamily of proteins are pro-apoptotic and mediate changes in the permeability 
of the mitochondrial membrane causing the release of cytochrome c into the cytoplasm 
(Green and Reed 1998).  The Bcl-2 subfamily of proteins inhibits mitochondrial 
cytochrome c release (Green and Reed 1998).  The BH3-only proteins inhibit Bcl-2 
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proteins to exert a pro-apoptotic effect (Miyairi and Byrne 2006).  Chlamydia has been 
shown to inhibit apoptosis by degradation of the proapoptotic BH3-only proteins (Fischer 
et al, 2004a, Dong et al, 2005).  In the absence of direct activation of the effector caspases 
this is sufficient to inhibit apoptosis (Fan et al, 1998, Fischer et al, 2004b).  Although other 
pathogens modulate gene expression of nuclear factor (NF)κB as an anti-apoptotic 
mechanism, this has not been conclusively demonstrated for chlamydia. 
 
2.7.3.2 Induction of cell death 
 
Although there have been reports that Chlamydia induces apoptosis late in the 
developmental cycle the results vary depending on the method used to detect apoptosis 
(Miyairi and Byrne 2006), as well as the cell line and type of chlamydia (Jungas et al 
2004). 
 
TNF-α released by infected macrophages has been implicated in the induction of apoptosis 
of T lymphocytes in vitro (Jendro et al, 2004). 
 
The gene encoding Chlamydia protein associated with death domain (CADD) is expressed 
and was found to localise with the Fas receptor in infected cells (Stenner-Liewen et al, 
2002).  Despite this association, there was no evidence of apoptosis even in cells where 
CADD and Fas were co-localised (Stenner-Liewen et al, 2002).  This indicates that unlike 
the ectopic expression model in which caspase-mediate apoptosis was detected, CADD 
may be involved in the inhibition of apoptosis (Stenner-Liewen et al, 2002). 
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The end of the infectious cycle is often characterised by death of the host cell.  Although 
this is described as having morphological characteristics of apoptotic cell death, this occurs 
without caspase-3 activation (Dumrese et al, 2005).  Dumrese et al (2005) have suggested 
that cell death at the end of the chlamydial cycle occurs via a process which they call 
“aponecrosis” since it displays features of both apoptosis and necrosis. 
 
The pro-apoptotic protein Bax may become activated during chlamydial infection 
independent of the caspase pathway (Perfettini et al, 2003b).  Wild type mice with 
functional pro-apoptotic Bax protein produced more infectious progeny with a lower level 
of inflammation than their Bax-deficient counterparts.  This suggests that in C. muridarum 
and possibly other Chlamydia. spp, a new round of infection may be mediated by Bax 
dependent apoptosis.  The production of chlamydia containing apoptotic bodies would 







The epidermis is the multilayered epithelium which forms a boundary between the human 
body and the surrounding environment (Holbrook 1994).  It is comprised of stratified 
squamous keratinising epithelium (Young and Heath 2000).  The main function of skin is 
protection against dehydration, radiation, mechanical damage and the invasion of microbes 
(Young and Heath 2000).   Because keratinocytes account for more than 80% of the 
epidermal cells (Holbrook 1994), it is these cells which form the barrier against the 
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external environment and are probably the first cell type with which C. trachomatis of the 
LGV biovar interacts in its disease pathogenesis. 
 
2.8.2 Structure and development in vivo 
 
Keratinocytes undergo maturation and have different features at the stages of its 
development (Holbrook 1994, Young and Heath 2000) but there are key structural features 
present at all the stages. 
 
Typical “house-keeping organelles” including the nucleus, rough endoplasmic reticulum 
(RER), Golgi, ribosomes and mitochondria are present in keratinocytes (Holbrook 1994).  
The cytoskeleton comprises keratin intermediate filaments which are aggregated into 
bundles, particularly at the desmosomes and around the nuclear envelope (Holbrook 1994).  
Microfilaments and microtubules provide order within the cytoplasm, assist in cell 
motility, and promote intracellular communication as well as communication between the 
cell and its environment (Holbrook 1994).  Desmosomes facilitate cell-to-cell adhesion and 
attachment of keratin within the cell (Holbrook 1994).  Adherens and gap junctions are 
also present (Holbrook 1994). 
 
The epidermis is a multilayered structure comprising four morphological layers: the 
stratum basale, stratum spinosum, stratum granulosum and stratum corneum, 
 
As keratinocytes move through these layers from the stratum basale on the basement 
membrane to the stratum corneum on the surface of skin they exhibit different features. 
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The stratum basale is the germinal layer where mitosis takes place.  These keratinocytes 
are columnar in shape and rich in ribosomes, mitochondria Golgi and RER (Holbrook 
1994). Keratin intermediate filaments are present, but keratin only accounts for 30% of the 
total protein at this stage (Holbrook 1994). 
 
As cells move up through the stratum spinosum they become flattened and polyhedral in 
shape (Young and Heath 2000) with spiny projections formed by bundles of keratin 
filaments which insert into the desmosomal plaques (Holbrook 1994).  Keratin filaments 
are present and arranged concentrically around the nucleus and inserted into the 
desmosomes (Holbrook 1994). 
 
Keratinocytes of the stratum granulosum become more flattened and develop irregularly 
shaped, electron dense keratohyalin granules which are deposited at the points of 
intersection of the keratin filament bundles (Holbrook 1994). 
 
Once in the stratum corneum, keratinocytes become more flattened, lose their nuclei and 
organelles, and the main cytoplasmic constituent is mature keratin (Young and Heath 
2000).  The cells in the deeper regions of this layer still possess desmosomes, but these are 
lost as the cells approach the outermost layers where they will ultimately be sloughed off 
(Young and Heath 2000). 
 
2.8.3 HaCaT cells 
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The HaCaT cell line is a spontaneously immortalised human adult skin keratinocyte cell 
line developed by Boukamp and co-workers in 1988 (Boukamp et al. 1988) and has 
remained nontumorigenic for more than 300 passages (> 6 years in culture) (Boukamp et 
al. 1994).  It was developed from a histologically normal male body skin specimen 
obtained from the distant periphery of a melanoma (second incision) and designated 
HaCaT to signify its origin from “human adult keratinocytes propagated under low Ca2+ 
conditions and elevated temperature” (Boukamp et al. 1988).  This cell line has been 
extensively studied; including differentiation in vitro (stratification and squame formation), 
and it expresses essentially all epidermal differentiation markers despite the chromosomal 
changes which occurred during adaptation to autonomous growth in vitro (Boukamp et al. 
1988).  HaCaT cells show a lack of tissue organisation when grown in organotypic 
cocultures with fibroblasts, but tissue organisation is restored upon supplementation with 
epidermal growth factor (Maas-Szabowski et al, 2003). 
 
HaCaT cells are used in studies of the cell cycle (Chaturvedi et al, 1999) and 
carcinogenesis (Boukamp et al. 1994).  These cells are susceptible to etoposide-induced 
apoptosis (Lee et al, 2005). 
 




There are two distinct cell types present at different regions of the cervix.  The 
endocervical canal is lined by tall columnar mucus-secreting cells (Young and Heath 
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2000).  The ectocervix, which protrudes into the vagina, is lined by a thick layer of 
stratified squamous epithelial cells with a high glycogen content (Young and Heath 2000). 
 
2.9.2 ME-180 cells 
 
The ME-180 cell line is a spontaneously immortalised human cervical cell line, developed 
in 1967 by Sykes and co workers (Sykes et al. 1970). It was derived from an omental 
metastasis of a highly invasive squamous cell carcinoma of the cervix.  However, after 107 
passages, the cells were still characteristic squamous cells with numerous desmosomes, 
bundles of tonofibrils and occasional keratohyaline granules. 
 
The ME-180 cell line is widely used in carcinogenesis studies and is sensitive to etoposide-
induced cytotoxicity (Tanaka et al, 2006). 
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CHAPTER 3 – MATERIALS AND METHODS 
 
3.1 Cell Culture 
 
3.1.1 Cell lines of choice 
 
McCoy cells were used for the propagation of C. trachomatis, while HaCaT and ME-180 
cells were used for the experimental component. 
 
The McCoy cell line (ATCC® number CRL-1696) is an adherent mouse fibroblast cell line 
of unknown origin, which is widely utilized for the propagation of Chlamydiae. 
 
The HaCaT cell line, a spontaneously immortalized human keratinocyte cell line, was 
donated by Professor Norbet E. Fusenig of the Cancer Research Centre, Hiedelburg, 
Germany, while the ME-180 human cervical cell line (ATCC® number HTB-33TM) was 
purchased from the American Type Culture Collection (ATCC). 
 
3.1.2 Cell culture media 
 
Since all the cells used in this study have different nutritional requirements, 3 different cell 
culture media were used to ensure optimal growth of each cell line. 
 
For McCoy cells the cell culture medium (CCM) used was Eagles Minimum Essential 
Medium (EMEM) (BioWhittakerTM, Walkersville, USA) supplemented with Earle’s 
balanced salt solution (EBSS), HEPES (25mM) (BioWhittakerTM, Walkersville, USA) to 
facilitate the maintenance of pH 7.4 and L-glutamine (2 mM) (BioWhittakerTM, 
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Walkersville, USA). Glutamine is added separately as this essential amino acid is more 
labile than other amino acids and is rapidly broken down to ammonia in liquid culture 
media (ATCC technical information).  HaCaT cells were grown in Roswell Park Memorial 
Institute-1640 (RPMI-1640) medium (BioWhittakerTM, Walkersville, USA) to which L-
glutamine (2 mM) and HEPES (10mM) were added.  ME-180 cells were grown in McCoy 
5a medium.  Sterile heat-inactivated fetal bovine serum (FBS) (Gibco, Scientific Group) 
was added to provide uncharacterised cytokines and growth factors which are essential to 
regulate cell replication and differentiation.  Since the rate of cell growth is proportional to 
the concentration of FBS in the media all three CCM was supplemented with 10% FBS for 
cells which had just been thawed or passaged, then reduced 2 to 5 % depending on when 
the cells were required for use in experiments.  Incubation for growth and experiments was 
carried out in an incubator with 5% CO2 in 95% air. 
 
3.1.3 Cultivation of cells 
 
All cells were stored in cryovials with storage medium and kept at either -70°C for short 
term storage or in a liquid nitrogen freezer at -196°C for long term storage.  In order to 
reconstitute frozen cells, the cells were rapidly thawed by placing the cryovial in a beaker 
containing water at a temperature of 37°C and gently swirled.  Once almost thawed, the 
cryovial was removed from the beaker, swabbed with 70% ethanol and transferred to a 
class II biosafety cabinet.  The cells were seeded into an equilibrated 75cm2 tissue culture 
flask which contained cell culture medium supplemented with 10% FBS.  The flask was 
then incubated at 37°C. 
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Cells were viewed with an inverted microscope daily to monitor the level of cell density 
and check for any possible contamination or cell deterioration. 
 
Every 2 to 3 days the cell culture medium was replenished.  Spent media was discarded, 
the monolayer was washed with phosphate buffered saline (PBS) (Oxoid) (Dulbecco A 
without Ca2+ or Mg2+, pH 7.3) to remove unattached cells, and fresh cell culture media 




Once the adherent cell monolayer was approximately 90% confluent it was passaged and 
the cells either seeded into several new flasks to propagate more cells, seeded into a 24- or 
96-well plate or Trak vials with coverslips for experiments, or cryopreserved. 
 
The passage procedure was the same for all three cell types except the HaCaT cells 
required an additional step: 
 
1. Spent cell culture medium was discarded and the monolayer washed thrice with 
prewarmed (37°C) PBS to remove unattached cells and to ensure that all FBS was 
removed since this would inhibit the action of the proteolytic enzyme trypsin. 
 
2. HaCaT cells only: 
Two millilitres of 0.05% ethylenediaminetetraacetic acid (EDTA) solution (Sigma, 
Steinheim, Germany) was added to the washed monolayer in the flask and incubated at 
37°C for 5 to 10 minutes or until intercellular spaces were visible between the cells on 
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microscopic examination.  Since EDTA is a chelating agent (Petrucci and Harwood 
1997), it binds Ca2+ thereby loosening the desmosomal attachments between the 
HaCaT cells (Hennings and Holbrook 1983, Kitajima 2002).  Once the intercellular 
spaces were visible the EDTA solution was removed (Makakole and Sturm 1999). 
 
3. About 1ml of 0.05% trypsin - 0.02% versene (EDTA) solution (BioWhittakerTM) was 
added, the flask gently tilted from side to side to ensure the solution covered the entire 
monolayer and the excess solution discarded.  After about 1 minute incubation on a 
warm surface the flask was gently tapped to dislodge the cells. 
 
4. One millilitre of FBS was added immediately and allowed to cover the entire 
monolayer to neutralise the action of trypsin before it caused cellular damage.  The 
FBS was aspirated with a Pasteur pipette and squirted against the base of the flask to 
remove most of the remaining attached cells and to break up cell clumps. Following 
this the cell-FBS suspension was aspirated and decanted into a sterile centrifuge tube. 
 
3.1.5 Cryopreservation of cells 
 
For cryopreservation of cells, cell suspensions were produced as described and an equal 
quantity of the appropriate freezing fluid (Appendix) was added drop by drop to the cell-
FBS suspension. The suspension was gently swirled between drops to slowly mix the cells 
with the freezing fluid.  The resulting cell suspension was aliquoted into cryovials (1.0 – 
1.5ml per cryovial) which were tightly capped and sealed with Parafilm. Date of storage, 
passage number and concentration of cells was recorded on each vial.  Cells were slowly 
frozen to -70°C by placing the cryovials in a closed polystyrene rack at -70°C.  Long term 
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storage of cells was carried out by transferring the vials into a liquid nitrogen freezer (-
196°C) once they had reached -70°C.  
 
3.1.6 Determination of cell numbers 
 
The Trypan blue dye exclusion assay, using a Neubauer haemocytometer, was used to 
enumerate viable and nonviable cells. 
 
A haemocytometer was wiped with 70 % ethanol and covered with a square coverslip.  
Twenty microlitres cell suspension was added to 20 µl 0.4% trypan blue solution (Sigma) 
(1:2 dilution) and mixed well by pipetting up and down.  A pipette was used to place a 
drop of this Trypan blue-cell suspension at the edge of the coverslip such that it was drawn 
under the coverslip by capillarity to fill the counting chamber.  Since trypan blue dye is 
actively removed from viable cells but remains in dead cells, viable and dead cells can be 
differentiated when visualised under a light microscope and the cells enumerated using the 
haemocytometer.  The number of viable (colourless) and non-viable (blue) cells were 
counted in the 5 primary squares: each corner square and the centre square.  Cells touching 
the top and left borders of the square were included in the count for that square, while 
those touching the bottom and right borders were not.  (Maleka et al 1996) Cells in clumps 
were counted as individual cells, but if there were too many clumps, the suspension was 
mixed more thoroughly, the haemocytometer cleaned and refilled and the count repeated. 
 
The number of viable and dead cells was then used to calculate the concentration, total cell 
number and percent cell viability. 
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Since each primary chamber has a volume of 1 x 10-4 ml, the concentration of cells per 
millilitre was determined using the formula: 
 
Concentration     =   N    x   104   x   dilution factor 
             5 
 
Where N = total number of cells in 5 primary squares 
 
Total cell number was calculated by multiplying the concentration in cells per ml by the 
total volume in ml: 
 
Total cell number     =     concentration    x     total volume 
 
The percent cell viability was calculated by dividing the number of viable (unstained) cells 
by the total number of cells (viable and nonviable) then multiplying by 100 as follows: 
 
% cell viability      =      no. of viable cells      x     100 
                    total no. of cells 
 
If the cells in each primary square were too numerous to count, the cell suspension was 
diluted with PBS, and the trypan blue dye exclusion assay repeated. 
 
3.2 Bacterial Culture 
 
3.2.1 Bacterial strains of choice 
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Experiments were conducted using 3 LGV reference strains originally isolated from 
bubonic aspirates of a group of military servicemen or seamen who had recently returned 
from Asia, and presented with classical LGV symptoms (Schachter et al, 1969).  These 
strains are: L1 strain 440 (ATCC® number: VR-901BTM), L2 strain 434 (ATCC® number: 
VR-902BTM) and L3 strain 404 (ATCC® number: VR-903TM). These strains are widely 
used for pathogenesis studies of LGV. 
 
We isolated three fresh clinical isolates from patients presenting in the primary stage of 
LGV (genital ulcers) at the Prince Cyril Zulu Communicable Diseases Clinic in Durban, 
South Africa for use in this pathogenesis study.  These strains are designated Ulcer Study 
(US)151, US162 and US197.  They were all shown to be serovar L2 using sequence 
analysis techniques.  The OG serovar E strain was isolated by Maleka and coworkers 
(1996) in our laboratory from a male patient presenting at the same clinic with urethritis.  
This strain was typed in the Division of Allergy and Infectious Diseases, Department of 
Medicine, University of Washington, Seattle, USA (Dr. M Lampe) using monoclonal 
antibody microimmunofluoresence. 
 
This study was approved by the Research Ethics Committee of the Nelson R. Mandela 
School of Medicine, University of KwaZulu Natal; reference number:  H184/04 
 
3.2.2 Propagation, isolation and storage 
 
3.2.2.1 Monolayer preparation 
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Since C. trachomatis is an obligate intracellular pathogen, in order to propagate this 
organism, a suitable host cell, such as the McCoy cell line, was required. 
 
McCoy cells were cultured in tissue culture flasks and passaged as described above.  
Approximately 8 x 104 cells suspended in 1ml CCM with 10% FBS were seeded into Trak 
vials, each containing a round glass coverslip.  After overnight incubation at 37°C with 5% 
CO2 in 95% air, the glass coverslip was removed from 1 vial, placed on a clean glass slide, 
and viewed at 100x magnification to verify integrity of the cells and ensure that the 




Once the McCoy cells were ready for infection, CCM was aspirated from each Trak vial, 
the monolayer washed once with PBS, and 500µl chlamydia growth medium for 
propagation (CGM-P) was added.  CGM-P comprised EMEM (BioWhittakerTM) with 
EBSS, nonessential amino acids (NEAA) and sodium pyruvate which had been enriched to 
yield final concentrations of the following: 10mM HEPES, 2mM L-glutamine, 
cycloheximide (1µg/ml), gentamicin (10µg/ml), Amphotericin B (5µg/ml), glucose 
(5.4mg/ml) and 10% FBS. 
 
Chlamydia EB suspended in 100µl sucrose-phosphate-glutamate buffer (SPG) was 
introduced into each Trak vial, except the negative control vial, to which 100µl sterile SPG 
was added.  Vials were centrifuged at 1200 x g for 1 hour, then incubated at 37°C for a 
further 1 hour.  The residual inoculum was aspirated and replaced with 1ml fresh CGM-P 
and the vials incubated for 2 days. 
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3.2.2.3 Isolation and storage 
 
After the incubation period, the negative control monolayer and 1 positive monolayer was 
stained and viewed using a fluorescent microscope to verify the presence of chlamydial 
inclusions in the positive monolayer, and eliminate the possibility of any crossover 
chlamydial contamination (negative monolayer). 
 
Once this had been verified, the excess CGM-P in the remaining vials was aspirated and 
replaced with SPG containing 10% FBS.  A few sterile glass beads were added and the 
vials vortexed to disrupt the McCoy cell monolayer and release the chlamydial EB.  The 
EB-SPG suspensions from all the vials of the same batch were pooled, mixed and 
aliquoted into sterile safe-lock Eppendorf tubes for storage at -70°C.  When more than 1 
serovar was to be harvested on the same day, this was done sequentially, not 
simultaneously, and the biosafety cabinet and all equipment used was swabbed with 70% 
ethanol between serovars. The safety cabinet’s air circulation system was allowed to run 
for 5-10 minutes to prevent cross contamination between chlamydial strains. 
 
3.2.3 Determination of the infectious titre 
 
Since the viability of chlamydial EB decreases during freezing (Aarnaes et al 1984), frozen 
EB suspensions from the same batch to be used for experiments were applied to determine 
the infectious titre on 80 to 90% confluent McCoy cell monolayers grown in a 24-well 
plate with a 12 mm round glass coverslip (Marienfield) in each well. 
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One vial EB suspension per batch was thawed, and 10-fold serial dilutions prepared in 
SPG.  These serial dilutions were used to infect the 80-90% confluent McCoy cell 
monolayers in the 24-well plate using the infection procedure described.  One hundred 
microlitres of SPG was used for the negative control in place of the 100µl EB-SPG 
suspension. 
 
After 2 days incubation, coverslips were stained then viewed with a fluorescent 
microscope. 
 
The number of inclusions per field was enumerated at 400x magnification and the average 
number of inclusions per field of view calculated.  The dilution at which the inclusions 
were counted was the dilution at which 5 to 40 inclusions were present in each field of 
view. 
 
The infectious titre was then calculated using the following formula: 
 
Concentration (IFU/ ml)  =  inclusions x 1’000µl    x C x D 
               n        V 
 
Where: n = number of fields counted 
  V = volume of inoculum (µl) 
  C = objective lens conversion factor 
  D = dilution (ml) 
 
The objective lens conversion factor is the numerical factor used to convert from the 
number of inclusions seen in a field of view with a certain objective lens, to the number of 
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inclusions present in the whole well.  Since conversion factors are affected by the area of 
the well and the area of the field of view visualised with each objective, the conversion 
factors vary and are calculated by dividing the area of the field of view by the area of the 
well. 
 




The chlamydial major outer membrane protein (MOMP) is present in all known serovars 
of C. trachomatis, and in both the EB and RB.  In MicroTrak® C. trachomatis Culture 
Confirmation Test kit (Trinity Biotech) monoclonal antibodies directed against this protein 
are conjugated to fluorescein isothiocynate (FITC) to specifically identify these organisms.  
The anti-C. trachomatis antibodies bind to the MOMP antigen, and cause chlamydial 
particles to fluoresce apple-green in contrast the host cells which stain red with the Evan’s 
Blue counter stain when viewed with a fluorescent microscope with the appropriate filter.  
 
3.3.2 Staining method 
 
The staining procedure was performed as outlined by the manufacturer with slight 
modifications. 
 
Excess media in the well or Trak vial was aspirated and monolayers fixed by the 
immediate addition of 1ml 95% ethanol in distilled water for about 10 minutes.  It was 
imperative that the monolayer did not dry out before the fixative was added; otherwise the 
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inclusions may have burst and become reduced in number.  After the fixation step, excess 
fixative was aspirated and the monolayers rinsed once with PBS to remove any unattached 
cellular debris.  While the monolayer was still moist 30µl equilibrated stain reagent 
(Appendix) was applied to the coverslip, and incubated at 37°C in a humidified chamber 
for 30 minutes.  The monolayer needed to be moist to ensure that the stain reagent covered 
the whole coverslip, and coverslips were incubated in a humidified chamber to prevent the 
stain drying on the monolayer which would cause non-specific binding.  After this 
incubation step, the coverslips were rinsed in distilled water with agitation for 10 seconds.  
Excess water was blotted off and the dry monolayers placed cell side down onto a drop of 
DPX mountant on a clean, labelled microscope slide.  Slides were either read immediately 
or stored in the dark at -20°C until read. 
 
3.3.3 Visualisation and photography 
 
Slides were visualised using a fluorescent microscope with a filter system for FITC (λ = 
520nm) and magnification at 100-400x (dry objective) for scanning and 500-1000x (oil 
immersion objective) for confirmation of morphology. 
 




Specimens were collected from adult male or female patients presenting with genital ulcer 
disease and/or lymphadenopathy at the Prince Cyril Zulu Communicable Diseases Clinic 
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in Durban.  Exclusion criteria for participation in the study were the use of antimicrobial 
agents in the preceding 4 weeks and refusal to participate. 
 
3.4.2 Specimen collection 
 
After consent was obtained, the specimen was collected by a registrar from the Department 
of Medical Microbiology who was trained in the collection of such specimens.  The base 
and edge of the ulcer/s was cleaned with a sterile dry gauze swab and a sterile disposable 
plastic loop was used to scrape the edge and base of the ulcer. The material was suspended 
in 1 ml chlamydia transport medium and the plastic loop was left in the container.  This 
was stored and transported on ice.  In addition a Dacron swab was also rolled over the 
ulcer then placed in 1 ml PBS for aetiological diagnosis by PCR (Sturm et al. 2005).  The 
specimens were transported to the laboratory within 4 hours of collection.  Specimen in 
chlamydia transport media were immediately frozen at -70°C, while the specimen in PBS 
was refrigerated and processed within 48 hours. 
 
3.4.3 Identification C.trachomatis, LGV biovar 
 
A C. trachomatis specific PCR was used to determine the presence of chlamydia in the 
ulcer specimens. An endonuclease restriction was employed to confirm that the organism 
was of the LGV biovar (Watson et al. 1991). 
 
3.4.4 Isolation and propagation 
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Ulcer specimens testing positive in the chlamydia PCR and with the LGV biovar 
restriction pattern were seeded on McCoy cell monolayers in CGM-P.  The frozen 
specimen was thawed immediately prior to use.  Three sterile glass beads were added to 
the specimen in chlamydia transport media then vortexed for 2 minutes with the disposable 
plastic loop still in place.  The loop was then removed with sterile forceps and discarded.  
The specimen suspension was transferred to a sterile cryovial.  Prepared McCoy cell 
monolayers with CGM-P were infected with 200 µl specimen suspension in duplicate. A 
negative control comprising 200 µl sterile SPG was also prepared. Cultures were processed 
as described for the reference strains.  After the 2 day incubation step, one Trak vial from 
each specimen, as well as the negative control was fixed and stained using the MicroTrak® 
Chlamydia trachomatis Culture Confirmation Test kit.  Slides were examined using a 
fluorescent microscope with a filter system for FITC to confirm the presence of chlamydial 
inclusions in the specimens and absence of chlamydial inclusions in the negative control.  
EB were harvested and passaged onto prepared McCoy cell monolayers approximately 3 
times until a sufficient titre was obtained for use in experiments. 
 




The CytoTox96® Non-Radioactive Cytotoxicity Assay (Promega) was used to quantify the 
level of chlamydia-induced cytotoxicity in HaCaT and ME-180 cells.  This assay 
quantifies the level of lactate dehydrogenase (LDH), a cytosolic enzyme which is released 
upon cell lysis (Sepp et al 1996).  The level of LDH released into the culture supernatent is 
detected using a coupled enzymatic reaction in which the tetrazolium salt is converted to a 
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red formazan product.  The wavelength absorbance data recorded are used to calculate the 
percentage cytotoxicity. 
 
Since there are several factors which affect the absorbance at the wavelength used in this 
assay, including FBS and phenol red which were both present in the chlamydia growth 
medium for experiments (CGM-E), four controls were set up: 
• The host cell spontaneous LDH release utilizes the supernatant from uninfected 
cells and corrects for the spontaneous release of LDH from the host cells. 
• The host cell maximum LDH release utilizes the supernatant from uninfected 
cells which have been lysed.  It is required in calculations in order to determine 
100% LDH release. 
• The volume correction control comprises culture medium without cells to which 
the lysis solution has been added in order to compensate for the volume change 
caused by the addition of lysis solution to the host cell maximum LDH release 
control. 
• A culture medium background control comprising only cell culture medium 
without cells corrects for the LDH activity contributed by serum in the cell culture 




HaCaT or ME-180 cells were seeded (1.5 x 104 cells in 100µl CCM per well) into flat-
bottom 96-well TC microtitre plates and incubated at 37°C overnight to yield an 80% 
confluent monolayer the following day.  Three wells for each cell line were trypsinized and 
the cell count used to calculate an appropriate dilution of the stock chlamydial inoculum to 
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produce a MOI of 0.025.  This low MOI ensured that only a few cells became infected in 
the first instance, allowing sufficient uninfected neighbouring cells for the progeny EB to 
infect after completion of the chlamydial lifecyle. 
 
CCM was aspirated from the wells and replaced with 100µl CGM-E comprised of RPMI-
1640 (BioWhittakerTM) with 10mM HEPES, 2mM L-glutamine, gentamicin (10µg/ml), 
Amphotericin B (5µg/ml), glucose (5.4mg/ml) and 10% FBS.   Cycloheximide was not 
used in any experiments, because it inhibits eukaryotic cell replication by interfering with 
the 60S ribosomal subunit (Elela and Nazar, 1997), which would prevent eukaryotic host 
cells from behaving as they would in an in vivo situation. 
 
Cells were infected in triplicate with 3 C. trachomatis reference strains (serovars L1, L2 
and L3), 1 OG strain (serovar E), 3 LGV clinical isolates or 50µl sterile SPG for the 
negative control and maximum LDH release control.  After addition of the inoculum or 
SPG, plates were centrifuged at 1200 x g for 1 h, incubated at 37°C or 33°C for 1 h, then 
the inoculum removed and replaced with 150µl fresh CGM-E. At this point 150µl CGM-E 
was added to 6 empty wells for subsequent use as the volume correction control and 
culture medium background control.  Plates were incubated at 37°C or 33°C for 5 days. 
 
Each day post-infection, 1 plate from each cell line and both temperatures for the HaCaT 
cell line, was removed from the incubator for use in the LDH assay and chlamydial growth 
curve study.  The remaining plates were centrifuged at 1200 x g for 1 h each day then 
returned to the incubator.  On the second day post-infection 100 µl fresh CGM-E was 
added to all remaining wells, while 50 µl fresh CGM-E was added on day 4. 
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For the LDH assay, lysis solution was added to the volume correction and maximum LDH 
release control.  The volume added was 10% of the volume of CGM-E in the well, 
therefore on days 1 and 2, 15µl was added, on days 3 and 4, 25µl lysis solution was added, 
while 30µl lysis solution was added on day 5.  The solution in each well was mixed by 
stirring with a pipette tip, and the plates returned to the incubator for 45 minutes until the 
cells had lysed.  The solution was mixed by pipetting up and down, then cellular debris 
pelleted by centrifugation at 250 x g for 4 minutes. 
 
Twenty-five microlitres supernant was transferred from each well to a clean well on a new 
flat-bottom 96-well TC plate.  Because of the high LDH activity, the superant was diluted 
with 25µl PBS to produce a final volume of 50µl.  Reconstituted substrate mix (50 µl) was 
added to each well. The plates were covered with foil and incubated at room temperature 
for 20 minutes.  The reaction was stopped with 50µl stop solution (1M acetic acid) and the 
absorbance read at λ 492nm using an Anthos 2010 version 1.7 microplate reader. 
 
Before calculation of the percentage cytotoxicity, the average absorbance of the volume 
correction control was subtracted from the maximum LDH release control, and the average 
absorbance values of the culture medium background control subtracted from all other 
absorbance values. 
 
The corrected absorbance values were used to calculate the percent cytotoxicity in the 
following calculation: 
 
% cytotoxicity     =    Experimental      –  Host Spontaneous       x  100 
     Host Maximum – Host Spontaneous 
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This experiment was performed 3 times in triplicate. 
 
No effector cell (chlamydia) spontaneous LDH release was measured since C. trachomatis 
is an obligate intracellular organism, and thus unable to replicate in the absence of a 
eukaryotic host.  These organisms rely on adenosine triphosphate (ATP) from their host, 
and there are no reports of this organism possessing LDH, an enzyme of the glycolytic 
pathway. 
 




Although chlamydial growth rates are known to differ between the biovars and reflect 
tissue tropisms, previous studies do not accurately reflect the in vivo situation. Cells that 
were not the native host cell treated with cycloheximide or DEAE-dextran were used to 
grow the organisms and the isolates have been passaged for decades under conditions 
different to those from which they were isolated originally. 
 
Here we eliminate some of those variables by growing C. trachomatis in cell lines derived 
from tissue affected in vivo  under conditions which do not impair the host cells from 
functioning normally (neither cycloheximide nor DEAE-dextran are used), and in addition 
to the reference strains, we used recently collected isolates from our setting.  To approach 
the in vivo situation as close as possible, a very low MOI (0.025) was used.  This ensured 
the availability of a sufficient number of uninfected cells for the progeny EB to infect and 





The same 96-well TC plates set up for the LDH assay in 5.2 were used for the chlamydial 
Growth Curve studies. 
 
After the supernatant was removed for use in the LDH assay, the remaining supernatant 
was aspirated and discarded.  The cells in the wells were immediately fixed with about 
200 µl 95% ethanol for 5 minutes.  The ethanol was removed and the plates allowed to dry, 
before being frozen at -70°C until needed. 
 
The experiment was performed 3 times in triplicate. 
 
On the day that the plates were visualised, they were allowed to reach room temperature. 
The cell monolayers were then moistened with 200µl PBS.  Plates were inverted to remove 
the PBS, then 15µl C. trachomatis Reagent from the MicroTrak® C. trachomatis Culture 
Confirmation Test was added immediately before the monolayers dried. Following this the 
plates were incubated in a humidified chamber at 37°C for 30 minutes with manual 
agitation every 10 minutes.  The reaction was stopped by washing the monolayers with 
200µl dH2O twice for 10 sec each then allowed to dry. 
 
3.6.3 Visualization and enumeration 
 
The 96-well TC plates were inverted and viewed at low magnification (100-400x) with an 
Olympus BH2-RFCA fluorescent microscope.  The number of chlamydial inclusions per 
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field of view (FOV) was enumerated using the 10, 20 or 40× objective lens depending on 
which objective yielded a countable number of inclusions.  For the 10 and 20× objectives, 
5 FOV were counted and averaged; for the 40x objective 10 FOV were counted and 
averaged. 
 
Objective lens conversion factors were calculated by dividing the area of 1 well in a 96-
well plate by the area of each objective lens FOV.  The number of inclusions per well was 
calculated by multiplying the average number of inclusions per FOV by the objective lens 
conversion factor. 
 
3.6.4 Photography and image analysis 
 
The 96-well TC plates were inverted and viewed at low magnification (100×) with a Nikon 
eclipse E600 fluorescent microscope using a filter with an excitation wavelength of 450-
490 nm and an emission wavelength of 520 nm.  Images were captured in colour using a 
Nikon ColorView Soft Imaging System digital camera with an exposure time of 2.500 sec 
and the red, green, blue balance set to 1.00, 2.00 and 2.00 respectively.  Images were 
analysed using Soft Imaging System version 3.2. 
 
In order to calculate the area of each image occupied by C. trachomatis (stained green) and 
the area occupied by cells (stained red), colour thresholds were set.  Two phases were 
defined, one to detect green and the other to detect red.  For phase green the thresholds 
were defined as follows: hue, saturation and intensity were 60-255, 140-255 and 20-255 
respectively; and in phase red, hue, saturation and intensity were 0-65.16, 100-200 and 10-
106 respectively.  These values were attained by reading the pixel value at various points 
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on numerous images, and the accuracy of the resultant phase definitions confirmed using 
the phase colour coding function which colour-coded the green phase blue, and the red 
phase pink.  The original image was compared with the colour-coded image to ensure that 
all the correct areas were selected, and the undesired areas omitted.  The ranges were then 
broadened or restricted until the colour thresholds were optimal.  The area occupied by 
C. trachomatis and the area occupied by cells was calculated using the phase analysis 
function on each 100× image captured. 
 
Chlamydial inclusion size was measured for the HaCaT cells at 33°C for days 2 to 5 post 
infection.  Inclusions were too small to be visually detected 1 day after infection under 
these conditions.  The detection parameters were setup to include particles with a minimum 
size of 60 pixels.  Inclusions touching the border were excluded.  Each image was 
separated into its red, green and blue components and the new image of the green 
component selected.  The detect function was utilized to select chlamydial inclusions.  
Each image was carefully compared with the original to ensure that only chlamydial 
inclusions were selected.  Since the software could not discriminate between 2 or more 
inclusions in contact with each other, any inclusions that were touching each other were 
excluded from the analysis using the delete particle function.  The particle results function 
was used to analyse each selected inclusion and measure various parameters, including the 
area (µm2), diameter (µm) and mean level of green that was detected per inclusion.   
Results were output in a Microsoft Excel spreadsheet and the inclusion parameters of the 
chlamydial strains compared. 
  
3.7  Transmission electron microscopy (TEM) 
 
 65
The ultrastructural development of the chlamydial inclusion in human keratinocytes and 
cervical epithelial cells, and the effect of the organism on the infected and exposed cells 
compared to an unexposed negative control over 48 hours, was investigated using 
transmission electron microscopy. 
 
3.7.1 Monolayer preparation and infection 
 
HaCaT and ME-180 cells were grown in tissue culture flasks.  Once confluent cells were 
trypsinised and 1 x 105 cells seeded to 24 well plates (Greinier) to which 12mm round 
Thermanox coverslips (Nunc) had been inserted into each well.  After 2 days, the cells 
were about 90% confluent.  Trypsinization and enumeration using the Trypan Blue dye 
exclusion assay and a haemocytometer revealed a cell count of approximately 2.5 x 105 
cells per well.  The residual CCM was aspirated, the monolayer washed once with PBS, 
then chlamydial growth medium added.  The chlamydial inoculum was thawed 
immediately prior to use, and diluted with SPG buffer.  Cells were infected with 100 µl 
chlamydial suspension at an MOI of 0.25, which equated to 1 chlamydial EB per 4 cells to 
ensure the presence of both infected and uninfected exposed cells in each well.  For the 
unexposed negative control, cells were treated with 100 µl sterile SPG buffer.  Cells were 
immediately centrifuged at 1200 x g for 1 hour, then transferred to an incubator.  This 
point was defined as T0.  HaCaT cells were incubated at 37°C and 33°C to compare the 
effect of C. trachomatis on the host cell at core body temperature (37°C) versus the 
temperature of human skin (33°C), while the ME-180 cells were only incubated 37°C 
because these cells could not survive at 33°C.  The residual inoculum was removed after 2 
hours in the incubator and replaced with 1 ml fresh CGM-E. 
 
 66
3.7.2 Monolayer processing 
 
At 1, 3, 9, 18, 24, 36 and 48 hours post-infection, 1 well for each strain, cell type and 
temperature combination was fixed and processed for transmission electron microscopy 
(TEM).  After washing with EMEM, the cell monolayers were transferred to a fresh 24-
well plate using sterile forceps and a dissecting needle.  The original plate was returned to 
the incubator, while the harvested coverslips with their cell monolayers were processed 
within the 24-well plate until the final step.  Cells were fixed with 2% gluteraldehyde in 
EMEM for 30minutes, then washed with EMEM twice for 5 minutes.  The fixed 
monolayers were covered by a layer of sterile EMEM and refrigerated until they could be 
processed (no more than 20 hours).  Cells were post-fixed, dehydrated and infiltrated 
directly in the 24-well plate (table 1).  In order to embed the cells in Spurr resin, a beam 
capsule was filled with Spurr resin and the coverslip placed on top of the beam capsule 
with cell-side down touching the resin.  The beam capsules were incubated at 60°C for 48 
hours to allow the resin to solidify. 
 
After 48 hours the coverslip was quickly removed while the resin was still warm allowing 
the cells to remain embedded in the Spurr resin. 
 
Table 2. Processing schedule for TEM 
Step Process Solution Temperature Time 
1 Fixation 2% gluteraldehyde in EMEM 24°C 30 min 
2 Wash EMEM 24°C 5 min 
3 Wash EMEM 24°C 5 min 
4 Wash Sodium cacodylate buffer 24°C 5 min 
5 Post-fixation 1% osmium tetroxidea 24°C 45 min 
6 Wash Sodium cacodylate buffer 24°C 5 min 
7 Wash Sodium cacodylate buffer 24°C 5 min 
8 Dehydration 50% ethanol 24°C 10 min 
9 Dehydration 70% ethanol 24°C 10 min 
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10 Dehydration 90% ethanol 24°C 10 min 
11 Dehydration 100% ethanol 24°C 10 min 
12 Dehydration 100% ethanol 24°C 10 min 
13 Dehydration 100% ethanol 24°C 10 min 
14 Infiltration Ethanol : Spurr resin (1:1)b 24°C 30 min 
15 Infiltration Spurr resinb 60°C 1 hour 
16 Infiltration Spurr resinb 60°C 1 hour 
17 Embedding Spurr resin 60°C 24-48 hours 
a protected from light 




The section of the resin block containing cells was sawed off and trimmed to produce a 
“mesa” with a trapezoidal shape.  Ultrathin sections (50-60nm) were cut and collected onto 
uncoated copper 200 mesh grids, then double stained with uranyl acetate and Reynold’s 
lead citrate for 3 and 2 minutes respectively (Reynolds 1963).  Uranyl acetate and 
Reynolds lead citrate was decanted and centrifuged to pellet any debris or solute crystals.  
Grids were floated on a drop of uranyl acetate for 3 minutes, rinsed twice with triple 
distilled water and blotted dry on Whatman filter paper. They were then placed in a drop of 
Reynolds lead citrate, rinsed twice with triple distilled water and blotted dry. 
 
3.7.4 Visualization and photography 
 
Sections were viewed using a Jeol 1011 transmission electron microscope at an 
accelerating voltage of 100 kV.  The TEM was interfaced with a Megaview III Software 
Imaging Systems camera unit. Images were captured digitally and measurements 
performed using iTEM analySIS (Germany) image analysing software. 
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The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazoliumbromide (MTT) assay was used 
to determine the level of mitochondrial activity in infected versus uninfected cell 
populations. 
 
The MTT assay is a colorimetric cell culture assay based on the principle that 
dehydrogenase enzymes in the intact mitochondria of metabolically active cells reduce the 
insoluble pale yellow tetrazolium MTT salt to slightly soluble, dark blue formazan crystals 
allowing the assay to detect living cells but not dead cells with the signal generated 
proportional to the level of activation (Mosmann, 1983).  This assay is used to determine 
cell proliferation, or the rate of cell survival in various medical, microbiological and 




HaCaT or ME-180 cells were seeded (1.5 x 104 cells in 100µl CCM per well) to flat-
bottom 96-well TC plates and incubated at 37°C overnight to yield an 80% confluent 
monolayer the following day.  Three wells for each cell line were trypsinized and the cell 
count used to calculate an appropriate dilution of the stock chlamydial inoculum to 
produce a MOI of 0.25.  Cells were infected in triplicate with C. trachomatis serovar L2, 
L3 or E in 50 µl SPG.  Sterile SPG was used for the uninfected control, while the positive 
control contained 20 µM etoposide. Etoposide is a cytotoxic compound shown to induce 
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caspase mediated apoptosis in HaCaT cells (Lee et al. 2005). After addition of the 
inoculum or SPG, plates were centrifuged at 1200 x g for 1 h, incubated at 37°C or 33°C 
for 1 h. The inoculation medium was then removed and replaced with 150µl fresh CGM-E. 
 
At 1, 3, 9, 18, 24, 36 and 48 hours post-infection the level of mitochondrial activity was 
measured using the MTT assay.  Ten microlitres of MTT salt solution (5µg/ml in PBS) 
was added to each well, and the cells were incubated at the experimental temperature for 2 
hours 30 minutes.  The culture media was aspirated, and the purple formazan crystals were 
dissolved in 150µl DMSO by pipetting up and down 5 times.  This solution was transferred 
to a fresh 96-well plate and the absorbance data read at test wavelength of 570 nm with a 
reference wavelength of 630 nm. 
 
The experiment was performed 3 times in triplicate. 
 




The terminal deoxynucleotidyl transferase (TdT)-mediated dUTP-biotin nick end labeling 
(TUNEL) assay was first developed in 1992 by Gavrieli et al.  This method detects cells 
undergoing programmed cell death (PCD) in situ at the single cell level without destroying 
cell and tissue architecture.  Apoptosis is associated with the activity of endogenous 
endonucleases which cleave double stranded genomic DNA at regular intervals and yield 
numerous 3’hydroxyls (3’-OH) available for TdT to label (Bortner et al. 1995; Didenko 
and Hornsby, 1996).  In the TUNEL assay, cells are treated with protease to expose the 
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nuclear DNA.  Thereafter TdT is added which binds to the 3’-OH ends of the cleaved 
DNA and facilitates the incorporation of biotinylated deoxyuridine (dUTP).  If this is the 
case, horseradish peroxidase (HRP)-labeled streptavidin is bound to dUTP.  These 
biotinylated nucleotides are detected using hydrogen peroxide, the substrate for HRP, and 




HaCaT or ME-180 cells were grown on glass coverslips in 24-well tissue culture plates for 
2 days until confluent.  The residual CGM-E was removed and replaced with 500µl CGM-
E, then infected with C. trachomatis serovar L2, L3, E, or the clinical isolates US151, 
US162 and US197 in 100 µl SPG at an MOI of 0.25.  One hundred microlitres sterile SPG 
was used for the uninfected control, TUNEL positive control, and TUNEL negative control 
(provided with the kit).  Monolayers were centrifuged at 1200 x g for 1 hour, then 
incubated at 37°C or 33°C for 1 hour.  The residual inoculum was aspirated, replaced with 
1ml CGM-E and the monolayers incubated at 37°C or 33°C for 2 or 5 days.   
 
After 2 days (or 5 days for the HaCaT cells at 33°C), the cells were fixed and stained for 
the TUNEL assay using the DeadEndTM Colorimetric TUNEL System (Promega) and 
C. trachomatis detection using the MicroTrak® Chlamydia trachomatis Culture 
Confirmation Kit (Trinity Biotech) as described below. 
 
Procedures were carried out according to manufacturer’s instructions with the following 
adaptations: 
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• Cells were processed on coverslips within the wells of a 24 well plate and mounted 
to glass slides after the staining procedure, instead of being processed on glass 
slides 
• Cells were fixed with 4 % formalin in PBS in stead of 10% buffered formalin, 4% 
paraformaldehyde solution or 10 % buffered formalin in PBS 
• Cells were permeabilized with 0.4% Triton® X-100 in PBS for 10 min at room 
temperature for ME-180 cells, and 37°C for HaCaT cells.  The manufacturer’s 
recommendation of 0.2% Triton® X-100 in PBS for 5 min did not permeabilize the 
HaCaT cells sufficiently. 
• Ten units per millilitre RQ1 DNase was used as the TUNEL positive control 
• At the end of the TUNEL assay staining procedure, the same slides were stained 
with the MicroTrak® C. trachomatis Culture Confirmation Test Kit  
 
Cells were processed directly in the wells at room temperature unless otherwise stated. 
 
Procedure: 
1. Wash with PBS 
2. Fix with 4% formalin in PBS for 25 min 
3. Wash twice with PBS for 5 min 
4. Permeabilize with 0.4% Triton® X-100 in PBS for 10 min (room temperature for ME-
180 cells; 37°C for HaCaT cells) 
5. Wash twice with PBS for 5 min 
6. DNase treatment for TUNEL positive control: 
a. Wash with 200µl DNase I buffer for 5 min 
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b. Treat with 200µl RQ1 RNase free DNase (10 unit/ml) (Promega) in  DNase 
I buffer for 10 min at 37°C 
c. Rinse with tdH2O 4 times 
d. Wash with PBS for 5 min 
7. Equilibrate with 100µl equilibration buffer for 5-10 minutes 
8. Prepare rTdT reaction mix by combining the following components per well: 
98µl equilibration buffer 
1µl biotinylated nucleotide mix 
1µl rTdT enzyme or 1µl autoclaved tdH2O for the TUNEL negative control 
9. Label with 100µl rTdT reaction mix for 60 min at 37°C with each glass coverslip 
covered with a plastic coverslip to ensure even distribution of the reagent and prevent 
evaporation 
10. The plastic coverslips were removed and the reaction stopped with 200µl 2X SSC for 
15 min 
11. Wash thrice with PBS for 5 min 
12. Block endogenous peroxidases with 0.3% hydrogen peroxide for 4 min 
13. Wash thrice with PBS for 5 min 
14. Bind with 200 µl streptavidin horse radish peroxidase (HRP) (1:500 in PBS) for 30 min 
15. Wash thrice with PBS for 5 min 
16. Prepare DAB stain solution: 
950 µl tdH2O 
50 µl 20x DAB substrate buffer 
50 µl DAB 20x chromagen 
50 µl 20x hydrogen peroxide 
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17. Stain with 100µl DAB solution for 15 min with each glass coverslip covered with a 
plastic coverslip to ensure even distribution of the reagent and prevent evaporation 
18. Remove plastic coverslips 
19. Rinse monolayer 5 times with tdH2O 
20. Counterstain for C. trachomatis detection using the MicroTrak® Chlamydia 
trachomatis Culture Confirmation Kit (Trinity Biotech) 
a. Moisten with PBS for 5 min 
b. Stain with 30µl stain reagent for 30 min at 37°C in a humidified chamber 
c. Wash with tdH2O for 10 sec 
21. Remove glass coverslip from well 
22. Blot 
23. Mount to glass slide with DPX mounting fluid 
 
Once the mounting fluid had solidified, the slides were viewed with a Nikon eclipse E600 
fluorescent microscope.  Slides were examined using bright field microscopy to identify 
cells with fragmented DNA and DAB positive nuclei; then switched to fluorescence 
(excitation wavelength 450-490 nm; emission wavelength 520 nm) and the same field of 
view examined for the presence and location of C. trachomatis-infected cells relative to 
DAB positive cells. 
 
Images were captured in colour using a Nikon ColorView Soft Imaging System digital 
camera.  For each field of view, DAB positive cells were captured in a bright field 
photograph, and the same field of view captured under fluorescence.  Each pair of images 








Because apoptosis has been defined as “caspase-mediated cell death with associated 
apoptotic morphology” (Samali et al 1999), a caspase detection assay was performed using 
the BioVisionTM CaspGLOW Fluorescein Caspase Staining Kit (BiocomBiotech).  The 
broad spectrum caspase family inhibitor Val-Ala-Asp-α-fluoromethylketone (VAD-fmk) 
binds irreversibly to Caspase-1 through to Caspase-10 (Garcia-Calvo et al. 1998). After 
conjugation to the fluorescent marker FITC, this cell permeable VAD-fmk-FITC conjugate 
enters viable cells and binds activated caspases.  Apoptotic cells are directly detected upon 
fluorescent microscopy examination. 
 
In order to elucidate whether or not chlamydia-induced molecules affect neighbouring 
uninfected cells, the caspase assay was coupled with the use of Transwell® Permeable 
Supports (Corning). This allows the separation of a layer of infected cells from a layer of 
uninfected cells.  This made it possible to differentiate between cytotoxicity caused by cell- 
to-cell interaction with an infected neighbouring cell or by secreted molecules. 
 
Transwell® Permeable Supports with a polyester (PE) membrane were used, since the PE 
membrane allowed better cell visibility than the polycarbonate or polytetrafluoroethylene 
membranes.  The membrane is compatible with histological fixatives, as well as many 
other chemicals and solvents.  The pore size was 0.4 µm, with a density of approximately 





ME-180 or HaCaT cells were cultured in wells of a 24-well plate overnight at 37°C until 
90% confluent.   
 
The following day, cells within the wells were infected, and cells seeded to the upper 
chamber of Transwell® Permeable Supports.  A well of each cell line was trypsinized and a 
cell count performed.  The number of cells obtained was used to calculate the number of 
chlamydial EB to be added to achieve an MOI of 2.  The CCM was aspirated from each 
well and replaced with 500µl CGM-E.  Cells were infected with C. trachomatis serovar E, 
L2 or L3, suspended in 100µl SPG or sterile SPG for the uninfected control and the 
caspase positive control.  Plates were centrifuged at 1200 x g for 1 hour, incubated at 37°C 
for the ME-180 cells, and 37 or 33°C for the HaCaT cells for 1 hour.  The residual 
inoculum was aspirated, 1ml fresh CGM-E added and the plates incubated overnight. 
 
On the same day, 2 x 104 ME-180 or HaCaT cells were seeded to the upper chambers of 
Transwell® Permeable Supports.  The appropriate CCM with 10% FBS was prepared; 
600µl and 100µl CCM was added to the lower and upper chambers respectively, and 
incubated at 37°C with 5% CO2 for 1 hour.  After this time, the CCM in the upper chamber 
was aspirated, and 2 x 104 cells suspended in 100µl CCM was added to the upper chamber 
of each well.  Plates were incubated for at least 24 hours at 37°C to allow cells to attach. 
 
Late the following afternoon, the Transwell® permeable supports were transferred to the 
24-well plates containing ME-180 or HaCaT cells incubated at 37 or 33°C.  CCM from the 
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upper chamber was aspirated, and the Transwell® immediately lifted out of the well and 
transferred to a well containing the appropriate cell monolayer infected with 
C. trachomatis or uninfected cells for the negative control.  Four hundred microlitres of 
CGM-E was aspirated from the surface of the liquid in each well to prevent overflow when 
the Transwell® was inserted.  The upper chamber was immediately replenished with 100µl 
CGM-E.  For the caspase positive control, an uninfected HaCaT and ME-180 cell 
monolayer grown on a 12 mm round glass coverslip (Marienfield) at the appropriate 
temperature was treated with 100µl CGM-E to yield a final concentration of 20mM 
etoposide. The plates were returned to the incubators overnight.  Sixteen hours later, the 
BioVisionTM CaspGLOW Fluorescein Caspase Staining Kit was used to identify apoptotic 
cells in the upper chamber which were exposed, but not infected.  The staining procedure 
was modified for use with adherent cells.  Two hundred microlitres stain solution (1µl 
FITC-VAD-fmk per 300µl CGM-E) was added to the wells of a fresh 24-well plate.  
CGM-E was removed from the upper chambers of the Transwells® which were then 
immediately transferred to the wells prepared with the stain solution, and an additional 100 
µl stain solution added to the upper chambers.  For the caspase positive control, CGM-E 
was removed and 300 µl stain solution added directly into the appropriate well on the 
original cell monolayer.  All plates were incubated at 37°C for 1 hour.  A Transwell® insert 
was not used for the caspase positive control due to significant background fluorescence of 
the PE membrane when subjected to fluorescence microscopy after incubation with 
etoposide. 
 
After 1 hour, plates were removed from the incubator, and the PE membrane was washed 
twice by aspirating the stain solution. The Transwell® inserts were then transferred to a 
fresh well of the 24-well plate containing 200µl wash buffer; 100µl wash buffer was added 
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to the upper chamber. Plates were incubated for 5 minutes at room temperature.  The 
Transwells® were removed from the wells 1 at a time, and the PE membrane carefully cut 
off the Transwell® support using a scalpel blade.  The membrane was placed on a glass 
slide with 2 drops of wash buffer, and covered by a glass coverslip.  For the caspase 
positive control, the coverslip was washed twice with 300µl wash buffer for 5 minutes 
each directly in the original well of the 24-well plate.  The round glass coverslip was 
removed from the well, and placed cell side down on a glass slide.  All slides were read 
with a Nikon eclipse E600 fluorescent microscope using a filter with an excitation 
wavelength of 450-490 nm and an emission wavelength of 520 nm.  Images were captured 
in colour using a Nikon ColorView Soft Imaging System digital camera. 
 
3.11 Statistical analyses 
 
Preliminary statistical analyses were performed with GraphPad Instat® version 3.00.  The 
method of Kolmogorov and Smirnov was used to test for Gaussian distribution to indicate 
whether the data was parametric or not.  Bartlett’s test was used to investigate significance 
amongst the standard deviations (SD) of the groups. 
 
After the preliminary statistics, analyses were performed using SPSS version 15.0.  One-
way Analysis of Variance (ANOVA) with Tukey’s post test was used when data was 
parametric and the standard deviations were similar for all groups.  When the data was 
parametric but the SD were not equal, or when the data was non-parametric, the Kruskal-
Wallis non-parametric ANOVA was used.  If there was a significant difference amongst 
the medians, GraphPad Instat was used to perform Dunn’s multiple comparison’s test 
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which only reports the range of significance, not the exact P value.  Significance was set at 
P ≤ 0.05. 
 
Data was transformed by log 10 for inclusions per 10 thousand cells, area green and size of 
individual inclusions before analyses were conducted.  Transformations did not affect the 
normality of the data, nor the variation amongst the SD for percentage cytotoxicity or the 
MTT assay, therefore these results were not transformed for analyses. 
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CHAPTER 4 - RESULTS 
 
4.1 Chlamydial growth curves 
 
ME-180 and HaCaT cells were infected with C. trachomatis and incubated at 37°C only 
for the ME-180 cells, and 37 and 33°C for the HaCaT cells.  Growth was analysed using 
two different indicators: area occupied by chlamydia, and number of inclusions per 10 
thousand cells.  Counting the number of inclusions is the more commonly used techinique, 
but it does not take into account the size of the inclusion, which in turn reflects the number 
of organisms. 
 
All strains tested were able to enter, and replicate in both cell lines at both temperatures.  
This is indicated by the presence of green fluorescent inclusions in the cell culture 
monolayers (figures 1 to 3), and by an increase in the area occupied by chlamydia, and 
number of inclusions per 10 thousand cells from 1 to 5 days post infection (figure 4). 
 
The mean area occupied by chlamydia (figure 1) and mean number of inclusions per 10 
thousand cells (figure 4) was plotted against days post infection for each strain, cell type 
and temperature.  Growth curves are the same regardless of whether the means or medians 
are plotted. 
 
Null hypothesis 1: C. trachomatis replicates at the same rate in ME-180 cells at 37°C, 
HaCaT cells at 37°C and HaCaT cells at 33°C. 




When overall chlamydial growth in culture was compared there was an extremely 
significant difference in chlamydial growth (P < 0.001) with parametric and non-
parametric methods. This difference was observed using either area occupied by 
chlamydia, or inclusions per 10 thousand cells. Growth in HaCaT cells at 37°C was 
significantly different to growth in HaCaT cells at 33°C (P < 0.001).  There was no 
significant difference between chlamydial growth in HaCaT and ME-180 cells at 37°C (P 
values 0.5 and 1.0 for area occupied by chlamydia and inclusions per 10 thousand cells 
respectively).  Null hypothesis 1 was rejected and alternate hypothesis 1 accepted. 
 
Null hypothesis 2:  All strains of C. trachomatis replicate at an equal rate in ME-180 cells 
at 37°C. 
Alternate hypothesis 2:  Some strains of C. trachomatis replicate more rapidly than others 
in ME-180 cells at 37°C. 
 
There was an overall significant difference amongst the strains for both area occupied by 
chlamydia and inclusions per 10 thousand cells (P<0.001 for both).  Using area occupied 
by chlamydia (Figure 5A), serovar E was significantly different to L1, L2 and L3 (P < 
0.001, P < 0.001 and P < 0.05 respectively). No differences were found between serovar E 
and any of the clinical isolates (P < 0.05).  The serovar L2 reference strain was 
significantly different (P <0.01) from all 3 clinical isolates, although sequence analysis 
techniques indicated that these isolates were also serovar L2.  Serovar L1 was significantly 
different to US162 and US197 (P < 0.001 and P < 0.01 respectively).   Serovar L3 was 
significantly different to US162 and US197 (P < 0.001 and P < 0.05 respectively). 
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The number of inclusions per 10 thousand cells yielded a different set of results (Figure 
5B).  Serovar E was not significantly different to L1, L2 or L3, and US162 was 
significantly different (P < 0.01) to all other strains except US197.  Null hypothesis 2 was 
rejected and alternate hypothesis 2 accepted. 
 
The ME-180 cell growth curves for 5 days post infection (figures 4A and 4B) indicated 
that the LGV reference strains, most notably serovar L2, replicated more rapidly than the 
clinical isolates or serovar E.  The area occupied by chlamydia increased each day for all 
strains tested.  But the number of L2 inclusions per 10 thousand cells increased steadily 
until 4 days post infection, followed by a sharp decline between day 4 and 5, despite an 
increase in area occupied by chlamydia during the same time frame.  Fluorescent 
micrographs of serovar L2 infected ME-180 cells 5 days post infection illustrated many 
green chlamydial particles (figure 1B).  Some inclusions were still intact, but numerous 
free chlamydial particles were dispersed across the monolayer which no longer appears 
intact.  This is in contrast to the clearly defined serovar E inclusions (figure 4C) on a 
typical intact ME-180 cell monolayer. 
 
Null hypothesis 3:  All strains of C. trachomatis replicate at an equal rate in HaCaT cells at 
37°C. 
Alternate hypothesis 3:  Some strains of C. trachomatis replicate more rapidly than others 
in HaCaT cells at 37°C. 
 
In the HaCaT cells at 37°C all strains of C. trachomatis replicated as indicated by a steady 
increase in the area occupied by chlamydia and the number of inclusions per 10 thousand 
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cells (figure 4C and 4D).  However, both growth curves demonstrate a more rapid increase 
in the number of L2 organisms. 
 
The mean of the combined area occupied by chlamydia and combined number of 
inclusions per 10 thousand cells is plotted in figure 5 for each strain of C. trachomatis 
used. 
 
There was an overall significant difference amongst the strains for both area occupied by 
chlamydia and inclusions per 10 thousand cells (P = 0.001 and P = 0.019 respectively).  
Post tests revealed a significant difference when L2 was compared with E, US162 or US 
197 (P values 0.020, 0.000 and 0.024 respectively).  Inclusions per 10 thousand cells only 
indicated a significant difference between L2 and US162 (P < 0.01).  Null hypothesis 3 
was rejected and alternate hypothesis 3 accepted. 
 
Differences amongst the strains were also analysed for each day post infection.  There was 
no significant difference in area occupied by chlamydia at 1 day post infection, but this 
became extremely significant (P < 0.001) from days 2 through to 5.  At day 2 there was an 
extremely significant difference when serovar E or US162 was compared with the 3 LGV 
reference strains (P < 0.001 for all).  These remained significant at day 3.  However, at day 
4 there was no longer a difference between E and L1 or L3 (P values 0.460 and 1.000 
respectively).  There was a significant difference between L2 and L1 (P = 0.004), and an 
extremely significant difference between L2 and all other strains (P < 0.001).  The 
significant difference was sustained through to day 5. 
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With inclusions per 10 thousand cells L2 was significantly different to E, L1, L3, US151, 
US162 and US197 (P values 0.012, 0.019, 0.000, 0.016, 0.000 and 0.000 respectively) at 
day 4.  At day 5 there was only a significant difference between L2 and E, L1, L3 and US 
197 (P < 0.01), but not between L2 and US151 or US197. 
 
Null hypothesis 4:  All strains of C. trachomatis replicate at an equal rate in HaCaT cells at 
33°C. 
Alternate hypothesis 4:  Some strains of C. trachomatis replicate more rapidly than others 
in HaCaT cells at 33°C. 
 
In the HaCaT cells at 33°C, the area occupied by chlamydia increased from day 1 to day 5 
(figure 4E).  For L1 and L2, this was a steady increase, while the area occupied by the 
other strains reached a plateau or decreased slightly from day 4 to 5.  At day 1, all strains 
began with zero inclusions per 10 thousand cells (Figure 3C) due to inclusions being too 
small to visualise at low power so soon after infection under these conditions.  The day 1 
zero values were excluded from statistical analyses to prevent skewing of the data. 
 
With the exception of L1 and L2, the number of inclusions per 10 thousand cells remained 
steady for the duration of the experiment (figure 4F).  The number of L2 inclusions per 10 
thousand cells remained the same from days 2 to 3, then doubled from day 3 to day 5.  The 
number of L1 chlamydial inclusions per 10 thousand cells was higher than any other strain 
at day 2.  It increased slightly from day 2 to 3, but the number of inclusions decreased 
substantially from days 3 to 5, and at day 5 there were less inclusions than at day 2. 
 
 84
In the HaCaT cells at 33°C, area occupied by chlamydia and inclusions per 10 thousand 
cells indicated a significant difference in the overall growth between strains (P = 0.024 and 
P < 0.001 respectively) (figure 5E and 5F).  Overall, area occupied by chlamydia indicated 
a significant difference between L2 compared to E or US162 (P values 0.036 and 0.011 
respectively).  The number of inclusions per 10 thousand cells revealed significant 
differences between L2 and E (P = 0.014), as well as significant differences for US162 
compared with all other strains (P < 0.001 for all except L3 where P = 0.028). 
 
At 5 days post infection the number of serovar L2 inclusions was significantly different to 
E, L1 and L3 (P values 0.018, 0.029 and 0.001 respectively), but only 1 clinical isolate, 
US162 (P <0.001).  There was no significant difference between L2 and the clinical 
isolates US151 and US197 (P values 0.355 and 0.088 respectively).  However, when area 
occupied by chlamydia was used as an indicator of growth at 5 days post infection, serovar 
L2 was significantly different (P < 0.001) to all strains except L3, which was not quite 
significant (P = 0.056).  L3 was also significantly different (P < 0.01) to all strains except 
L2.  Null hypothesis 4 was rejected and alternate hypothesis 4 accepted. 
 
Visual inspection of the fluorescent micrographs revealed a difference in the maximum 
inclusion size attained by different chlamydial strains in HaCaT cells at 33°C.  Chlamydial 
inclusions begin small, but as the bacteria within inclusions replicate, the inclusions swell 
and increase in size.  However, not all strains of C. trachomatis appeared to reach the same 
maximum size.  
 
Null hypothesis 5: There is no difference in the size of chlamydial inclusions produced by 
different strains of C. trachomatis grown in HaCaT cells at 33°C. 
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Alternate hypothesis 5:  Some strains of C. trachomatis produce larger inclusions than 
others when grown in HaCaT cells at 33°C. 
 
The size of chlamydial inclusions was quantified by measuring the area (µm2) of individual 
inclusions in HaCaT cells at 33°C from 2 to 5 days post infection.  In figure 6, the median 
inclusion size, as indicated by area (µm2) was plotted against the number of days post 
infection for each strain of C. trachomatis.  At day 2, most inclusions were about 100µm2.  
The L2 inclusions grew rapidly from days 2 to 4, and the L3 inclusions grew rapidly from 
day 3 to 4, while the other strains exhibited more moderate inclusion growth.  There was 
however a sharp decline in the median inclusion size from days 4 to 5 for both L2 and L3.  
Despite the low median inclusion size, the maximum inclusion size for these strains at day 
5 was still higher than the maximum inclusion size produced by any other strain.  The data 
are skewed by the presence of numerous smaller inclusions at this time point.  The spread 
of area values is plotted for each day post infection in figure 6. 
 
The overall data indicated an extremely significant difference in inclusion size amongst the 
strains (P < 0.001), and post testing revealed extremely significant differences between 
most pairs of strains.  There were also extremely significant differences between the strains 
at each day post infection (P < 0.001).  The P values for individual strains summarized in 
table 2.  Null hypothesis 5 was rejected and alternate hypothesis 5 accepted. 
 
4.2 Transmission electron microscopy 
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TEM was used to investigate the ultrastructural effect that LGV and OG C. trachomatis 
had on their host cells, and to assess the replication cycle under conditions different to 
those described in the literature. 
 
In HaCaT and ME-180 cells at 37°C, both biovars exhibited the typical biphasic 
chlamydial replication cycle comprising both EB and RB. 
 
The spherical EB were approximately 350 nm in diameter with an electron-dense core of 
about 200 nm diameter.  Within this core was a darker region surrounded by aggregates of 
electron dense material (figure 8A).  The core was encased by a single 7nm membrane.  
The surrounding periplasmic space of 8-17 nm was enclosed by a prominent trilaminar 
outer envelope which was about 8 nm thick. 
 
With maturation, the RBs are larger at almost 1µm in diameter and more pleomorphic in 
shape.  The RB cell envelope exhibited a “ruffled-ballerina-skirt” (Peterson and de la Maza 
1988) appearance with some RB having a region of well-defined double trilaminar cell 
envelope while undergoing binary fission (figure 8B).  In this region the periplasmic space 
appeared septated with electron-dense structures perpendicular to the two membranes. 
 
Figure 9A illustrates a membrane-bound chlamydial inclusion in the cytoplasm of the cell 
at 18 hours post infection.  The infectious EB has already developed into a RB and 
undergone several rounds of binary fission.  Eleven RBs are seen within this inclusion.  
The inclusion is located adjacent to the nucleus, and has been pushed aside and become 
crescent-shaped as the inclusion of replicating bacteria grew.  By 24 hours post-infection 
some RB had already developed into EB, while others continue to replicate at the 
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periphery of the inclusion.  At 36 hours post infection (Figure 9B) the inclusion occupied 
most of the cell.  The nucleus had been pushed aside and the inclusion, which comprised a 
mixture of RB, intermediate bodies (IB) and EB, is surrounded by a thin layer of 
cytoplasm. 
 
In the HaCaT cells at 33°C, serovar E replicated in the typical manner described above for 
HaCaT cells at 37°C, albeit slightly slower – EB were first seen at 36 hours post infection 
compared to 24 hours post infection at 37°C.  With serovar L2, some intermediate bodies 
were present at 36 hours post infection, but EB were not detected.  At 48 post infection, no 
EB were detected within the chlamydial inclusion, instead 2 EB were seen migrating 
through the cytoplasm in a non-membrane bound state (figure 10C).  Both of these EB 
displayed the typical morphological characteristics and size of EB that were observed 
within inclusions. 
 
The ultramicroscopic effect of C. trachomatis on their host cells was also investigated. 
 
Uninfected ME-180 cervical cells were polygonal or round in shape, with some giant cells.   
Adjacent cells were connected by numerous desmosomal attachments.  The spherical 
nucleus was centrally located and encapsulated by a thin ring of tonofilaments.  Two or 3 
nucleoli were present.  In the cytoplasm, mitochondria were located in close proximity to 
the nucleus, while polyribosomes tended to be concentrated on the periphery of the cell.  
Several small vacuoles were also noted in the cytoplasm of uninfected cells. 
 
In this cell line, infection with either serovar resulted in similar cytopathic changes within 
the host cell.  At 1, 3 and 9 hours post-infection, organelle and cytoplasmic degeneration 
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were present.  Figure 11B shows the cytoplasm of a serovar E infected ME-180 cell with a 
degenerate mitochondrion with sparse cristae and a lucent matrix; whorled membranous 
myelin bodies indicative of involuting mitochodria, and regions of cytoplasmic lysis. 
 
Although chlamydia were usually compartmentalised within an inclusion in infected cells, 
in some instances there was no distinct division between the host cell cytoplasm and 
inclusion matrix with its associated chlamydial particles.  Figure 11C illustrates the close 
association between several mitochondria and chlamydial RB and EB.  In figure 11D two 
EB appear to migrate through the cytoplasm towards the host cell plasmalemma. 
 
At 48 h after serovar L2 infection, an ME-180 cell housed numerous EB within membrane-
bound vesicles (figure 12A, 12B).  Since this cell only had one small immature inclusion 
with RB only, it is likely that these EB were taken up by the cell after an inclusion in a 
neighbouring cell burst.  At this time point some mitochondrial pathology was noted in a 
serovar L2 infected cell with a non-membrane bound EB in the cytoplasm (figure 12C).  
Mitochondria were swollen, the cristae were fragmented and electron dense deposits were 
present in the mitochondrial matrix. 
 
Uninfected HaCaT keratinocytes at 37 or 33°C were polygonal in shape, with a centrally 
located nucleus containing 1 to 4 nucleoli.  Invaginations of the nucleus were common as 
well as regions of nucleoli margination, which are indicative of active protein synthesis.   
The cytoplasm contained numerous mitochondria and polyribosomes, as well as a few 
small vacuoles.  Tonofilaments were usually located in regions of cell-to-cell attachments, 




Cytopathic changes were noted in HaCaT cells at 37°C as early as 1 hour post infection.  
With serovar E infection the mitochondrion was the main organelle involved.  At 1 hour 
post infection swollen mitochondria with a lucent matrix and reduced cristae were noted.  
This phenomenon was not observed from 3 to 24 hours post infection but appeared again at 
36 and 48 hours post infection (figure 13C).  This corresponds with the time at which new 
immature inclusions with RB only were beginning to form.  This gross mitochondrial 
pathology was not observed in serovar L2 infected nor in uninfected cell monolayers.  In 
serovar E infected monolayers, myelin figures indicative of degenerate mitochondria were 
present from 3 hours post infection (figure 13B).  In contrast, organelle integrity in serovar 
L2 infected monolayers was maintained for longer – myelin figures were first observed at 
18 hours post infection (figure 14B).  However, the markedly swollen mitochondria 
described for serovar E infected cells were not observed in serovar L2 infected monolayers 
at any of the times tested. 
 
Many chlamydial inclusions contained a diffuse electron dense granular substance in a 
lucent matrix.  Vacuoles which appeared to contain this same substance were observed.  In 
figure 14C a serovar E infected HaCaT cell at 37°C is captured releasing the contents of 
one such vacuole into the extracellular space. 
 
There were no noticeable morphological differences between the uninfected HaCaT cells 
incubated at 33°C versus those incubated at 37°C. 
 
Apart from the formation of inclusions, C. trachomatis did not exert noticeable 
ultrastructural pathological changes on HaCaT cells at 37°C during the time period 
investigated.  Some myelin figures were present in the early stages post infection, but 
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generally mitochondria were intact.  Like the HaCaT and ME-180 cells, mitochondria were 
located in the vicinity of the chlamydial inclusion. 
 
Mitotic figures were observed in the ME-180 cell monolayers and HaCaT cell monolayers 
at both 37 and 33°C regardless of whether or not the monolayers had been infected. 
 
4.3 MTT assay 
 
The MTT assay was used to quantify the level of mitochondrial activity in chlamydia 
infected cells relative to uninfected cells for 48 hours post infection.  Data are expressed as 
a percentage of the level of mitochondrial activity in uninfected cells.  The etoposide 
treated positive control exhibited the expected decrease in percentage mitochondrial 
activity over 48 hours under all experimental conditions (figure 15).  These data are 
excluded from the analyses.  Data from the uninfected untreated negative control is 
included since it represents a baseline of 100% mitochondrial activity under the conditions 
tested. 
 
Null hypothesis 6:  There is no difference in the level of mitochondrial activity in ME-180 
cell at 37°C when infected with various strains of C. trachomatis compared to each other 
and uninfected cells 
Alternate hypothesis 6:  There is a difference in the level of mitochondrial activity in ME-
180 cell at 37°C when infected with various strains of C. trachomatis compared to each 
other and uninfected cells 
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Chlamydia infected ME-180 cell monolayers generated 92 to 102% mitochondrial activity 
compared to the negative control.  There was no overall significant difference in the level 
of mitochondrial activity amongst the strains and negative control (P = 0.102).  Nor was 
there a significant difference amongst mitochondrial activity assessed at any of the time 
points measured.  Null hypothesis 6 was accepted and alternate hypothesis 6 rejected. 
  
Null hypothesis 7:  There is no difference in the level of mitochondrial activity in HaCaT 
cells at 37°C when infected with various strains of C. trachomatis compared to each other 
and uninfected cells 
Alternate hypothesis 7:  There is a difference in the level of mitochondrial activity in 
HaCaT cells at 37°C when infected with various strains of C. trachomatis compared to 
each other and uninfected cells 
 
In the HaCaT cells at 37°C the level of mitochondrial activity 1 hour after C. trachomatis 
infection was 84%, 90% and 93% for serovars E, L2 and L3 respectively, compared to the 
negative control, which by definition, produced 100% mitochondrial activity.  Differences 
amongst the groups was significant at this time point (P = 0.001).  Serovars E and L2 were 
significantly different to uninfected cells (P < 0.001 and P = 0.027 respectively), but 
serovar L3 was not (P = 0.243).  There was also a slight significant difference between 
serovars E and L3 (P = 0.049), but not serovars E and L2 (P = 0.360).  Mitochondrial 
activity was partially restored by 3 hours post-infection and remained between 92% and 
105% compared to uninfected cells for all chlamydial strains tested from 3 to 48 hours post 
infection.  The difference in mitochondrial activity, regardless of the time point post 
infection at which this was measured, reached significance (P < 0.001).  Serovar E was 
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significantly different to the uninfected cells (P < 0.01), but no other comparisons reached 
significance.   Null hypothesis 7 was rejected and alternate hypothesis 7 accepted. 
 
Null hypothesis 8:  There is no difference in the level of mitochondrial activity in HaCaT 
cells at 33°C when infected with various strains of C. trachomatis compared to each other 
and uninfected cells 
Alternate hypothesis 8:  There is a difference in the level of mitochondrial activity in 
HaCaT cells at 33°C when infected with various strains of C. trachomatis compared to 
each other and uninfected cells 
 
In the HaCaT cells at 33°C, the level of mitochondrial activity in chlamydia infected cells 
at various time points post infection ranged from 94% to 104%.  No significant differences 
were detected amongst the overall levels of mitochondrial activity (P = 0.424) or at any of 
the time points tested.  Null hypothesis 8 was accepted and alternate hypothesis 8 rejected. 
 
4.4  Lactate dehydrogenase detection 
 
ME-180 and HaCaT cells were infected with C. trachomatis and incubated at 37°C only 
for the ME-180 cells, and 37 and 33°C for the HaCaT cells, and the percentage 
cytotoxicity assessed each day post-infection for 5 days.  In figure 16, the percentage 
cytotoxicity is plotted against days post infection. 
 
Null hypothesis 9: C. trachomatis is equally cytotoxic to ME-180 cells at 37°C, HaCaT 
cells at 37°C and HaCaT cells at 33°C. 
Alternate hypothesis 9: C. trachomatis more cytotoxic to some cell lines tested than others. 
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There was an overall significant difference in the median level of C. trachomatis induced 
cytotoxicity amongst cell lines and temperatures (P = 0.006).  There was a slight 
significant difference between the HaCaT cells at 37°C and 33°C (P < 0.05), and no 
significant difference between the ME-180 cells and HaCaT cells at 37°C.  Null hypothesis 
9 was accepted and alternate hypothesis 9 rejected. 
 
In both cell lines, at both temperatures, the median percentage cytotoxicity was close to 0 
for the first 2 days post-infection (figure 16).  In the HaCaT cells at 33 and 37°C, the 
median percentage cytotoxicity did not exceed 2% and 4% respectively, while 
C. trachomatis had a more dramatic effect on the ME-180 cell line. 
 
Null hypothesis 10: All strains of C. trachomatis are equally cytotoxic to ME-180 cells at 
37°C. 
Alternate hypothesis 10:  Some strains of C. trachomatis are more cytotoxic to ME-180 
cells at 37°C than others. 
 
In the ME-180 cells, the initial level of cytotoxicity was about 1%.  At day 3, there was a 
slight increase in the level of cytotoxicity for most strains.  By the fifth day post-infection, 
serovar L2 had induced 11.9 % cytotoxicity on the cell line, in contrast to all the other 
strains which exerted a protective effect, indicated by the negative percentage cytotoxicity. 
 
The overall percentage cytotoxicity exerted on ME-180 cells at 37°C did not reach 
significance (P = 0.283).  But when the effect of the C. trachomatis strains was assessed on 
a day-by-day basis there was a significant difference (P < 0.001) amongst the strains in this 
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cell line 5 days post infection.  Serovar L2 was significantly different to all 3 clinical 
isolates.  Post-tests indicated a significant difference between serovar L2 and all 3 clinical 
isolates (P < 0.01), but not the other strains.  Null hypothesis 10 was rejected and alternate 
hypothesis 10 accepted. 
 
In the HaCaT cells, the median percentage cytotoxicity approximated zero for the first 3 
days after infection, and even at 5 days post infection, the median percentage cytotoxicity 
did not exceed 2 and 4 % for the HaCaT cells at 33 and 37°C respectively. 
 
Null hypothesis 11: All strains of C. trachomatis are equally cytotoxic to HaCaT cells at 
37°C. 
Alternate hypothesis 11:  Some strains of C. trachomatis are more cytotoxic to HaCaT 
cells at 37°C than others. 
 
In general there are differences in the percentage cytotoxicity exerted on HaCaT cells at 
37°C by the strains of C. trachomatis tested.  The overall median percentage cytotoxity 
was 4%.  If only 4% of cells in an area of approximately 30mm2 (area of one well in a 96 
well plate) in the skin lyse and die this is unlikely to cause a noticeable ulcer.  US162 
produced significantly less cytotoxicity than serovar E or L3 (P values 0.016 and 0.049).  
Null hypothesis 11 was rejected and alternate hypothesis 11 was accepted. 
 
Null hypothesis 12: All strains of C. trachomatis are equally cytotoxic to HaCaT cells at 
33°C. 
Alternate hypothesis 12:  Some strains of C. trachomatis are more cytotoxic to HaCaT 
cells at 33°C than others. 
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In the HaCaT cells at 33°C differences in percentage cytotoxicity amongst the strains was 
not quite significant (P = 0.053).  Null hypothesis 12 was accepted and alternate hypothesis 
12 rejected. 
 
4.5 TUNEL Assay 
 
The TUNEL assay was used to investigate the spatial relationship between chlamydia 
infected cells and cells undergoing cell death. 
 
Figure 17 illustrates the TUNEL assay controls for the ME-180 cell line.  Figure 17A 
indicates the DNAase treated positive control.  Note the presence of numerous brown DAB 
positive nuclei (arrow heads).  Apoptotic cells are also present.  The nuclei of these cells 
are smaller and darker than the cells which were DAB positive due to DNAase treatment.  
The TUNEL negative control (figure 17B) omits the TdT enzyme; no dark brown DAB 
positive nuclei are present.  The uninfected cell monolayer (figure 17C) demonstrates only 
a few DAB positive nuclei as would be expected in normal cell turnover.  The controls for 
the HaCaT cell line at 37°C and 33°C are similar (not shown). 
 
In both the ME-180 cells and HaCaT cells at 37°C, more DAB positive cells were 
observed 2 days after infection with the LGV reference strains and clinical isolates than 
with the serovar E OG strain.  Images of light micrographs and fluorescent micrographs of 
the same field of view indicated that cells with DAB positive nuclei were often located 
immediately adjacent to infected cells (figure 18).  This was occasionally observed in 
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serovar E infected ME-180 or HaCaT cell monolayers.  Infected cells with a DAB positive 
nucleus were also observed. 
 
With the HaCaT cells at 33°C, chlamydial inclusions at day 2 were small for all strains 
tested.  There was about the same number of DAB positive cells in the infected and 
uninfected monolayers.  When the incubation step was extended to 5 days, the inclusions 
were larger, but there was still no increase in the number of DAB positive cells except for 
serovar L3 which exhibited a slight increase in the number of DAB positive cells, while the 
serovar E OG strain exhibited a slight decrease. 
 
At high magnification (X 1000), small non-nuclear DAB positive particles were observed 
in ME-180 and HaCaT cells monolayers grown at 37°C, but not in HaCaT cells at 33°C.  
These particles appeared to be housed within the chlamydial inclusion and had a diameter 
of about 0.7 µm (figure 19). 
 
4.6 Caspase detection 
 
The caspase assay coupled with Transwell® permeable inserts was used to elucidate 
whether chlamydia-induced cytotoxicity occurred in infected and neighbouring cells alone, 
or whether C. trachomatis infection could cause apoptotic activity in uninfected cells over 
a distance.  This was assessed in ME-180 and HaCaT cells at 37°C, as well as HaCaT cells 
at 33°C. 
 
Figure 20 illustrates caspase positive cells in uninfected cell monolayers.  The cells in C, 
D, G, H, K and L have been exposed to chlamydia-infected cells via shared culture 
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medium across a permeable membrane.  The cells in A, E and I were exposed to uninfected 
cells, while the cells in B, F and J were treated with the apoptotic agent, etoposide. 
 
Under all conditions tested, the etoposide treated positive controls housed at least 10 times 
the number of caspase positive cells observed in the untreated unexposed negative control.  
With the ME-180 cells, the average number of caspase positive cells per 200 X field of 
view was 1.8 and 2.7 for serovar E and L2 respectively, compared to 1.0 for the negative 
control.  With the HaCaT cells at 37°C there were 1.9 and 3.1 caspase positive cells for 
serovars E and L2 respectively, compared to 1.1 for the negative control.  In the HaCaT 
cells at 33°C there was an average of between 1 and 2 caspase positive cells per 200 X 
field of view for the negative control and both serovar E and L2.  These results indicate 
that chlamydia-infected ME-180 and HaCaT cells at 37°C may exert a cytotoxic effect on 

































Figure 1.  Fluorescent micrographs of 
ME-180 cells 5 days post infection at 
37°C depicting uninfected (A), serovar 
L2 infected (B), and serovar E-infected 
monolayers (C).  Chlamydia are stained 
green; host cells are stained red.  Notice 
the abundant serovar L2 inclusions and 
the free chlamydial particles which are 
dispersed across the monolayer in 
contrast to the serovar E inclusions which 
are well defined and fewer in number.     
































Figure 2.  Fluorescent micrographs of 
HaCaT cells 5 days post infection at 
37°C depicting uninfected (A), serovar 
L2 infected (B), and serovar E-infected 
monolayers (C).  Chlamydia are stained 
green; host cells are stained red.       
Notice the abundant serovar L2 
inclusions with some free chlamydial 
particles compared to the relatively few, 
well defined serovar E inclusions.   


































Figure 3.  Fluorescent micrographs of 
HaCaT cells 5 days post infection at 
33°C depicting uninfected (A), serovar 
L2 infected (B), and serovar E-infected 
monolayers (C).  Chlamydia are stained 
green; host cells are stained red.       
Serovar L2 inclusions (B) occupied a 
larger area of the monolayer and 
displayed a wider variation in the size of 
individual inclusions than serovar E.  




































































































































































































































Figure 4.  Chlamydial growth curves as indicated by mean area occupied by chlamydia (A, 
C, E), and mean number of inclusions per 10 thousand cells (B, D, F) in ME-180 cells at 
37°C (A, B), HaCaT cells at 37°C (C, D), and HaCaT cells at 33°C (E, F). 





























Figure 5.  Overall chlamydial growth as indicated by mean area occupied by chlamydia (A, 
C, E) and number of inclusions per 10 thousand cells (B, D, F) in ME-180 cells at 37°C 
(A, B), HaCaT cells at 37°C (C, D), and HaCaT cells at 33°C (E, F).  Error bars represent 
± 1 standard error of the mean. 












































































































































































































































































































































Table 3.  Significance levels for chlamydial inclusion size in HaCaT cells at 33°C 
 
 E L1 L2 L3 US151 US162 US197 
E  *** *** *** *** *** *** 
L1 ***  *** ns *** ns Ns 
L2 *** ***  *** *** *** *** 
L3 *** ns ***  *** ns ** 
US151 *** *** *** ***  *** ** 






US197 *** ns *** ** ** ***  
E  ns ** ** ns ns Ns 
L1 ns  ** *** ns ns Ns 
L2 ** **  *** ns ns Ns 
L3 ** *** ***  *** ** *** 
US151 ns ns ns ***  ns Ns 





US197 ns ns ns *** ns ns  
E  ns *** ns ns ns Ns 
L1 ns  *** ns ns ns Ns 
L2 *** ***  *** *** *** *** 
L3 ns ns ***  ns ns Ns 
US151 ns ns *** ns  ns Ns 





US197 ns ns *** ns ns ns  
E  * *** *** ns ns Ns 
L1 *  *** ns ns ns Ns 
L2 *** ***  ns *** *** *** 
L3 *** ns ns  ns ** Ns 
US151 ns ns *** ns  ns Ns 





US197 ns ns *** ns ns ns  
E  ns ns ns ns ns Ns 
L1 ns  ns ns ns ns Ns 
L2 ns ns  ns * ns * 
L3 ns ns ns  ns ns Ns 
US151 ns ns * ns  ns Ns 





US197 ns ns * ns ns ns  
ns, not significant 
* P < 0.05 
** P < 0.01 












Figure 9. TEM micrographs of C. trachomatis infected cells at 37°C.  (A) ME-180 cell 18 
h after serovar E infection, and (B) HaCaT cells 36 h after serovar L2 infection. 
Nu, nucleus; I, chlamydial inclusion 
Figure 8.  TEM micrographs showing the ultrastructure of a C. trachomatis EB (A) and a 
RB undergoing binary fission (B).  Notice the well defined structure in the region of the 
RB attached to the inclusion membrane (circled) 
 
Figure 9.  TEM micrographs of C. trachomatis infected cells at 37°C.  (A) ME-180 cell 18 h after serovar 
E inf ction, and (B) HaCaT cells 36 h after ser var L2 fection. 
Notice the immature in lusion with RB only at 18 h post infection, compared to 36 h post i fection where 
the inclusion containing both RB and EB has taken over the cell. 








Figure 10.  TEM micrographs of HaCaT 
cells 48 hours after infection with 
C. trachomatis at 33°C, (A) serovar E 
infection, (B, C) serovar L2 infection. 
Notice the relative abundance of EB in the 
serovar E inclusion compared to the lack of 
EB in the serovar L2 inclusion at the same 
time point.  In C, a serovar L2 EB is seen 
in the cytoplasm of an infected cell. 
 





















Figure 11.  TEM micrographs of ME-180 cells at 37°C illustrating the cytoplasm of an 
uninfected cell (A) and C. trachomatis serovar E infected cells at 1 hour (B) and 36 hours 
(C, D) post infection.  
Notice the cytopathic changes in the cytoplasm of cells at 1 h post infection (B) compared to 
the uninfected cells (A).  In C and D, C. trachomatis exists in a non-membrane bound state.  
In C, the EB and RB are in close proximity to numerous intact mitochondria (M).  In D, 2 
EB appear to migrate through the cytoplasm towards the plasmalemma of their host cell.  











































Figure 12.  TEM micrographs of serovar 
L2 C. trachomatis infected ME-180 cells 
48 h post infection at 37°C. 
In figure A, notice the numerous EB 
within the cytoplasm of a cell containing 
an immature inclusion with RB only.  At 
higher magnification a membrane (arrow 
heads) enclosing each EB is visible (B).  
Swollen mitochondrion with degenerate 
cristae and regions of cytoplasmic lysis 
are observed alongside a non-membrane 
bound EB (C). 



































Figure 13.  TEM micrographs of HaCaT 
cells at 37°C illustrating the cytoplasm 
of an uninfected cell (A), and a serovar E 
infected cell at 18h (B) and at 48 h (C) 
post infection. 
Notice difference between the intact 
mitochondrion in the uninfected cell 
shown in A, compared to the swollen 
mitochondria with a lucent matrix and 
reduced cristae in the serovar E infected 
cell in C. 
M, mitochondrion; My, myelin figure; 











































Figure 14.  TEM micrographs of HaCaT 
cells at 37°C illustrating the cytoplasm of 
cells 36 h after C. trachomatis serovar L2 
infection (A, B) and 24 hours after serovar 
E infection (C). 
Notice the intact mitochondrion (M) in 
13A compared with the mitochondrion of 
an uninfected cell (12A).  Some myelin 
figures are also present (13B).  Notice also 
the vacuole of diffuse electron dense 
granular material which is being released 
from a serovar E infected HaCaT cell. 
I, inclusion; M, mitochondrion; My, 
myelin figure; N, nucleus; RB, reticulate 




















































































































































Figure 15.  Relative percentage of mitochondrial activity in ME-180 cells at 37°C (A), 
HaCaT cells at 37°C (B), and HaCaT cells at 33°C (C) taken at various time points during 
the first 48 hours after chlamydial infection.  Mitochondrial activity was quantified using 













































































































































Figure 16.  Median percentage C. trachomatis-induced cytotoxicity for 5 days post-




























































Figure 17.  ME-180 cell controls for the 
TUNEL assay.  (A) DNase treated 
positive control, (B) TdT free negative 
control, and (C) uninfected control.  Note 
the abundance of dark brown DAB 
positive nuclei (arrows) in the positive 
control, absence in the negative control, 
and presence in small numbers in the 
uninfected control 
Original magnification X 400 
 










Figure 18.  ME-180 cells 2 days post-infection with C. trachomatis serovar E (A, B) or L2 
(C, D).  The TUNEL stained bright field micrographs on the left represent the same field 
of view as the fluorescent micrographs on the right.  Note the spatial relationship between 
the DAB positive nuclei and chlamydial inclusions in the L2 infected monolayer 
(indicated by blue circles). 























Figure 19.  Bright field (A, C) and 
fluorescent micrographs (B) of the same 
field of view of a C. trachomatis serovar 
E infected ME-180 cell monolayer at 
37°C.  Notice the small extranuclear 
TUNEL positive specks which have been 
stained with the DAB chromagen 
(brown).  In the fluorescent micrograph 
(B) C. trachomatis is stained green and 
the cells are stained red.  A comparison 
of the position of the chlamydial 
inclusion with that of the DAB positive 
specks indicates that these specks may be 
inside the inclusion.  The diameters of 5 
TUNEL positive specks are indicated in 
figure C, which represents a rotated 
enlargement of the blocked area in A. 




































ME-180 cells at 37°C 
C D G H 
I J 
HaCaT cells at 37°C 
HaCaT cells at 33°C 
Figure 20.  Micrographs of caspase 
positive cells in uninfected ME-180 and 
HaCaT cell monolayers after exposure 
to uninfected cells (A, E, I), 20 µM 
etoposide (B, F, J), serovar E infected 
cells (C, G, K) or serovar L2 infected 
cells (D, H, L) for 16 hours.  Only the 
caspase positive apoptotic cells are 
shown.  The green component of the 
fluorescent micrographs was selected 
and the images binarized. 
Original magnification X 200 
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CHAPTER 5 – DISCUSSION 
 
Despite more than 99.6% genetic identity between C. trachomatis serovars (Carlson et al 
2004) there are marked differences in virulence, growth rates, tissue tropism and disease 
profile.  Serovars D-K of the OG biovar cause discharge disease (urethritis or cervicitis) 
which may progress to epididymitis and prostatitis or pelvic inflammatory disease in males 
and females respectively; strains of the LGV biovar cause LGV which is characterised by 
genital ulcers and lymphadenopathy (Ward 2002) or proctitis in gay men (Nieuwenhuis et 
al 2004).  Numerous differences in in vitro culture requirements (Lee 1981) have been 
reported, as well as a difference in the length of the replication cycle (Miyairi et al 2006).  
More recently molecular analyses have revealed small genetic differences which reflect the 
tissue tropism and disease profile of these organisms (Carlson et al 2004, Caldwell et al 
2003, Fehlner-Gardiner et al 2002). 
 
We aimed to further characterise the behavioural differences between strains of the OG 
and LGV biovar, and compare LGV reference strains with fresh clinical isolates from our 
setting.  
 
Previous studies have utilized cells which were not the native host cell, conditions which 
did not resemble those at the initial site of infection and reference strains rather than fresh 
clinical isolates.  In this study we utilized conditions which more closely resemble the 
initial site of infection for each biovar.  Because the first target of infection for the LGV 
organisms is skin, keratinocytes were used, while cervical cells are one of the primary 
targets of the OG strain.  Both cell lines were infected with both biovars for comparison 
purposes.  Both the HaCaT keratinocytes and the ME-180 cervical cells have retained the 
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typical characteristics of their wild-type counterparts (Boukamp 1988, Sykes 1970).  The 
ME-180 cell line was used instead of the HeLa cell line since the ME-180 cell line is 
newer and thought to approximate the behaviour of native cervical cells more closely than 
HeLa cells.  Cycloheximide or other substances which alter the host cell metabolism were 
not used in order to ascertain the effect of the organism on host cells under conditions 
which resemble the in vitro situation as closely as possible.  But centrifugation was used to 
infect the cells.  A low MOI was used to ensure the availability of uninfected cells for the 
progeny organisms to infect. This study is also unique in that there are no published reports 
on C. trachomatis infection of keratinocytes, despite the fact that skin is the first site of 
infection for the LGV organisms.  The 3 LGV clinical isolates were passaged no more than 
five times in our laboratory and this was done in McCoy cells using the method described 
in 3.2.  This was necessary to produce suffient numbers of the organism for use in 
experiments.  Chicken eggs where not used.  The reference strains we received had been 
stored in the yolk sac of chicken eggs and had been passaged as follows: serovar L1 (strain 
440L), 25 times; serovar L2 (strain 434B), 10 times and serovar L3 (strain 404L) 26 times.  
Subsequent to this these strains were passage 6 to 8 times in our laboratory in McCoy cells 
using the method described in 3.2. 
 
In the chlamydial growth curve experiments the three LGV reference strains grew more 
rapidly than the OG strain or the fresh clinical isolates in ME-180 cells at 37°C.  This is 
indicated by both area occupied by chlamydia and inclusions per 10 thousand cells.  There 
was a decline in the mean number of L2 reference strain inclusions per 10 thousand cells 
from day 4 to 5 post infection with a steady increase in area occupied by chlamydia during 
the same time frame.  This is explained by the rupture of inclusions under these conditions 
resulting in decreased inclusion counts.  Immunofluorescence at this time point indicated 
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numerous free chlamydial particles scattered over the now disrupted monolayer.  These 
organisms were included in the area occupied by chlamydia measurement but not the 
inclusion counts.  In summary, the LGV reference strains showed a different growth 
pattern than the clinical isolates and the OG strain which was also a clinical isolate from a 
patient with urethritis. These differences might relate to the higher number of in-vitro 
passages of the reference strains or to the fact that the clinical isolates, including the OG 
strain were never grown in chick embryos. 
 
All strains of chlamydia tested entered, and replicated in HaCaT cells at both 37 and 33°C 
to produce visible inclusions.  At 37°C, replication of the L2 reference strain was 
significantly more rapid than any other strain, including the L1 and L3 reference strains 
and the fresh LGV clinical isolates which were categorized as serovar L2.  This dramatic 
difference in behaviour between the L2 reference strain and fresh L2 clinical isolates 
indicates a need for fresh clinical isolates for use in pathogenesis studies.  
 
Chlamydial replication in HaCaT cells was significantly slower for all strains tested at 
33°C despite the fact that 33°C is the temperature of human skin which is the first target of 
infection for the LGV organisms.  At 1 day post infection inclusions in monolayers 
incubated at 33°C were smaller than those in monolayers incubated at 37°C and too small 
to visualize and enumerate at low magnification.  Both van Ooij et al (1998) and Fields et 
al (2002) reported a smaller inclusion size when infected cells were incubated at a lower 
temperature.  In both studies HeLa cells were infected with C. trachomatis serovar L2 at 
37°C for 1 hour, and then incubated at 32 or 37°C for at least 24 hours.  Inclusions were 
smaller when incubated at 32°C than at 37°C. Haemophilus ducreyi, one of the other 
causes of genital ulcer disease, shows optimal growth at 33°C (Sturm and Zanen, 1984). It 
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has been postulated that this is responsible for the difference in prevalence of chancroid 
between male and female. Such a difference does not exist for other genial ulcers. This is 
in keeping with the optimal growth of C. trachomatis biovar LGV at 37°C. LGV infection 
in the male patient might induce a more intense inflammatory response as compared to H. 
ducreyi infection, increasing the local temperature from surface to core level. 
 
Growth curves plotted for chlamydial growth in HaCaT cells at 33°C were different when 
area occupied by chlamydia and inclusions per 10 thousand cells were used as an indicator 
of growth.  Inclusions per 10 thousand cells only takes the number of inclusions into 
account, whereas mean area occupied by chlamydia takes into account both the number of 
inclusions present and the size of the inclusions.  This is a more accurate reflection of the 
actual number of organisms because in general, the larger the inclusion, the more 
organisms present. 
 
The growth curve produced using inclusions per 10 thousand cells showed an increase in 
the number of serovar L2 reference strain inclusions.  This indicates that the progeny EB 
for this strain were infectious when grown in HaCaT cells at 33°C.  This is in agreement 
with the results obtained by Fields et al (2002) using the same strain.  The number of 
inclusions produced in monolayers infected with other strains was either stable throughout 
the times tested, or declined.  Since the serovar L2 reference strain was shown to replicate 
more rapidly than any other strain at 37°C, and the dramatic increase in inclusions per 10 
thousand cells at 33°C only occurred between days 4 and 5 post infection, it is possible that 
an incubation period of 5 days is too short for the same effect to be observed with the other 
strains tested.  The decline in inclusions per 10 thousand cells observed with serovar L1 
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and L3 may be due to the rupture of mature inclusions.  The resulting inclusions produced 
by progeny EB could be too small to be detected at this time point. 
 
In contrast, mean area occupied by chlamydia indicated an increase in the number of 
organisms from day 1 to day 5 for all strains tested.  Again the L2 reference strain 
replicated more rapidly than any other strain tested. This likely indicates that the L2 
reference strain is better adapted to in vitro growth than the others.  
 
Visual inspection of the stained monolayers indicated a difference in the maximum 
inclusion size attained by different strains of C. trachomatis grown in HaCaT cells at 33°C.  
These observations were quantified by measuring the size of individual inclusions using 
image analysis software.  While the maximum size of inclusions for the clinical isolates 
and serovar E reached little more than 1000 µm2, the maximum inclusion size for the L1, 
L2 and L3 reference strains was 1873, 4489 and 3178 µm2 respectively.  Of particular 
interest is the fact that the fresh clinical isolates were also shown to be serovar L2.  This 
again indicates a difference in the behaviour of the reference strains compared to the fresh 
clinical isolates.  Either the reference strains have been modified by decades of culture 
under conditions different to those in vivo, or the strains present in our setting are different 
to the reference strains.  Either way, fresh clinical isolates are imperative for pathogenesis 
studies of LGV in our setting. 
 
The chlamydial replication cycle of an LGV and an OG strain was compared in ME-180 
and HaCaT cells at 37°C, and in HaCaT cells at 33°C using TEM. 
 
Both EB and RB exhibited the same morphology that has been described in the literature. 
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EB were spherical with a 350 nm diameter with an electron dense core of tightly packed 
DNA.  This core was enclosed by a trilaminar cytoplasmic membrane and outer envelope.  
These structures were previously described and measured by Ward (1983) who reported 
similar measurements to those reported in this study.  In addition, we report that the 
electron dense core was not centrally located yielding a periplasmic space which varied 
from 8 to 17 nm.  The tiny projections present on the external surface of the outer envelope 
(figure 8A) have been described by Matsumoto et al (1976) and Stokes (1978) in 
C. psitacci EB.  These structures span the outer envelope terminating in small round 
protrusions on the inner surface of the outer envelope.  The authors propose that these 
structures may have a role in EB uptake by cells, resistance of the organism to lysosomal 
enzymes or other functions. 
 
The RBs were larger at almost 1µm in diameter and demonstrated a more irregular shape.  
The outer envelope has been described to exhibit a “ruffled-ballerina-skirt” appearance 
(Peterson and de la Maza 1988).  This may be due to a loss of the rigid polypeptide 
structure of the EB cell wall (Matsumoto and Manire 1970) and the absence of sulphur 
containing amino acids which allow sulphur bridging between polypeptide chains and 
confer stability (Tamura and Manire 1967).  RBs lack the electron dense core present in 
EB.  During this stage the DNA is unravelled to allow transcription and translational.  This 
is the metabolically active life form which replicates by binary fission (Ward 1983).  RBs 
undergoing binary fission were often intimately associated with the inclusion membrane 
and some exhibited an apparently rigid region of well-defined double trilaminar cell 
envelope.  The periplasmic space was bridged by electron-dense structures perpendicular 
to the two membranes to create a septated appearance.  This was previously observed by 
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Peterson and de la Maza (1988) in HeLa cells infected with C. trachomatis (L2), C. psittaci 
and the TWAR-183 strain.  Wyrick (2000) explains these structures as the same 
projections present on the EB.  They are hollow and extend from the RB, through the 
inclusion membrane to the host cell cytoplasm.  This may allow the exchange of energy 
and nutrients from the host cell to the replicating RB, or alternately, these structures may 
function as a TTSS. 
 
Together these results indicate that RB structure is the same regardless of the host cells in 
which they are grown. 
 
The typical biphasic replication cycle that has been extensively described (Ward 1983) was 
observed for both strains when grown in ME-180 or HaCaT cells at 37°C. 
 
In the HaCaT cells at 33°C the replication cycle was the same for the OG strain, albeit 
slightly slower.  With the L2 reference strain, a few intermediate bodies were observed at 
36 h post infection.  At 48 hours post infection, L2 inclusions still comprised replicating 
RB and no detectable EB.  This is contrasted by the presence of numerous EB present in 
serovar E inclusions 48 hours after infection at 33°C. Since no electron microscopy was 
done using an L2 clinical isolate, these differences can either be the result of differences 
between OG and LGV biovars or between clinical isolates (OG) and laboratory adapted 
reference strains. Although no EB were observed inside L2 inclusions at 48 hours post 
infection, EB were detected in a non membrane bound state in the cytoplasm of cells 
containing an inclusion of RB (figure 10C).  In HaCaT keratinocytes at 33°C a state of 
persistent infection may be established.  Serovar L2 C. trachomatis may escape the 
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chlamydial inclusion and migrate through the cytoplasm of the host cell towards the 
underlying layers of the skin without rupture of the original host cell. 
 
When viewed in light of the giant inclusions observed in the immunofluorescence growth 
curve experiment, it is possible that the L2 reference strain does not exit the host cell via 
cell lysis when grown in keratinocytes at 33°C.  Instead an inclusion with continuously 
replicating RB is maintained.  As EB develop, they escape from the inclusion, and migrate 
through the cytoplasm to infect the underlying layers of skin.  Ward (1983) has suggested 
the possibility of small numbers of EB being released from persistently infected cells via 
budding of the host cell membrane in a manner similar to that of Rickettsia prowazeki.  
Unlike the persistent state of infection described in the literature, the RBs observed in this 
study were not markedly swollen with aberrant morphology (Beatty et al 1994b).  
Schramm and Wyrick (1995) investigated the host cell cytoskeletal requirements of 
C. trachomatis serovar E versus L2.  In the model of infection proposed by the authors, 
serovar E is said to be released from the apical surface of infected polarized cells, in 
contrast to serovar L2, which is released from the basolateral surface to infect the 
underlying tissues.  This model, together with our observation of free L2 EB migrating 
through the cytoplasm explains the classical presentation of the disease – inguinal 
lymphadenopathy which frequently occurs without history of a genital ulcer, and when a 
genital ulcer is present it is transient and painless (Schachter and Osoba 1983). 
 
The difference in the clinical presentation of LGV – absence of an ulcer versus painful 
ulcer – may be determined by the level of inflammation at the site of infection.  An 
inflammatory response at the site infection would cause a local increase in the temperature 
of skin.  The organism would replicate more rapidly resulting in tissue damage and the 
 125
presence of an ulcer.  In the absence of an inflammatory response the temperature of skin 
would remain at 33°C.  The organism may establish a persistent state of infection without 
lysis of the host cell.  Instead infectious EB will be continuously shed to infect the 
underlying tissues and ultimately migrate to the inguinal lymph nodes without the 
formation of an ulcer. 
 
In our setting patients usually present in the primary stage, and the ulcer is painful, rather 
than the painless ulcers described in the literature (Sturm et al 2005).  The difference in 
clinical presentation may also be attributed to a difference in the physiology of the 
organisms isolated.  All 3 reference strains were isolated from bubonic aspirates in a group 
of military servicemen or seamen who had recently returned to the USA from Asia 
(Schachter et al 1969).  Only 4 of the 11 patients in the group had primary lesions, and 2 of 
these hadn’t even noticed the primary lesion which was detected on examination.  The 
fresh clinical isolates used in this study were isolated from genital ulcers before inguinal 
lymphadenopathy occurred.  Other climatic and patient demographic factors may also 
affect the clinical presentation of the disease. 
 
Either way, skin cells (and cervical cells) do not escape unaffected.  The organism does 
enter and undergo its typical lifecycle.  Like other studies (Fields et al. 2002, Campbell et 
al 1989), intracytoplasmic inclusions form in the perinuclear region for both biovars under 
all conditions tested.  As the inclusion grows it pushes the nucleus aside.  Mitochondria are 
intimately associated with the inclusion like in the studies of Friis (1972) and Peterson and 
de la Maza (1988).  This is expected since chlamydiae require ATP from their host cells 
and RB have been shown to transport ATP and ADP via an ATP-ADP exchange 
mechanism but EB cannot (Hatch et al 1982). RBs also tend to be located at the periphery 
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of the inclusion.  This was described previously (Peterson and de la Maza, 1988, Phillips et 
al, 1984)  Together these results indicate that the overall effect of LGV and OG 
C. trachomatis on HaCaT keratinocytes and ME-180 cervical cells is not unlike that 
observed with other chlamydiae like C. psittacii on other cell lines. 
 
Because the aim of this study was to investigate potential pathological differences between 
the LGV and OG organisms, the cytoplasm of infected cells was examined. 
 
In the ME-180 cells organelle and cytoplasm degeneration was noted at 1, 3 and 9 hours 
post infection for both biovars indicating that LGV and OG strains of C. trachomatis have 
a similar ultrastructural effect on this cell line.  In some inclusions at the later stages of 
infection there was no membrane separating the organism from the host cytoplasm.  In the 
microcinematographic study by Campbell et al (1989) inclusions of the trachoma organism 
were seen to burst while still inside their host cell.  LGV organisms were not included in 
the study, but in the current study some inclusions without any distinct membrane were 
observed for both biovars allowing RB and mitochondria to exist side by side (figure 11C).  
EB were also captured in a nonmembrane bound state migrating through the cytoplasm 
(figure 10C, 11D, 12C).  The absence of an inclusion membrane at the later stages of 
infection and non membrane bound organisms were also described by Todd and Caldwell 
(1985). This suggests that host cell lysis and exocytosis is not the only way these 
organisms are released from host cells. 
 
At 48 hours after infection mitochondrial pathological changes were observed in 
monolayers infected with the LGV organism but not the OG organism.  Swollen 
mitochondria with fragmented cristae and electron dense deposits in the mitochondrial 
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matrix were observed.  These degenerate mitochondria looked different to the “disrupted” 
mitochondria observed by Friis (1972) in his study on C. psittaci on L-929 cells.  
 
In HaCaT cells at 37°C, the mitochondrion was the main organelle to exhibit pathological 
changes.  Because swollen degenerate mitochondria in serovar E infected cells occur early 
in the infectious cycle, and not in L2 infected cells, it is unlikely to be caused by “over-
worked” mitochondria.  Instead it may be due to a preformed EB cytotoxin such as that 
described by Belland and co-workers in 2001.  This preformed cytotoxin was produced by 
an OG isolate but not serovar L2, and was shown to induce cell rounding and cytoskeletal 
collapse when host cells were infected at a high multiplicity of infection.  It is also possible 
that this early pathological effect could be due to chlamydial endotoxin or the lipid A 
component of the chlamydial endotoxin and warrants further investigation. 
 
Because myelin figures were present with both biovars throughout infection it is likely that 
this is a result of another pathogenic mechanism other than a preformed toxin.  Myelin 
figures, also known as myeloid bodies, are membrane bound aggregates of smooth 
membranes arranged in a concentric or reticular fashion (Hruban et al 1972).  They are part 
of the lysosome family.  Although they may be present in normal cells, myeloid figures 
tend to accumulate in cells treated with a variety of drugs and disappear after removal of 
the drug.  The absence of myelin figures in the uninfected control cells in our study, 
indicates that the presence of these structures was chlamydia-induced, and not due to the 
treatment of the cells during the infection process. 
 
The large secretory vesicle voiding its material to the extracellular space (figure 14C) 
housed sparse flocculent and particulate matter in an electron lucent matrix. This resembles 
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the matrix of chlamydial inclusions, as well as the lysosomes containing partially degraded  
mucopolysaccharide observed in a liver biopsy of a patient with Hurler’s disease 
(Ghadially 1982).  This same cell with the secretory vesicle housed an inclusion with a 
morphologically similar matrix.  Giles et al (2006) report the presence of numerous 
vesicles emanating from the chlamydial inclusion of serovar E infected polarised HEC-1B 
cells.  The vesicle matrix featured in our study looks identical to those in the electron 
micrographs reported in this paper.  Giles et al (2006) demonstrated the presence of the 
inclusion membrane proteins IncA, IncF and IncG in the vesicle membrane as well as 
chlamydial heat shock proteins copies 2 and 3.  We demonstrate the fusion of a 
morphologically identical vesicle with the host cell plasmalemma. 
 
In the HaCaT cells at 33°C, there were no noticeable ultrastructural pathological changes 
observed other than the typical features of C. trachomatis infection in other cells, including 
the presence of some myelin bodies.  Both strains produced the same effect on their host 
cells. 
 
Mitotic cells were observed under all conditions tested regardless of the cell line, 
temperature, the infecting organism or time post infection.  Crocker et al (1965) reported 
no delay in the HeLa cell cycle when cells were infected at a low MOI such as that used in 
this study.  The cell cycle was delayed when L cells or HeLa cells were infected with 
C. psittaci or C. trachomatis respectively at a high MOI (Horoschak and Moulder 1978, 
Bose and Liebhaber 1979). 
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Although dead and degenerate cells were visualised with TEM, one cannot accurately 
compare the relative quantity of these cells, because in cell culture monolayers, dead cells 
are sloughed off into the culture medium and are thus unavailable for TEM assessment.  
 
The MTT assay was employed to quantify the mitochondrial pathology observed in the 
TEM studies.  This assay is based on the cleavage of tetrazolium salts by dehydrogenase 
enzymes present in active mitochondria (Mosmann 1983).  The assay is not usually used to 
investigate the cytotoxicity of bacteria on eukaryotic cells due to the ability of bacterial 
metabolic enzymes to also cleave the tetrazolium salt (Grare et al, 2008).  We used this 
assay because C. trachomatis is an obligate intracellular pathogen which relies on ATP 
generated by its host cell’s mitochondria (Hatch et al, 1982). The first published report of 
MTT assay use in a study on C. pneumoniae was by Kartikasari et al in 2006. These 
authors used the test to measure cell viability. 
 
In the current study, no significant differences in the level of mitochondrial activity was 
detected at any time point in ME-180 cells at 37°C or HaCaT cells at 33°C.  This is in 
keeping with the lack of significant ultrastructural mitochondrial pathology observed under 
these conditions. 
 
In the HaCaT cells at 37°C, there was an extremely significant decrease in the level of 
mitochondrial activity in serovar E infected monolayers and a significant decrease in the 
level of mitochondrial activity in serovar L2 infected monolayers when compared to the 
uninfected control at 1 hour post infection.  This indicates that the numerous swollen 
mitochondria with a lucent matrix and reduced cristae observed at this time point do have a 
significant effect on host cell metabolism in these monolayers.  The restoration of 
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measured mitochondrial activity from 3 hours post infection supports the fact that these 
pathological mitochondria were not observed from 3 to 24 hours post infection.  Markedly 
swollen mitochondria were visualized again at 36 and 48 hours post infection.  This 
corresponded with a decline in the level of mitochondrial activity at 36 hours post 
infection, but did not reach significance.  This may be due the fact that these swollen 
mitochondria were not observed in all cells within the monolayer.  Other cells in the 
monolayer may have been actively metabolizing to compensate for the damage caused by 
chlamydial infection.  Because the MTT assay measures mitochondrial activity in a 
population of cells, not at the single cell level, the results reflect the overall level of 
mitochondrial activity.  A reduction of mitochondrial activity in a subset of cells would 
thus be diluted out by all the actively metabolizing neighbouring cells. 
 
The LDH assay was used to investigate cytotoxic activity in cell monolayers infected with 
several strains of C. trachomatis at low MOI for 5 days.  No significant difference in the 
level of cytotoxic activity was measured amongst any strains grown in HaCaT cells at 37 
or 33°C.  In ME-180 cells at 37°C, there was no significant difference in cytotoxicity 
amongst strains from day 1 to 4 post infection.  At day 5 the serovar L2 reference strain 
exhibited a median cytotoxic effect of almost 12%, in contrast to all other strains which 
had a protective effect on the monolayer at this time point.  Significance was reached 
between the L2 reference strain and the L2 clinical isolates.  This again points to the need 
for fresh clinical isolates to be used in pathogenesis studies. 
 
Despite that lack of measured cytotoxic activity with the LDH assay, this does not mean 
that C. trachomatis does not cause cytotoxic effects on HaCaT cells.  The LDH assay has 
been reported to under estimate cytotoxicity in cases where the cytotoxic agent only affects 
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intracellular activity (Weyermann et al 2005).  Because Todd and Caldwell (1985) 
observed host cell lysis as the only mechanism of EB release from host cells, one would 
have expected higher cytotoxicity values measured by the LDH assay.  These results 
suggest that HaCaT keratinocytes are more resistant to LGV chlamydia induced cell lysis 
than the HeLa cells used in Todd and Caldwell’s study, and that EBs are consequently 
released from HaCaT cells via a mechanism other than cell lysis.  The increase in inclusion 
counts from 1 to 5 days post infection unequivocally shows that the organism does exit its 
initial host cell to infect other neighbouring cells.  The lack of detectable cytotoxicity at 2 
days post infection after one completed chlamydial lifecycle, implies that the organism 
exits the initial cell to infect a new one via a mechanism other than host cell lysis.  If 
suffient numbers of the initial host cells lysed upon release of the EB, LDH would be 
released into the culture media, and a cytotoxic effect would have been detected. 
 
The TUNEL assay was used to determine the spatial relationship between C. trachomatis 
infected cells, and cells undergoing cell death.  This assay has been criticised for false 
positives in apoptosis detection, due to inadequate discrimination between the different 
types of cell death (Jarvis et al. 2002).  It is used in this study due to the ability to counter 
stain for C. trachomatis and identify a spatial relationship between infected cells, and cells 
with fragmented nuclear DNA (Schöier 2001) indicative of cell death, regardless of the 
biochemical mechanism by which cell death was caused. 
 
In both cell lines at 37°C more TUNEL positive cells were observed with both the LGV 
reference strains and the LGV clinical isolates than with serovar E.  This indicates that the 
LGV strains exert a greater cytotoxic effect on both cell lines than serovar E at 37°C.  The 
fact that TUNEL positive cells were frequently located immediately adjacent to an infected 
 132
cell indicates that this occurs either by cell-to-cell interaction or a secreted molecule which 
acts over a short distance.  Although some infected cells had a TUNEL positive nucleus, 
the majority did not.  A study by Schöier et al (2001) reports an increase in the number of 
TUNEL positive uninfected cells in a C. trachomatis infected McCoy cell monolayer 
compared to an uninfected monolayer.  They do not report a difference between the 
number of TUNEL positive cells in the serovar L2 versus the serovar E infected 
monolayers.  The same authors reported that 96% of apoptotic cells did not contain a 
chlamydial inclusion in the serovar L2 infected monolayer compared to 99% in serovar E 
infected monolayers. 
 
In the HaCaT cells at 33°C, there was no elevation in the number of TUNEL positive cells 
in infected versus uninfected cells at 2 or 5 days post infection, except a slight increase in 
TUNEL positive cells in the L3 infected monolayer and a slight decrease in TUNEL 
positive cells in the serovar E infected monolayer at 5 days post infection.  This indicates 
that C. trachomatis is more cytotoxic to HaCaT cells at 37°C than at 33°C. 
 
At high magnification small non-nuclear TUNEL positive particles were observed in both 
cell lines at 37°C but not 33°C (figure 19).  These were located in the same region as the 
inclusion and appeared to be inside the chlamydial inclusion.  These particles could either 
be DNA fragments which had been transported into the chlamydial inclusion for use by the 
organism, or the organism itself.  Because these particles were round and uniform in size, 
resembled the morphology of replicating RB (many particles were clustered in pairs), and 
had a diameter of about 0.7 µm, it is likely that these TUNEL positive particles were RB.  
If so, these results indicate the presence of large amounts of double-stranded DNA with 
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available 3’hydroxyl overhangs present in RB for the TdT enzyme to bind causing TUNEL 
positivity (Didenko and Hornsby, 1996). 
 
The caspase assay coupled with Transwell® permeable inserts served two functions.  It 
determined whether chlamydia induced cytotoxicity was apoptotic and whether or not 
chlamydia-induced cytotoxicity was mediated via a secreted molecule. 
 
In both cell lines at 37°C serovar E exposed monolayers and serovar L2 exposed 
monolayers demonstrated almost double and almost triple the number of caspase positive 
cells respectively compared to the monolayer exposed to uninfected cells.  Because 
apoptosis is defined as “caspase-mediated cell death with associated apoptotic 
morphology” (Samali et al 1999), caspase positivity indicates that cell death is occurring 
via apoptosis.  Infected cells were separated from uninfected cell monolayers by 
Transwell® permeable inserts.  The permeable polyester membrane allowed continuity 
between the CCM in the upper and lower chambers enabling secreted molecules from the 
infected monolayer to affect the uninfected monolayer.  The presence of elevated numbers 
of caspase positive cells in the uninfected monolayers exposed to infected monolayers, 
indicates that C. trachomatis induces the secretion of a molecule which diffuses through 
the permeable membrane to induce apoptosis in uninfected cells at 37°C. 
 
At 33°C there was no difference in the number of caspase positive cells in the monolayers 
exposed to infected cells versus the monolayers exposed to uninfected cells.  This indicates 
that no apoptosis inducing molecule is secreted by HaCaT cells infected with 
C. trachomatis at 33°C during the time period tested. 
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These results confirm those of the TUNEL assay – at 37°C C. trachomatis, most notably 
the LGV organisms, cause an increase in the level of cytotoxicity in uninfected cells.  This 
would be advantageous to the organism.  Death of neighbouring uninfected cells would 
cause erosion of the skin and ulcer formation which would enable the organism to 
penetrate the skin and migrate to the lymph nodes faster.  Conversely, the preservation of 
neighbouring uninfected cells at 33°C would allow the organism to migrate to the lymph 
nodes and establish a site of infection in the lymph nodes before the patient becomes aware 
that he or she is infected. 
 
In ME-180 cells at 37°C all strains tested grew.  Area occupied by chlamydia indicated a 
difference between the three reference strains compared to serovar E and the fresh clinical 
isolates, but the number of inclusions per 10 thousand cells did not.  The decline in the 
number of serovar L2 inclusions from day 4 to 5 with an increase in the area occupied by 
chlamydia during the same time period was associated with rupture of the inclusions.  This 
leaves free chlamydial particles dispersed across the monolayer which contribute towards 
the area occupied by chlamydia but not inclusions per 10 thousand cells.  This observation 
was verified by the elevated level of LDH in the supernatant of L2 infected monolayers at 
5 days post infection.  LDH is a cytosolic enzyme.  Its presence in the cell culture media 
indicates lysis of the host cells as would normally occur during the release of LGV 
chlamydial organisms from their host cells (Sepp et al 1996). 
 
On ultrastructural analysis both strains exhibited the normal biphasic replication cycle 
when grown in ME-180 cells at 37°C.  Pathological changes in the host cell cytoplasm 
were noted, but these were similar for both L2 and E.  In some infected cells the inclusion 
membrane was absent, and EB were seen to migrate through the cytoplasm in a non-
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membrane bound state and possibly be released by a mechanism other than host cell lysis.  
However, our LDH and fluorescent microscopy studies indicate that cell lysis is a major 
mechanism of L2 EB release from host cells when cells are infected in larger numbers.  
Although some mitochondrial pathology was noted in L2 infected monolayers at 48 hours 
post infection, this did not reach significance in the MTT assay. 
 
The increased numbers of TUNEL positive cells in biovar LGV infected monolayers but 
not the biovar OG infected monolayer, indicates that under the conditions tested the LGV 
strains induce a cytotoxic effect on neighbouring uninfected cells.  The elevated numbers 
of caspase positive cells in monolayers exposed but not infected with the LGV strains 
indicates that this cytotoxic effect occurs via apoptosis and is mediated by a secreted 
molecule. 
 
In the HaCaT cells at 37°C, all strains tested replicated, but the L2 reference strain 
replicated far more rapidly than any other strain.  Unlike the ME-180 cell line, high values 
for area occupied by chlamydia were not accompanied by increased cytotoxicity as 
indicated by LDH activity. 
 
Ultrastructural analysis indicated that replication occurred via the previously described 
biphasic replication cycle in HaCaT cells at 37°C.  In this cell line cytopathic changes 
involving the mitochondrion were noted as early as 1 hour post infection.  Swollen 
degenerate mitochondria occurred in the serovar E infected monolayer at 1, 36 and 48 
hours post infection.  Because this occurred at the times when EB were initiating infection, 
it is likely that this cytotoxic effect is due to a preformed EB cytotoxin such as that 
described by Belland et al (2001).  The significance of this observation was confirmed by a 
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reduction in the level of mitochondrial activity in serovar E infected monolayers at these 
time points, although statistical significance was only reached at 1 hour post infection. 
 
Increased numbers of TUNEL positive cells in biovar LGV infected monolayers but not 
the biovar OG infected monolayer, indicates that organisms of the LGV biovar induce a 
cytotoxic effect on neighbouring uninfected cells.  The elevated numbers of caspase 
positive cells in monolayers exposed but not infected with the LGV strains indicates that 
this cytotoxic effect occurs via apoptosis and is mediated by a secreted molecule. 
 
In HaCaT cells at 33°C all strains tested replicated as indicated by the presence of visible 
inclusions and an increase in the area occupied by chlamydia.  But only the L2 reference 
strain produced a substantial increase in the number of inclusions per 10 thousand cells.  
This indicates that at 33°C the L2 reference strain was able to produce infectious progeny 
which were released from the primary host cell to infect another cell.  Because the L2 
reference strain replicated far more rapidly than the other strains, it is possible that the time 
period investigated was too short too allow completion of the replication cycle and 
subsequent production of inclusions which were large enough to visualize at a low 
magnification.  The dramatic difference in the growth curve produced by area occupied by 
chlamydia compared to inclusions per 10 thousand cells, coupled with the subjective 
observation that the LGV reference strains produced larger inclusions prompted a 
comparison of chlamydial inclusion size.  The LGV reference strains, especially serovar 
L2 did produce inclusions which were significantly larger than those produced by the OG 
strain or the fresh clinical isolates. 
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Ultrastructural analysis of the chlamydial developmental cycle indicated that the serovar E 
strain replicated via the typical biphasic developmental cycle, albeit at a slower rate, while 
the L2 reference strain did not.  At 48 hours post infection serovar L2 inclusions did not 
contain EB, only replicating RBs.  This is contrasted by the serovar E strain, and 
chlamydial growth at 37°C – 48 hour old inclusions housed mostly EB under these 
conditions.  Two EB were detected in a non membrane bound state within the cytoplasm of 
two infected cells.  This indicates that at 33°C infection with the L2 reference strain may 
enter a persistent state of infection where an inclusion of continuously replicating RB is 
maintained.  As EBs, develop they exit the chlamydial inclusion and migrate through the 
cytoplasm where they are released from the host cell to infect neighbouring cells. 
 
Elevated levels of cytotoxicity compared to uninfected monolayers were not detected with 
the LDH assay, the MTT assay, the TUNEL assay or the caspase assay in HaCaT cells at 
33°C.  This indicates that these EB are released from the persistently infected host cell via 
a mechanism which does not involve death of the host cell.  Since both the TUNEL assay 
and the caspase assay with Transwell® permeable inserts did not indicate an elevated level 
of cytotoxic activity, C. trachomatis of either biovar does not induce apoptosis in 
neighbouring cells when grown at 33°C in HaCaT cell monolayers. 
 
The observed differences in chlamydial behaviour of the LGV biovar at 33 versus 37°C 
may explain may explain the differences in clinical presentation.  The classical 
presentation of LGV describes inguinal lymphadenopathy which may or may not be 
preceded by a painless genital (Schachter and Osoba 1983).  In our setting patients usually 
present in the primary stage before development of inguinal lymphadenopathy and the 
ulcer is usually painful (Sturm et al 2005).  Because inflammation causes a local increase 
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in temperature, the presence or absence of an inflammatory response at the site of infection 
may determine whether or not ulceration occurs.  In the absence of an inflammatory 
response, the temperature remains at 33°C causing infected cells to enter into a state of 
persistent infection.  Under these conditions a few EB are released at a time via a 
mechanism such as budding, which does not cause lysis of the host cell or cytotoxicity of 
neighbouring uninfected cells.  No ulcer is formed.  The presence of an inflammatory 
response at the site of infection may cause a local increase in temperature causing the 
organism to replicate rapidly.  The organism does not enter into a persistent state of 
infection.  Instead, numerous EB are released from the host cell at the end of the first round 
of replication to infect neighbouring cells.  This may or may not result in lysis of the host 
cell, but a secreted molecule induces apoptotic cell death of neighbouring uninfected cells.  
This aggressive pathogenic mechanism erodes the keratinocyte layer of skin and causes an 
ulcer. 
 
There was a significant difference in the behaviour of the serovar L2 reference strain and 
the fresh clinical isolates in the following investigations: 
• growth rate under all conditions tested 
• inclusion size in HaCaT cells at 33°C 
Although the reference strain behaved similarly to the clinical isolates in the TUNEL 
assay, the above observations of the difference between the L2 reference strain and the 
fresh clinical isolates throws some doubt on all studies, including ours, which draw 
conclusions from this strain. 
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CHAPTER 6 - CONCLUSIONS 
 
C. trachomatis of both biovars enters and multiplies in HaCaT and ME-180 cells at 37°C.  
In HaCaT cells at 33°C the number of organisms increase, but the L2 reference strain is the 
only strain to demonstrate its ability to produce infectious progeny at 33°C.  This was 
indicated by an increase in the number of inclusions from 2 to 5 days post infection.  
 
The serovar L2 reference strain replicates more rapidly than the other strains tested, 
including the fresh clinical isolates which were also serovar L2. 
 
In HaCaT cells at 33°C the inclusions produced by the reference strains reach a much 
larger maximum size than those produced by the stored clinical OG isolate or the fresh L2 
clinical isolates. 
 
These behavioural differences between the L2 reference strain and the fresh clinical 
isolates unequivocally demonstrate a need for fresh clinical isolates when performing LGV 
pathogenesis studies. This is likely the case for all C.trachomatis serovars. 
 
At an ultrastructural level there is no difference in the interaction of chlamydia and its host 
cell when grown in cervical cells or keratinocytes at 37°C compared to the published 
literature.  This holds true for the OG strain at 33°C but not the LGV strain at 33°C.  L2 
infected keratinocytes at 33°C enter a state of continuous infection allowing a few EB to be 
released from the host cell at a time.  
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Because of the difference in behaviour of the LGV organism at 37 versus 33°C, the 
temperature at the site of infection may determine whether or not an ulcer is formed.  If the 
temperature is raised due to inflammation, the organism replicates rapidly to form an ulcer.  
In the absence of inflammation, the temperature at the site of infection remains low, 
enabling the organism to enter a state of continuous infection whereby EB are continuously 
shed.  This would enable the organism to pass through skin and migrate to the lymph nodes 
without ulcer formation. 
 
Chlamydial infection of HaCaT and ME-180 cells at 37°C causes organelle damage within 
infected host cells.  Infection of HaCaT cells with the OG biovar but not the LGV biovar at 
37°C results in significant mitochondrial damage early in the infectious cycle.  This is 
likely due to the previously described preformed EB cytotoxin which is present in 
organisms of the OG biovar but not the LGV biovar. 
 
LGV organisms induce apoptosis of neighbouring uninfected cells via a secreted molecule 
when grown at 37°C but not 33°C.  Apoptosis of uninfected cells exposed to cells infected 
with an OG strain also occurs, but at a much lower level.  This is different to the preformed 
EB cytotoxin since it occurs later in the developmental cycle. 
 
The observed difference between the L2 reference strain and the fresh L2 clinical isolates 
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APPENDIX A – REAGENTS AND MEDIA 
 
Phosphate buffered saline (PBS) (Dulbecco A) 
 
5 PBS tablets (Oxoid) 
500ml distilled water 
 
Five PBS tablets were dissolved in 500ml autoclaved distilled water.  The PBS was 






1 PBS tablet 
100ml distilled water 
 
One PBS tablet and 0.05g EDTA was dissolved in approximately in 80ml autoclaved 
distilled water.  The pH was adjusted to approximately 7.4 using 7.5% sodium bicarbonate 
and the volume brought up to 100ml.  The solution was autoclaved at 121°C for 10 
minutes, pipetted into 1ml aliquots and refrigerated until use. 
  
McCoy cell freezing fluid 
 
30ml EMEM with EBSS, NEAA, sodium pyruvate, L-glutamine and HEPES 
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10ml dimethyl sulphoxide (DMSO) (Fluka, Steinheim, Germany) 
10ml FBS 
 
Ten millilitres of DMSO and 10ml of FBS were added to 30ml of EMEM and the solution 
filter-sterilized through a 0.22µm filter into a sterile container. 
 
HaCaT cell freezing fluid 
 
30ml RPMI-1640 with L-glutamine and HEPES 
10ml glycerol (BDH Laboratory supplies, Poole, England) 
10ml FBS 
 
Ten millilitres of glycerol and 10ml of FBS were added to 30ml of RPMI-1640 and the 
solution filter-sterilized through a 0.22µm filter into a sterile container. 
 
ME-180 cell freezing fluid 
 
40 ml McCoy 5a medium 
5 ml   DMSO 
5 ml   FCS 
 
Five millilitres of DMSO and 5 ml of FBS were added to 40ml McCoy 5a medium and the 
solution filter-sterilized through a 0.22µm filter into a sterile container. 
 






 glutamic acid 
 Distilled water 
  
The sucrose, KH2PO4, Na2HPO4.7H2O and glutamic acid were dissolved in approximately 
in 400ml autoclaved distilled water, the pH was adjusted to approximately 7.4 using 7.5% 
sodium bicarbonate and the volume brought up to 500ml.  The solution was filter sterilised 
through a 0.22µm filter, then aliquoted and stored at -20°C until use. 
 
MicroTrak® C. trachomatis Reagent 
 
MicroTrak® C. trachomatis Culture Confirmation Test (8H019UL): 
C. trachomatis reagent – fluorescein-labelled mouse monoclonal antibodies specified to 
C. trachomatis; protein-stabilized phosphate buffer; Evans Blue counter-stain; 0.01% 
sodium azide 
Reconstitution diluent – deionized water; 0.1% sodium azide 
 
The metal seal and rubber stoppers were removed from the C. trachomatis reagent vial and 
the reconstitution diluent vial.  The lyophilized C. trachomatis reagent was reconstituted 
by the addition of 3.0ml reconstitution diluent.  The vial was gently swirled to dissolve the 
contents and the reconstitution date recorded on the vial.  The reagent was allowed to reach 
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room temperature of 20-25°C for 15 minutes before use and stored at 2-8°C for 12 weeks 
from the date of reconstitution. 
 
2% Gluteraldehyde Solution 
 
8 ml    25% gluteraldehyde 
96ml    EMEM 
 




10.0g Vinylcyclophene dioxide (VCD) (TAAB®) 
6.0g Diglycidyl ether of polypropylene glycol (DER 736) (TAAB®) 
26.0g Nonenyl succinic anhydride (NSA) (TAAB®) 
0.4g Dimethylaminoethanol (DMAE) (Sigma®) 
 





A saturated solution of uranyl acetate (421.15 g/ml) was prepared in 50% ethanol:water 
and the solution allowed to settle for 4 hours.  It was refrigerated until required and 





2.66 g  Lead nitrate 
3.52 g Sodium citrate 
60 ml Distilled water 
16 ml 1N Sodium hydroxide 
 
Lead citrate was dissolved in 60 ml distilled water.  On the addition of sodium citrate, a 
precipitate formed and was left to stand at room temperature for 30 minutes.  After 30 
minutes 1 N sodium hydroxide was added which dissolved the precipitate causing the 




APPENDIX B – CALCULATIONS 
 
Calculation of objective lens conversion factors 
 
In order to calculate the conversion factor, the field area and hence the field diameter of 
each objective lens must be known. 
 
The field diameter is calculated by dividing the eyepiece field of view number by the 
objective magnification and the tube factor.  Then the radius (r), which is half the diameter, 
is used to calculate the area of the field of view.  The objective lens conversion factor is 
then equal to the area of the well divided by the field area for a particular objective lens. 
 
E.g.  40x objective 
 
Objective field diameter = eyepiece field of view number ÷ objective magnification ÷ tube 
factor 
       = 20 ÷ 40 ÷ 1 
       = 0.5 mm 
 
Radius = diameter ÷ 2 
 = 0.5 ÷ 2 
 = 0.25 mm 
 
Objective field area = π r2 
   = (22÷7) x 0.252 
   = 0.196 mm2 
 
Area of well  = π r2 
   = (22÷7) x 82 
   = 201 mm2 
 
Objective conversion factor  = area of well ÷ objective field area 
    = 201 ÷ 0.196 
    = 1024 
 











10x 2 1 3.143 64 
40x 0.5 0.25 0.196 1024 















100x 0.2 0.1 0.031 6400 






APPENDIX C – RAW DATA 
 
Chlamydial growth curve – inclusions per 10 thousand cells 
 
ME-180 cells at 37°C 
 
Day Strain Inclusions per 10 thousand cells Mean 
1 E 140 347 177 192 174 200 220 182 206 204 
1 L1 175 163 233 183 156 218 289 258 342 224 
1 L2 128 128 209 261 69 165 182 130 175 161 
1 L3 151 163 325 227 35 26 244 198 160 170 
1 US151 151 198 151 279 183 227 190 190 137 189 
1 US162 70 58 116 35 139 200 38 99 114 97 
1 US197 93 175 186 183 96 270 190 92 175 162 
2 E 258 200 163 61 148 113 152 92 30 135 
2 L1 378 416 384 270 374 366 266 258 198 323 
2 L2 169 175 256 252 165 131 235 320 53 195 
2 L3 148 189 215 261 174 105 106 152 23 153 
2 US151 189 160 177 200 200 244 198 244 296 212 
2 US162 55 75 70 69 18 69 38 38 46 53 
2 US197 163 184 131 122 96 156 84 61 92 121 
3 E 229 163 163 78 209 96 137 190 882 239 
3 L1 405 774 1115 218 235 131 1551 2472 2480 1042 
3 L2 436 934 235 244 113 592 2380 2601 2684 1136 
3 L3 495 221 1449 69 122 156 342 578 289 413 
 178
3 US151 157 451 256 52 96 322 342 943 1095 413 
3 US162 70 111 82 200 61 113 38 99 68 94 
3 US197 165 160 294 183 122 113 228 396 296 217 
4 E 1529 1233 945 662 1254 435 1225 1087 1225 1066 
4 L1 892 1455 1315 453 827 244 2692 3156 4343 1708 
4 L2 4608 4841 7656 3405 6827 4380 3544 6601 5978 5316 
4 L3 722 454 1362 383 174 627 472 1217 1399 757 
4 US151 1042 672 620 1724 235 1315 624 684 1080 888 
4 US162 58 82 70 348 401 113 1301 791 114 364 
4 US197 788 1038 335 1306 618 940 160 198 358 638 




4 7447 1306 1776 1384 6069 9598 6434 5872 
5 L2 4887 6400 5469 2647 2473 1602 2406 1853 2752 3388 
5 L3 7656 4282 4631 2282 1785 1193 2890 3377 2327 3380 
5 US151 2013 2385 1850 1541 2055 1602 4313 2031 958 2083 
5 US162 896 1885 315 827 1446 1306 2327 1149 2023 1353 
5 US197 3154 2467 989 862 1524 801 1141 1521 2342 1645 
 
HaCaT cells at 37°C 
 
Day Strain Inclusions per 10 thousand cells Mean 
1 E 134 124 147 90 90 202 141 125 110 129 
1 L1 223 214 195 202 225 180 31 78 47 155 
1 L2 121 147 140 202 157 225 63 78 78 135 
 179
1 L3 198 163 230 135 202 112 78 31 78 136 
1 US151 179 163 112 157 67 67 31 47 47 97 
1 US162 57 51 70 112 45 22 16 78 78 59 
1 US197 150 108 102 157 22 90 63 78 31 89 
2 E 179 121 89 112 157 45 266 172 157 144 
2 L1 220 239 258 225 225 225 125 110 110 193 
2 L2 144 191 188 157 157 135 282 219 125 178 
2 L3 201 214 191 135 135 157 110 110 172 158 
2 US151 115 150 226 67 90 67 282 251 251 167 
2 US162 41 70 51 45 22 67 219 235 329 120 
2 US197 172 92 179 112 202 67 251 251 329 184 
3 E 102 182 166 129 168 118 63 219 392 171 
3 L1 434 440 810 196 247 264 1144 360 141 448 
3 L2 191 1225 182 309 820 539 564 909 689 603 
3 L3 287 341 303 118 230 213 204 47 78 202 
3 US151 360 421 290 124 219 101 172 157 360 245 
3 US162 73 29 48 129 45 376 799 235 219 217 
3 US197 453 332 440 174 140 101 251 282 251 269 
4 E 1850 574 1084 1045 1644 2642 1253 1770 1692 1506 
4 L1 3011 5129 2743 2135 492 584 924 1128 1222 1930 
4 




3 7160 5831 
4 L3 1365 2143 753 1137 292 261 846 188 1065 894 
4 US151 1174 1161 1850 1183 922 1367 1911 2334 1582 1498 
4 US162 179 204 204 645 1843 707 1050 1864 1410 901 
 180
4 US197 217 957 230 1306 1213 799 2381 705 924 970 
5 E 1250 1123 1097 2995 3640 1905 3290 3556 3541 2489 
5 L1 5920 4491 2194 461 415 492 1159 1896 2272 2144 
5 











5 L3 3789 1301 2220 1751 399 507 1661 3306 3697 2070 
5 US151 1263 1505 778 5422 5345 3226 5060 5687 4042 3592 
5 US162 1072 89 574 5453 6405 2611 3212 8977 5248 3738 
5 US197 357 510 1110 3395 2780 3210 3447 4778 2538 2458 
 
HaCaT cells at 33°C 
 
Day Strain Inclusions per 10 thousand cells Mean 
2 E 186 83 135 115 102 128 111 123 111 121 
2 L1 114 135 166 204 204 217 190 211 245 187 
2 L2 114 125 145 229 191 90 123 100 123 138 
2 L3 73 125 104 102 77 77 134 156 78 103 
2 US151 145 93 135 141 90 178 234 111 111 138 
2 US162 52 93 73 64 51 90 78 134 56 77 
2 US197 156 73 62 64 90 128 134 144 56 101 
3 E 186 135 156 64 77 90 144 67 134 117 
3 L1 166 238 197 141 153 165 256 245 290 206 
3 L2 145 166 166 141 90 90 100 178 134 134 
3 L3 62 114 83 128 77 77 67 167 144 102 
3 US151 156 145 177 115 153 90 167 134 144 142 
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3 US162 83 73 104 77 77 102 111 78 44 83 
3 US197 218 125 135 178 102 38 44 178 144 129 
4 E 145 166 156 141 64 64 78 56 144 113 
4 L1 186 114 156 77 90 128 156 190 156 139 
4 L2 125 156 114 90 345 217 67 144 144 156 
4 L3 41 135 62 115 204 293 56 44 100 117 
4 US151 208 156 145 141 64 90 67 123 178 130 
4 US162 52 166 31 26 51 90 56 123 56 72 
4 US197 145 197 186 51 102 153 78 134 100 127 
5 E 145 83 208 77 51 26 156 78 44 96 
5 L1 156 62 114 128 77 64 44 89 78 90 
5 L2 270 114 259 153 1021 357 67 123 211 286 
5 L3 52 83 83 77 115 51 33 100 33 70 
5 US151 177 166 156 115 204 115 78 44 89 127 
5 US162 114 52 41 26 38 13 23 56 33 44 
5 US197 197 104 285 153 64 102 44 44 56 117 
 
Chlamydial growth curve – area occupied by chlamydia 
 
ME-180 cells at 37°C 
 
Day Strain Area occupied by chlamydia (µm2) Mean 
1 E 0.1 0.1 0.1 0.3 0.1 0.3 0.4 0.4 0.4 0.2 
1 L1 0.2 0.6 0.5 0.1 0.1 0.1 0.7 0.8 0.7 0.4 
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1 L2 0.4 0.4 0.4 0.6 0.1 0.3 0.4 0.4 0.3 0.3 
1 L3 0.3 0.4 0.4 0.1 0.0 0.0 0.2 0.4 0.2 0.2 
1 US151 0.3 0.2 0.2 0.1 0.3 0.2 0.5 0.2 0.3 0.3 
1 US162 0.1 0.2 0.2 0.1 0.0 0.2 0.1 0.1 0.1 0.1 
1 US197 0.4 0.2 0.6 0.0 0.0 0.3 0.2 0.2 0.3 0.2 
2 E 0.3 0.2 0.2 0.1 0.0 0.0 0.1 0.4 0.1 0.2 
2 L1 0.9 1.7 1.1 1.5 0.7 1.3 1.7 1.4 1.9 1.4 
2 L2 1.1 1.3 0.9 1.1 0.6 1.5 1.7 1.2 1.0 1.1 
2 L3 2.1 2.1 2.1 0.9 1.4 1.8 1.3 1.5 0.9 1.6 
2 US151 0.3 0.4 0.3 0.2 0.2 0.6 0.3 0.5 0.5 0.4 
2 US162 0.2 0.1 0.2 0.1 0.1 0.2 0.1 0.2 0.1 0.1 
2 US197 0.2 0.3 0.3 0.1 0.2 0.5 0.4 0.1 0.1 0.2 
3 E 0.5 0.6 0.4 0.2 0.2 0.2 0.8 0.6 0.5 0.4 
3 L1 3.6 6.5 6.0 2.0 1.3 1.4 10.9 11.7 15.3 6.5 
3 L2 6.5 3.2 3.0 1.6 2.2 3.3 19.2 15.1 13.2 7.5 
3 L3 4.3 6.4 7.3 2.1 2.0 0.8 4.3 6.2 3.6 4.1 
3 US151 0.7 2.0 0.5 0.3 0.2 0.5 1.0 2.8 1.3 1.0 
3 US162 0.5 0.6 0.8 0.3 0.3 0.3 0.3 0.4 0.3 0.4 
3 US197 0.9 0.9 1.0 0.4 0.4 0.2 1.1 0.9 1.6 0.8 
4 E 3.6 0.7 1.3 0.6 2.0 1.0 2.0 4.8 4.3 2.2 
4 L1 11.2 16.9 9.1 2.5 2.0 1.8 6.8 12.4 11.7 8.3 
4 L2 30.4 14.2 18.3 10.5 17.5 11.9 59.8 38.6 24.0 25.0 
4 L3 4.4 13.2 13.1 1.4 2.3 3.3 16.0 7.3 4.6 7.3 
4 US151 2.3 1.4 2.5 3.2 0.5 3.1 1.8 1.0 2.4 2.0 
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4 US162 0.3 0.6 0.6 2.2 0.3 0.3 5.0 0.8 0.4 1.2 
4 US197 2.5 4.6 2.3 1.3 0.8 1.2 1.4 3.3 1.7 2.1 
5 E 3.2 1.7 2.7 4.0 4.3 2.0 5.4 3.8 6.8 3.8 
5 L1 40.4 46.5 39.1 2.0 3.5 1.9 69.4 44.9 62.7 34.5 
5 L2 120.4 101.5 79.3 20.0 39.5 18.5 61.8 53.3 54.5 61.0 
5 L3 34.4 41.6 16.7 3.1 3.9 4.6 28.7 31.9 28.9 21.5 
5 US151 7.2 8.5 9.3 1.4 2.4 2.8 10.2 6.5 5.1 5.9 
5 US162 5.0 10.8 3.7 1.2 1.6 1.9 3.4 3.2 1.9 3.6 
5 US197 8.7 4.6 5.0 1.3 1.7 3.2 3.4 4.7 6.9 4.4 
 
HaCaT cells at 37°C 
 
Day Strain Area occupied by chlamydia (µm2) Mean 
1 E 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 
1 L1 0.2 0.2 0.2 0.3 0.2 0.5 0.0 0.0 0.0 0.2 
1 L2 0.2 0.2 0.1 0.2 0.3 0.3 0.0 0.0 0.0 0.1 
1 L3 0.2 0.2 0.2 0.1 0.2 0.1 0.0 0.0 0.0 0.1 
1 US151 0.1 0.2 0.1 0.1 0.0 0.3 0.0 0.0 0.1 0.1 
1 US162 0.1 0.2 0.1 0.1 0.1 0.2 0.0 0.0 0.0 0.1 
1 US197 0.1 0.1 0.1 0.3 0.1 0.1 0.0 0.0 0.0 0.1 
2 E 0.3 0.4 0.4 0.2 0.2 0.2 0.2 1.0 0.3 0.4 
2 L1 1.7 1.9 2.5 0.9 1.1 1.0 0.4 0.6 0.6 1.2 
2 L2 1.3 1.4 1.2 0.4 1.0 0.9 0.8 1.1 1.2 1.0 
2 L3 1.6 1.6 1.2 1.7 0.9 1.8 0.6 0.5 0.6 1.2 
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2 US151 0.7 1.4 1.2 0.3 0.2 0.2 0.5 0.6 0.7 0.7 
2 US162 0.2 0.4 0.1 0.2 0.1 0.3 0.4 0.4 0.5 0.3 
2 US197 0.8 0.6 0.8 0.6 0.7 0.4 0.6 0.3 0.6 0.6 
3 E 0.9 0.9 0.7 0.2 0.7 0.5 1.2 0.5 1.3 0.8 
3 L1 2.3 4.0 3.7 1.6 0.9 2.9 1.5 1.7 1.6 2.2 
3 L2 2.7 3.0 3.5 1.3 3.2 1.7 2.8 2.1 3.8 2.7 
3 L3 3.3 3.0 2.2 0.6 1.0 1.4 2.0 2.4 3.2 2.1 
3 US151 1.4 1.6 1.1 0.3 0.8 0.9 1.5 0.8 0.9 1.0 
3 US162 0.3 0.2 0.4 0.8 0.4 2.0 0.8 0.6 1.1 0.7 
3 US197 0.8 0.7 0.6 0.2 0.6 1.4 0.7 1.1 0.7 0.8 
4 E 2.1 1.4 1.5 2.8 4.4 1.5 5.6 2.1 6.4 3.1 
4 L1 5.2 6.2 11.8 3.0 5.4 2.8 3.0 3.3 5.2 5.1 
4 L2 25.0 16.7 15.7 12.8 14.8 6.2 8.9 15.7 23.0 15.4 
4 L3 5.3 3.9 4.0 2.8 1.3 2.0 2.3 4.9 2.3 3.2 
4 US151 2.2 0.9 2.4 2.2 2.2 4.5 2.0 1.4 2.7 2.3 
4 US162 0.5 0.7 0.4 1.7 0.5 1.1 2.3 4.1 5.0 1.8 
4 US197 0.8 2.9 3.8 3.5 2.2 1.5 4.1 1.1 8.4 3.2 
5 E 2.8 2.6 4.2 5.2 8.5 8.8 5.5 13.4 6.8 6.4 
5 L1 12.4 6.9 14.7 1.8 3.3 1.4 4.0 12.9 12.5 7.8 
5 L2 30.4 13.5 39.8 29.7 40.0 35.0 71.1 57.0 62.0 42.1 
5 L3 11.7 7.3 19.0 2.3 1.9 2.0 2.9 15.3 6.4 7.7 
5 US151 3.7 3.4 3.5 11.2 10.2 8.4 6.3 10.8 3.2 6.8 
5 US162 1.4 0.6 0.9 14.1 18.4 13.9 3.4 8.4 6.8 7.5 
5 US197 1.0 5.3 2.5 6.5 5.2 9.5 8.3 18.0 4.6 6.8 
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HaCaT cells at 33°C 
 
Day Strain Area occupied by chlamydia (µm2) Mean 
1 E 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
1 L1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
1 L2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
1 L3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
1 US151 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
1 US162 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
1 US197 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
2 E 0.1 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 
2 L1 0.2 0.1 0.0 0.2 0.2 0.2 0.1 0.2 0.1 0.2 
2 L2 0.2 0.1 0.1 0.3 0.1 0.2 0.1 0.1 0.2 0.1 
2 L3 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 
2 US151 0.1 0.0 0.0 0.2 0.2 0.2 0.1 0.1 0.2 0.1 
2 US162 0.1 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 
2 US197 0.1 0.1 0.1 0.2 0.1 0.2 0.1 0.2 0.2 0.1 
3 E 0.2 0.2 0.2 0.4 0.1 0.1 0.3 0.4 0.2 0.2 
3 L1 0.2 0.5 0.3 0.4 0.3 0.3 0.3 0.6 0.5 0.4 
3 L2 0.2 0.5 0.8 0.6 1.2 0.4 0.5 0.5 0.5 0.6 
3 L3 0.2 0.3 0.1 0.3 0.4 0.5 0.2 0.2 0.3 0.3 
3 US151 0.1 0.2 0.3 0.2 0.4 0.2 0.4 0.2 0.3 0.2 
3 US162 0.0 0.1 0.0 0.1 0.1 0.3 0.2 0.1 0.3 0.1 
3 US197 0.3 0.1 0.3 0.2 0.4 0.1 0.3 0.4 0.5 0.3 
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4 E 0.4 0.4 0.4 0.2 0.3 0.4 0.3 0.2 0.3 0.3 
4 L1 0.7 0.7 0.9 0.6 0.6 0.4 0.6 0.7 0.5 0.6 
4 L2 0.9 1.1 0.6 0.6 1.5 2.6 0.6 0.6 1.0 1.1 
4 L3 0.2 0.6 0.3 0.4 0.6 0.5 0.8 0.6 0.5 0.5 
4 US151 1.0 0.7 0.7 0.3 0.5 0.2 0.1 0.5 0.3 0.5 
4 US162 0.2 0.3 0.3 0.2 0.1 0.1 0.3 0.4 0.2 0.2 
4 US197 0.7 0.5 0.5 0.5 0.4 0.2 0.2 0.5 0.3 0.4 
5 E 0.7 0.2 0.3 0.3 0.4 0.2 0.3 0.2 0.2 0.3 
5 L1 0.9 0.3 0.2 0.7 0.5 0.7 0.3 0.3 0.4 0.5 
5 L2 3.3 1.8 1.3 2.0 2.6 3.2 1.3 0.6 1.0 1.9 
5 L3 0.3 1.1 1.4 1.3 1.2 1.5 0.8 0.9 0.6 1.0 
5 US151 0.4 0.2 0.5 0.5 0.3 0.2 0.4 0.2 0.2 0.3 
5 US162 0.3 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.2 
5 US197 0.4 0.5 0.6 0.3 0.5 0.6 0.2 0.3 0.3 0.4 
 
Inclusion size in HaCaT cells at 33°C 
 
Day Strain Inclusion size (µm2) 
2 E 42      85      50      82      77      74      41      87      97      90      63      37      45      
46      66      95     131     186     180     123     165      76      43      37      72     202      
75     188     383      89     193      54      96      75     117      98      66     147     122      
89     108     154      85      59     163     131      94     121     115     148      88     
127     136 
2 L1 235     196      76      65     291     143      68     121      59      47      40      89     
113      50     133      57      67      66     167      52      66      46     167     163      66     
 187
165      50     119     103     178      67     218     108     112      49      89      77      
75     191     182      98     214      77     113     103     265     118     163      36     
132      48     123     377      94     120     297      41      95     120      76      44      
57      80      99     154     106      83      62     103      80      99     128      86      93      
71     146     143     101      88     109     209     153      39     133      77      43      
60     129      54      66     51   179      87      93      57      69 
2 L2 131     110     182     311     125     200     121     236      62     144     120      36      
72     301      72     100      58      49      49      44     138     237      51      82     544     
309     127     290      46     126     334     107     114     159     199      62     220     
142     288      60     136     101     218      78     173     388     157     169      66     
162      91     136     252      51     137     107     237     232     198     243     193    
111     231     125     103     143      52     160     234     138     154     171     130      
98     182 
2 L3 40      76      85      51      57      46      37      36      51      85      59      60     103    
50      49      36      71     128      40      73     122      65      49      75      70      41      
77      59      57   57      91 
2 US151 172     116      90     296      91      40     294      76      76      63      65     251     
131     156     122     130      87     167     125     133      55     127      99     114     
151     108      41      92      50      99      62     102     208     244     179     257     
240     163     165     186     104   93     138     136     117     128     130     138      
56     130     166     102     150     141     146      88      67     156      51     140     
144     220     157     196      45     252     217      76     114     102      57 
2 US162 60      52     105      63      80      66      80      62      80      47      62      95      49      
66     159      63     122     214      91      62     167      47     186      67     115     
150     324     168      63     115     141     157      47     118     124      92      60     
128     142     178     172     154     144 
2 US197 93      70      86     108     182      99     167     103      63     147     107     112      
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67     126      86     149      65     238     108      59     124      49      50      60     177     
124      70     103      54      85     201     176     170     160      73      43     153     
224     158     118      54     131     169     153     107     127     174     165     140     
241     106     153      91      85      50     154      79     151     107      53     242      
73     126      91     193     110     165     178     137      87     143     144      72      
83     136     134     146      66     131      66     106     135      89      67      80 
3 E 195     131     351     129     227     178     130     144     147     133     123     241     
255     289     141      66     263     122     254     338     222     100     237      66      
65     149     179     214     267     331     154     158     309     136      37     402     
159     194     341      74     431     209     167      44     274     234      45     181     
101      72      56     387     189     196     102      69      85     127     321     110     
344     235     121     319     211     342     260     195     439     198     140     121     
196     159     467     281     276     394     233     190     253     279     440     408     
170     287     330      38     275     378     149     196     233 
3 L1 64     201      61     450     113     218     126     300     424     454     409     157     
638     278     292     146     172      48      67     111      94     362     366     315      
51     474     207     730     233      88     302     547      80     353      79     105      
51     278     372     108     328     622     388     749     250      67     563     631      
78     173      83     345     202     572      36     142     167     309     421     105     
596     341      70     118     335     195      45     165     23     255     338     554     
775      97     315     859     470     331     329      91     180     497      88     399     
477     295     314     453      63      44      62     315     265      88     400     156     
378     639  
3 L2 183     285     205     289     251     180     600      60     492     447     450     395      
45     580     266     747     153    1205    1127     317     581     262     117     834     
721    1485     635     766     540     659     860     889     910     549     486     121     
273     987      96    1454     241      76    1345     529     749    1369     102     482     
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661     424    1148     231    1001    1560     131     619     249     331     866     744     
338     253     988     391      98     485      70     537     966     522      72      85     
774     721    1146     717     168     179     301     466     404     179      76     579     
796     872     560     430     552      56     356     103 
3 L3 38     483     127     132      41      40     133     469     741     357      43     519     
560     107     182     411     195     712     173      92     147     133     199     199     
328     261     427      45      57      50     152     157     260     117     218     436     
241     198     345     420     441      55     441      72     104     157      59     395      
72      71     124      56      44      41     475      83      82     423     170      36     449     
186     105     204     439     345     157     414     589     449     156     415     234     
133      36     198      89      70 
3 US151 78     107     245     105     153     144      57      59     187      46     117     367     
183     231     151     257      77     363     166     218     324     165     222     440      
49     288     252     330      72     344     190     395     198     167     153     211     
177     118     140     305     104     249     158     117     401      58     214     110      
44      86     178     360     200     282     148     259     143     159     139     256     
478     227     230     251      92     247     331     301     469     206     259     283     
112      91     315     341     217     452     172     238     265      93     325     142     
189      73     402      91     136     174     257     244      86 
3 US162 142      64     143     154     240     207     226     289      55     173      82      96     
265     123     273     182     275      60     292     241      36     194     269     191      
45     141     379     152     210     156     293      72     306     312     236      59     
511     375      44     303     278     276     166     547     207     334     238      98 
3 US197 201     242     354     312     133     124     404     246     298     201     191     160      
71     150     182     128     254     284     201     164     267     248     316     358     
217     125     167     172     181     263     215     347     102     387     400     321      
61     163     269     253     304     165     129      45     154     154      63      92      
 190
79     220      37      56     372     285     258     366     253     427     261      58     
141     132     681     178     220      81     330     109     243      37      83      46     
147     285      57      98     229     158      65     196     129     178     186     118      
66     366     372     313     318     279     209     160     220      76     200     328     
276     290     355     222      82     111     323     392 
4 E 188     509     256     428     183     591     211     551     335     462     131     463     
188     466     520     441     351     477     193     344     288     327     159     193     
249     287     101     251     582     283     625     418     272     172     205     404     
430     475     143     249     354      54      54     293     117     257     179     225     
297     365     665     507     459     313      67     277     225     407     156     562     
256     318     144     262      82     179      38     136      66     505     198     370     
481     169     120     119      82     644     133     436     497     114     420     298     
370      85      75     376      43      67     228     336     214      41 
4 L1 303     330     967     268     670    1048    1188     378     352     821     217      66     
158     178      86     762     149      85     278     341    1118     565      89     122     
460     871    1525      63      51     144     103     251      56     838     538      78      
98    1118     775      48     571     646    1011     417     600    1108    1500     437     
560     163     315     149     476     612     327      40     931     131     421     439     
380      43     721     296     195     537     608     333     792      75     224     492     
163     295     671    1020     826     679     507     225    1040     302     225     105     
320     639     794     569      85     678     756      66     687     147      89      58     
586     917     405     920 
4 L2 1041     741    1615     322     105      36      51     707    1131    1277     118     767      
79    1408     975     650     228     676    1529     721     780    1018    1049    1244     
655     816     670     398     819     555     290     844     679      66    1751     655     
440    1487     167     585    1133     870      36     969     163     542      67     105    
2370     644    1171      48    1387     609     691     187    3542    4489     158     
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658    1711    2550    1512    1149     395     329    1680     496     713    1321    
1653     493    1162      40     654     173     681     827     541     639    2178     697     
947     211    2106    1167    1469     875 
4 L3 221      97     479     135     515     806     760      57      36    1675     927    1211     
633    1159     632      38     811     335      45      70      50    2628     325     257     
830      44     953     941    1482    1213    2296      47    1133    1223    1443    
1699    1130     597    1104     431     699     834    1303    1377     146     838      
36     133      43    1278     119 
4 US151 548     617     351     440      45     422     283     608     225     486     838     352     
107     322      49     429     539     475     292     355     472     577     480     411      
43     468     140     492     423     535     238     821     253     284     559     476     
598     130     272     370     389     487     463     273     615     660     614     475     
457     528     425     474     356     438     449      78     230     626     579     225     
130     325     260     284     650     159     144     109     204     214     254     249     
597     354     475     507     143      96     219     290     331     150     465     330     
285     126     241     450     340     409     538     101     451     643     284      48     
228     625     128      89      87     284     464     150     110      83     318     155     
462     337          
4 US162 475      56     641      42      56     446     289     395     393     558     605     353      
43     565     242     372     133      64     194     253     598    1010     419     831     
425     475     253     576     109     188      63     149      94     299     183     428     
460     167     608     127     264      46     146     247     245     407     356     430     
273     494     213     247      83     104    1165     327      97     526     499     181      
44     254      88     961     134     376      75     380     305 
4 US197 98     444     138     440     790     550     414     312     547     346     541     430     
600     532      42     115     537     630     188     480     557     301     270     193     
243     307     461     375     147     121     377     141     366     126     502     418     
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199     381     385     301     477     399     135     853     106     943     446     423     
404      56      98      53     301     436     426     239     259     447     235     104     
290     515     280     283     430     293     588     428     424     171     421     143     
420     528     606     362     360      67     769     140     166     345     113     167     
331     208      49     250     104     273     206      44     421      93     383     463     
577     507     517     416     357     471     273     567     811     256     298     676     
395     466     299     290     454     482     307     380     333 
5 E 622     593     472     570     325     746     462     931     112     879     262     499     
505      79     385      62     67      79     421     103     440      65      69      82     305     
128      41     526     264     229      61     408     624      50     322     295     485     
446      75      89     712      39     136     187     399     485     669      47     152     
195      82     431     486      62     567     153      47     332     902     607      99     
459     302      87     272     478     366     490     180     550     531     307     544     
310     117     653      46     260 
5 L1 41    1083     104     876      45      53    1318     169     641     821    1195      54     
113     750      69      59      57     318      65     934     326     646     192     265     
152      80      40      72      45      57    1873    1138    1165     632     201     126     
117    1066     242    1580     108    1051     791      91     230     937      49      50      
72      39      62    1273     719     270      70      53     431     150     337      49     
622    1263     613      85     640     288     983     145     739    1116     417 
5 L2 2327     576     212    2538     748    1493     760     982     324     174     468      48     
418     382     285      99    1346     212     197     151     399     145     678     238     
115     337     473     217      98     528     273     129     661     493     827     159     
959     585     715     617     276     111     278     305     176     326     184     509     
618    2996     933    2737    1309    2279     667    1166     954    1176    1453    
1130      73    1034     662     596     785      38      40    1447    2371     879    1156     
858     825    2009     898     157      47      42      44      60      67      36    2120     
 193
865    2366    2401     756    1473     176      47    2312     57      85      39     454    
1706      59     239     295     649      92     112     192      62    1788     904     314     
265     169    2565     379     470    1660      99     311     396     161     973     226     
366     136     460      85     124     140     492      39     212     244     404     120     
446     237     662     452     630     729     458    1201     131     791     876     395     
965     544     105     692      59    1743     295     658      81     421     917     486     
547     544     354     180     161     117      56     530      77      79     715    1413     
886     650    1454     745     724      82      88      48    1504    1050     834     331      
49      95      38      36      83     524     397    1792     649    1615     112    2328     
973    3645     130     611     204    1686    1033     148 
5 L3 274      91      56      72      44    1552    1421     584     866    1075    1685     956      
63     431      81    1675    1288    2372     472      57     269    2433     667      41     
767    3178      36      47    1007    2807      91    1098      69    2076    2027     395      
42      38      36     113     228    1601      76    2182      72      37      42      59     
648     551      90      50      60      54     162      58     121    1546      43      67      
55     151      44      80     824    2221      99    1757      83     144    2131      79    
2334      37     594      62      42      44     142     143    2494    1921    1877     367    
1920      51     502      38    1047     597     628    1059     992 
5 US151 706      36     349     546     793     151     262     212     332     318      83     162     
259     722     538      54     507      75     244      47     488      41     354     502    
1176     199     598     354     567      41      56     119     557     650     813      72     
436     490     731      41      46     110     115     250     263     232     704     340     
451     509     594      79      85     150     673     109     305      66     148     521     
448     404      59     261     266     348     390     560     200     482      64      41     
550      78     200     488      93     206      69     734      83     185 
5 US162 550     912     620     584      57     397     770     688     557     349     224     267     
128     905     385     456     266     140     166     320     503      40     381     178     
 194
263     502     321     133     341     161     288     380     494      83     272     165     
191     420     250      98     544     307     445     535 
5 US197 99     679     228     155     215     368      72     218     394     658     576     446     
111     235     411     575     439     203      60     539      43     685      63     221      
83     172     376     646     139     534     482     591     159     369     434     238     
647      86      95     154      76     107     524     315     480     415     432     141      
76     556     892     457      73      62      36     215     120      66      82     143      61      
62     492     392      92     175     735     107     537     137     483      60      58     
689     417     499      60     576     554     270     269     440     580     715     154     




ME-180 cells at 37°C 
 
Hrs Strain % mitochondrial acitivity Mean 
1 Spont* 95 103 102 114 104 82 107 94 99 100 
1 E 102 104 123 80 87 77 91 90 100 95 
1 L2 97 100 115 90 87 76 103 60 112 93 
1 L3 104 120 123 93 99 95 100 89 102 103 
1 Eto# 110 119 86 76 72 77 88 107 106 93 
3 Spont 87 115 98 107 97 96 79 102 119 100 
3 E 82 116 90 106 89 95 77 85 87 92 
3 L2 104 111 119 97 91 96 77 100 90 98 
3 L3 102 103 110 96 98 86 79 96 94 96 
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3 Eto 101 102 118 84 96 103 87 94 73 95 
9 Spont 101 99 99 86 103 112 126 87 87 100 
9 E 106 111 113 102 113 125 74 84 77 100 
9 L2 107 102 102 82 100 108 75 83 87 94 
9 L3 92 98 98 79 103 109 88 104 74 94 
9 Eto 94 98 109 136 81 84 82 77 97 95 
18 Spont 101 102 96 110 101 89 88 101 110 100 
18 E 106 102 105 103 99 109 101 98 99 102 
18 L2 112 115 110 100 118 86 96 87 90 101 
18 L3 109 104 97 115 102 106 70 87 92 98 
18 Eto 92 91 86 101 113 79 64 89 93 90 
24 Spont 109 91 100 92 98 110 100 94 106 100 
24 E 95 103 103 94 99 102 87 114 120 102 
24 L2 104 104 104 94 97 102 90 93 88 97 
24 L3 95 93 83 98 101 99 85 93 100 94 
24 Eto 75 77 70 77 72 75 69 60 64 71 
36 Spont 94 98 108 107 99 93 109 94 97 100 
36 E 99 110 110 128 96 88 90 83 84 99 
36 L2 96 102 107 104 81 80 91 80 85 92 
36 L3 96 103 101 115 103 102 73 76 77 94 
36 Eto 35 42 43 45 41 56 27 27 29 39 
48 Spont 104 106 89 109 96 94 90 98 112 100 
48 E 108 114 108 105 105 107 90 89 99 103 
48 L2 108 96 106 108 96 97 80 89 94 97 
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48 L3 93 95 91 108 88 94 85 84 99 93 
48 Eto 14 10 14 57 45 50 12 10 12 25 
* spontaneous mitochondrial activity without chlamydia 
# cells treated with etoposide 
 
HaCaT cells at 37°C 
 
Hrs Strain % mitochondrial acitivity Mean 
1 Spont* 85 114 101 92 112 97 89 114 97 100 
1 E 89 72 90 86 84 89 83 83 78 84 
1 L2 88 95 84 99 84 86 85 91 95 90 
1 L3 99 97 81 100 96 97 93 87 90 93 
1 Eto# 95 111 95 89 102 104 94 101 100 99 
3 Spont 98 95 106 99 103 98 96 106 98 100 
3 E 99 84 99 91 93 103 84 88 94 93 
3 L2 106 104 114 91 99 96 83 100 90 98 
3 L3 99 100 103 83 86 89 112 94 89 95 
3 Eto 105 106 107 94 86 112 91 96 88 98 
9 Spont 110 96 94 108 101 91 107 100 93 100 
9 E 103 98 107 71 108 112 90 109 99 100 
9 L2 97 99 94 99 122 115 105 103 96 103 
9 L3 102 102 99 89 104 91 103 93 96 98 
9 Eto 111 105 99 97 99 79 106 102 102 100 
18 Spont 103 100 97 99 92 109 97 104 100 100 
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18 E 101 101 103 80 101 99 91 89 95 95 
18 L2 92 91 96 88 103 114 93 90 86 95 
18 L3 102 106 97 112 103 103 89 92 92 99 
18 Eto 102 96 95 107 109 101 78 79 81 94 
24 Spont 103 97 100 100 96 104 106 102 92 100 
24 E 109 104 102 92 92 99 99 91 100 99 
24 L2 106 126 108 109 94 100 102 95 101 105 
24 L3 106 108 105 133 94 102 101 94 87 103 
24 Eto 99 94 103 86 94 95 71 70 77 88 
36 Spont 100 102 98 90 96 114 112 92 97 100 
36 E 90 94 88 96 93 111 98 84 92 94 
36 L2 84 91 96 86 104 111 103 84 92 94 
36 L3 92 89 94 85 84 110 102 83 94 92 
36 Eto 67 71 70 60 59 75 64 67 60 66 
48 Spont 104 97 99 104 98 99 105 96 99 100 
48 E 100 89 97 127 93 130 99 96 89 102 
48 L2 96 91 97 111 125 127 91 87 81 101 
48 L3 98 84 90 101 113 108 90 77 84 94 
48 Eto 61 57 62 19 21 23 47 44 44 42 
* spontaneous mitochondrial activity without chlamydia 
# cells treated with etoposide 
 
HaCaT cells at 33°C 
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Hrs Strain % mitochondrial acitivity Mean 
1 Spont* 93 100 107 108 96 96 94 103 103 100 
1 E 94 94 89 85 106 105 96 101 101 97 
1 L2 106 103 102 96 110 84 84 94 87 96 
1 L3 96 99 92 101 143 113 92 96 88 102 
1 Eto# 98 104 103 104 112 105 92 91 97 101 
3 Spont 98 104 98 106 98 96 109 110 81 100 
3 E 74 96 95 80 122 95 94 91 96 94 
3 L2 95 102 105 101 104 115 93 95 83 99 
3 L3 100 102 101 99 115 119 106 91 100 104 
3 Eto 91 94 100 95 107 91 107 131 89 101 
9 Spont 105 96 99 89 119 92 98 106 97 100 
9 E 92 99 119 105 88 100 74 81 87 94 
9 L2 104 104 101 107 105 101 86 84 75 97 
9 L3 106 100 97 127 88 105 65 93 75 95 
9 Eto 106 101 91 86 76 79 62 105 90 88 
18 Spont 104 99 97    118 85 97 100 
18 E 103 102 110    90 118 90 102 
18 L2 94 92 81    89 105 117 96 
18 L3 109 103 109    103 104 87 102 
18 Eto 96 99 90    82 102 78 91 
24 Spont 88 110 102 90 110 101 110  125 104 
24 E 80 95 88 95 115 118 111 106 115 103 
24 L2 82 86 104 94 113 110 106 122 121 104 
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24 L3 78 86 102 56 101 103 123 112 102 96 
24 Eto 79 97 102 90 90 96 95 78 110 93 
36 Spont 103 102 95 127 73 100 103 95 101 100 
36 E 81 96 86 102 91 91 95 92 97 92 
36 L2 89 95 95 107 95 90 103 92 101 96 
36 L3 89 85 71 96 91 91 100 93 103 91 
36 Eto 81 88 82 107 81 86 76 71 75 83 
48 Spont 108 100 92 98 95 107 101 98 101 100 
48 E 99 90 100 111 101 112 108 99 93 101 
48 L2 93 92 101 118 96 113 95 93 91 99 
48 L3 96 83 93 103 120 101 96 93 90 97 
48 Eto 79 90 79 61 75 79 69 71 69 75 
* spontaneous mitochondrial activity without chlamydia 
# cells treated with etoposide 
 
Lactate dehydrogenase assay - % cytotoxicity 
 
ME-180 cells at 37°C 
 
Day Strain % cytotoxicity Mean 
1 E -0.3 2.4 1.7 0.0 -0.1 -0.4 0.2 0.2 -0.2 0.4 
1 L1 0.5 1.1 0.8 0.4 0.3 1.6 -0.1 -0.2 0.1 0.5 
1 L2 2.1 0.5 0.5 -0.7 0.4 0.3 -0.8 -0.3 -0.7 0.1 
1 L3 2.1 1.0 1.3 0.0 -0.8 -0.2 0.6 -0.5 -0.4 0.3 
1 US151 1.6 1.0 1.2 0.8 0.2 0.3 -0.6 -0.3 -0.1 0.4 
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1 US162 0.8 0.8 0.9 0.0 -0.3 0.0 -0.5 0.2 0.4 0.2 
1 US197 1.5 0.1 1.5 0.8 -0.2 0.9 0.4 0.4 -0.1 0.6 
2 E 1.6 2.2 0.5 -1.5 -0.9 -0.9 -0.2 0.7 0.5 0.2 
2 L1 1.5 0.6 1.4 -0.3 -0.4 -0.2 1.3 1.5 0.5 0.7 
2 L2 0.4 2.2 1.1 -2.7 -1.3 -0.2 1.7 0.2 0.2 0.2 
2 L3 1.3 1.6 0.8 -1.1 -1.0 0.0 1.7 0.7 0.7 0.5 
2 US151 1.3 1.0 0.6 -0.1 -0.3 -0.5 1.6 1.1 1.1 0.6 
2 US162 1.6 0.7 0.0 -0.4 0.8 1.1 0.5 0.7 2.2 0.8 
2 US197 1.3 1.1 1.3 -0.6 0.3 0.6 0.5 0.5 0.2 0.6 
3 E 2.2 1.1 0.1 0.0 0.5 0.6 2.7 -1.7 0.4 0.7 
3 L1 2.6 1.5 4.1 2.3 0.6 4.3 4.5 1.6 3.6 2.8 
3 L2 -0.4 1.2 0.4 0.1 -0.5 -1.5 2.1 1.4 3.2 0.6 
3 L3 2.3 2.4 1.6 1.1 1.3 0.3 4.0 2.5 2.2 2.0 
3 US151 3.1 2.4 1.4 3.1 1.6 1.8 3.4 3.2 4.0 2.6 
3 US162 3.4 2.2 3.2 1.5 1.4 1.2 3.3 2.8 3.5 2.5 
3 US197 3.2 2.8 1.8 0.6 1.9 1.0 3.8 2.7 2.2 2.2 
4 E -5.3 -4.6 -7.1 2.5 2.0 3.0 1.8 1.3 1.5 -0.6 
4 L1 1.1 1.2 -0.9 4.3 3.3 4.0 -0.3 -0.1 0.5 1.5 
4 L2 0.0 -0.6 -2.3 3.7 5.2 3.3 10.7 8.0 7.4 3.9 
4 L3 1.6 -1.0 -1.2 3.6 3.8 3.2 2.4 0.8 -0.9 1.4 
4 US151 3.3 1.9 1.5 3.9 2.7 1.4 0.0 0.1 0.0 1.6 
4 US162 -0.1 -0.2 -0.8 2.6 1.6 2.9 -0.3 -0.7 -0.5 0.5 
4 US197 -2.6 -0.7 -1.1 3.4 2.0 2.1 0.2 1.2 -0.2 0.5 
5 E -4.6 -6.1 -7.2 0.8 -0.7 0.2 -7.9 -5.8 -5.6 -4.1 
 201
5 L1 -2.7 -6.8 -7.6 -2.0 -1.1 -1.9 -1.8 -5.4 -4.6 -3.8 
5 L2 11.9 -0.9 -4.0 10.7 14.2 6.2 41.0 34.3 22.9 15.1 
5 L3 -2.9 -4.6 -8.6 -1.6 -1.6 -2.0 -2.8 -7.9 -7.5 -4.4 
5 US151 -6.9 -7.2 -9.4 -3.1 -2.2 -2.7 -10.8 -11.6 -11.3 -7.2 
5 US162 -7.9 -9.2 -10.2 -4.2 -5.9 -6.6 -11.3 -11.1 -11.5 -8.6 
5 US197 -8.3 -10.5 -11.1 -5.1 -3.3 -4.6 -11.4 -11.4 -11.4 -8.6 
 
HaCaT cells at 37°C 
 
Day Strain Values Mean 
1 E -0.7 -0.3 -0.4 0.4 0.6 0.0 3.5 2.9 0.8 0.7 
1 L1 -1.0 -0.8 -0.7 0.1 0.0 0.1 3.5 4.1 4.2 1.1 
1 L2 -1.2 -1.1 -0.6 -0.2 -0.1 0.2 1.3 4.1 6.2 1.0 
1 L3 -0.9 -0.9 0.0 0.8 0.6 0.1 4.5 3.5 3.3 1.2 
1 US151 -0.6 -0.8 -0.9 0.7 0.7 0.7 4.3 3.5 2.8 1.1 
1 US162 -1.3 -1.6 -0.5 0.7 0.6 0.8 5.2 5.7 4.7 1.6 
1 US197 -0.9 -0.2 0.0 0.4 0.8 0.6 2.0 2.6 2.3 0.9 
2 E 0.0 0.4 0.4 0.3 -0.5 -0.2 -0.7 -0.3 -0.8 -0.1 
2 L1 0.4 -0.2 0.5 0.0 -0.6 -0.9 -0.2 -0.2 -1.0 -0.2 
2 L2 0.4 -0.6 0.3 -1.0 -1.5 -0.9 -0.8 -0.3 -0.2 -0.5 
2 L3 -0.4 -0.2 -0.6 0.2 -0.2 -0.6 -0.5 -0.8 -0.8 -0.4 
2 US151 0.0 -0.7 -0.1 1.0 0.0 -0.3 -0.7 -0.5 -0.1 -0.1 
2 US162 0.5 -0.2 -0.1 0.8 0.0 0.3 . 0.3 0.0 0.2 
2 US197 0.1 0.4 0.1 1.6 0.4 1.0 -0.4 -0.3 -0.1 0.3 
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3 E -0.5 -0.4 0.6 0.1 0.0 0.0 -2.7 -2.6 -2.3 -0.9 
3 L1 2.5 1.5 2.3 -0.6 0.2 0.2 -2.2 0.3 -0.8 0.4 
3 L2 0.0 0.4 -0.2 -0.7 -0.1 -0.9 -0.7 -1.7 -0.7 -0.5 
3 L3 1.3 0.8 1.4 0.7 -0.6 -0.2 -1.4 -1.1 -1.3 0.0 
3 US151 2.7 2.9 3.1 -0.5 -0.4 -0.1 0.6 -2.0 -1.7 0.5 
3 US162 3.3 3.4 2.9 -1.0 -0.4 0.2 -0.8 -0.1 -1.3 0.7 
3 US197 2.0 0.9 1.3 0.1 0.2 -0.4 -1.3 -0.1 -1.3 0.2 
4 E 0.6 -1.7 3.0 -1.0 -1.9 -1.2 -2.9 -1.4 -2.1 -1.0 
4 L1 3.0 3.9 3.6 -2.5 -0.2 -0.9 1.9 -0.4 -0.7 0.9 
4 L2 -0.8 -2.1 -1.4 -0.6 -0.4 -0.5 1.2 0.3 -0.3 -0.5 
4 L3 3.3 3.9 3.7 -1.5 -3.0 -0.7 -0.8 -1.9 -2.1 0.1 
4 US151 4.1 5.2 3.3 3.7 1.8 2.1 -1.3 -2.3 -2.5 1.6 
4 US162 4.9 6.9 6.9 0.1 0.7 4.7 0.2 0.1 0.9 2.8 
4 US197 4.6 4.9 5.3 1.2 -0.1 0.5 -1.4 0.2 0.4 1.7 
5 E 4.8 6.4 1.7 -0.5 -1.2 -3.5 -0.1 6.2 -0.4 1.5 
5 L1 0.8 -0.1 0.5 -0.1 -0.6 2.2 0.5 0.6 0.8 0.5 
5 L2 4.4 2.3 3.2 -0.3 2.5 3.0 7.1 5.9 4.9 3.6 
5 L3 -0.6 -1.3 0.8 -1.7 -1.3 2.3 1.9 2.3 3.7 0.7 
5 US151 5.9 3.3 2.7 3.5 0.8 2.0 0.0 0.6 -0.7 2.0 
5 US162 6.1 6.7 6.3 4.1 3.0 2.7 0.3 0.7 1.5 3.5 
5 US197 2.0 2.3 -1.7 -6.2 0.0 -0.3 0.4 -1.4 -1.0 -0.6 
 
HaCaT cells at 33°C 
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Day Strain Values Mean 
1 E 0.0 0.1 0.0 0.2 0.7 0.4 -2.4 -2.2 -2.3 -0.6 
1 L1 0.2 -0.1 -0.5 0.5 0.9 0.3 -2.0 -1.9 -2.3 -0.6 
1 L2 -0.1 -0.3 -0.1 1.0 0.5 0.3 -2.4 -2.0 -2.3 -0.6 
1 L3 0.0 0.0 0.0 -0.2 0.5 0.3 -1.9 -2.0 -2.2 -0.6 
1 US151 0.2 0.8 0.1 0.4 0.7 0.4 -2.2 -1.5 -2.2 -0.4 
1 US162 -1.5 0.2 -0.8 0.6 0.5 0.7 -1.8 -2.1 -2.2 -0.7 
1 US197 0.6 1.0 0.1 -0.1 0.1 0.5 -2.3 -0.6 -2.2 -0.3 
2 E -0.6 -0.8 -0.7 -0.7 -0.1 -0.6 -0.3 -0.8 -0.1 -0.5 
2 L1 -1.1 -0.7 -0.1 -0.6 -1.3 -0.4 1.3 1.3 0.5 -0.1 
2 L2 -1.2 0.6 -0.7 -0.4 -0.1 -0.7 0.6 -0.1 0.7 -0.1 
2 L3 -1.8 -0.3 -0.9 0.9 -0.1 -0.3 -0.2 -0.1 1.4 -0.2 
2 US151 0.6 0.5 0.3 -0.3 0.2 -0.4 1.2 0.7 0.8 0.4 
2 US162 -0.6 0.4 -0.3 -0.1 -1.0 -0.9 1.0 0.3 0.7 -0.1 
2 US197 0.8 0.1 0.1 0.1 0.3 0.5 0.7 0.4 1.5 0.5 
3 E -1.3 1.0 -0.2 0.5 -0.4 0.0 -2.2 -2.0 -1.7 -0.7 
3 L1 -0.6 -1.2 -0.4 0.0 0.3 -0.2 -2.2 -2.3 -1.4 -0.9 
3 L2 -0.5 0.8 -0.8 0.3 0.6 0.7 -1.4 -2.4 -1.8 -0.5 
3 L3 -0.4 -1.5 -1.7 0.3 0.3 0.7 -3.1 -2.8 -1.5 -1.1 
3 US151 0.9 1.3 2.0 -0.8 0.9 -0.4 -1.5 -1.2 -1.8 -0.1 
3 US162 -0.2 1.0 -0.2 0.0 -0.1 0.6 -0.4 -0.7 -1.0 -0.1 
3 US197 0.8 1.0 0.8 0.7 0.1 -0.5 -1.3 -1.3 -1.5 -0.1 
4 E 0.3 -0.4 -1.7 -1.7 -0.3 -0.7 3.4 1.4 0.9 0.1 
4 L1 1.1 1.0 1.0 0.4 -0.1 -2.8 0.8 0.7 1.2 0.4 
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4 L2 0.6 0.9 0.8 -0.1 -1.5 -0.9 -0.5 -1.1 0.9 -0.1 
4 L3 0.5 0.4 0.7 -0.8 -1.2 -1.2 1.0 0.8 -1.6 -0.2 
4 US151 0.5 0.8 0.6 1.4 -0.4 -0.5 4.2 2.9 1.7 1.2 
4 US162 0.6 -0.4 -0.5 1.0 0.4 1.4 0.3 1.3 2.4 0.7 
4 US197 -1.6 -1.4 -1.6 1.3 0.9 0.2 1.0 1.0 2.5 0.3 
5 E -1.0 -2.1 0.2 1.9 3.5 0.6 16.8 12.7 8.7 4.6 
5 L1 -1.5 0.6 -1.2 1.1 -0.6 0.4 17.2 11.1 20.4 5.3 
5 L2 -1.3 1.8 1.7 2.6 1.9 -0.5 19.9 7.4 10.2 4.8 
5 L3 0.1 -2.0 2.2 4.0 2.5 0.8 21.1 14.9 13.1 6.3 
5 US151 1.9 -0.7 1.5 4.0 2.3 -0.9 21.2 6.0 11.1 5.2 
5 US162 -1.0 -0.3 1.8 5.2 2.6 2.4 19.0 11.5 8.0 5.5 
5 US197 -0.8 0.5 -1.5 3.7 4.2 3.0 9.1 10.3 15.0 4.8 
 
